Q2 2024 --12-31 false 0001173489 false false false false 0 0 1 2 1 3 4 0 0 1 1 1 0.5 0 0 0 0 00011734892024-01-012024-06-30 thunderdome:item 00011734892024-04-012024-06-30 xbrli:shares 00011734892024-06-30 00011734892023-01-012023-06-30 00011734892023-04-012023-06-30 iso4217:USD iso4217:USDxbrli:shares 0001173489us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-30 0001173489us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-30 0001173489us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-30 0001173489us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-30 0001173489us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberceva:UnrealizedGainsLossesOnAvailableForSaleMarketableSecuritiesMember2023-04-012023-06-30 0001173489us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberceva:UnrealizedGainsLossesOnAvailableForSaleMarketableSecuritiesMember2024-04-012024-06-30 0001173489us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberceva:UnrealizedGainsLossesOnAvailableForSaleMarketableSecuritiesMember2023-01-012023-06-30 0001173489us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberceva:UnrealizedGainsLossesOnAvailableForSaleMarketableSecuritiesMember2024-01-012024-06-30 0001173489us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberceva:UnrealizedGainsLossesOnCashFlowHedgesMember2023-04-012023-06-30 0001173489us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberceva:UnrealizedGainsLossesOnCashFlowHedgesMember2024-04-012024-06-30 0001173489us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberceva:UnrealizedGainsLossesOnCashFlowHedgesMember2023-01-012023-06-30 0001173489us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberceva:UnrealizedGainsLossesOnCashFlowHedgesMember2024-01-012024-06-30 0001173489us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-30 0001173489us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-06-30 0001173489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-06-30 0001173489us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-30 0001173489us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-04-012023-06-30 0001173489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-04-012023-06-30 0001173489us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-30 0001173489us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-01-012023-06-30 0001173489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-06-30 0001173489us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-31 0001173489us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-03-31 0001173489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-03-31 0001173489us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-31 0001173489us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-12-31 0001173489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-31 0001173489us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-30 0001173489us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2024-06-30 0001173489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-06-30 0001173489us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-30 0001173489us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2024-04-012024-06-30 0001173489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-04-012024-06-30 0001173489us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-30 0001173489us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2024-01-012024-06-30 0001173489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-06-30 0001173489us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-31 0001173489us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2024-03-31 0001173489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-03-31 0001173489us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-31 0001173489us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-12-31 0001173489us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-31 0001173489ceva:DerivativesDesignatedAsCashFlowHedgingInstrumentsMember2023-04-012023-06-30 0001173489ceva:DerivativesDesignatedAsCashFlowHedgingInstrumentsMember2024-04-012024-06-30 0001173489ceva:DerivativesDesignatedAsCashFlowHedgingInstrumentsMember2023-01-012023-06-30 0001173489ceva:DerivativesDesignatedAsCashFlowHedgingInstrumentsMember2024-01-012024-06-30 0001173489ceva:ForeignExchangeForwardContractsMemberceva:DerivativesDesignatedAsCashFlowHedgingInstrumentsMember2023-04-012023-06-30 0001173489ceva:ForeignExchangeForwardContractsMemberceva:DerivativesDesignatedAsCashFlowHedgingInstrumentsMember2024-04-012024-06-30 0001173489ceva:ForeignExchangeForwardContractsMemberceva:DerivativesDesignatedAsCashFlowHedgingInstrumentsMember2023-01-012023-06-30 0001173489ceva:ForeignExchangeForwardContractsMemberceva:DerivativesDesignatedAsCashFlowHedgingInstrumentsMember2024-01-012024-06-30 0001173489ceva:ForeignExchangeOptionContractsMemberceva:DerivativesDesignatedAsCashFlowHedgingInstrumentsMember2023-04-012023-06-30 0001173489ceva:ForeignExchangeOptionContractsMemberceva:DerivativesDesignatedAsCashFlowHedgingInstrumentsMember2024-04-012024-06-30 0001173489ceva:ForeignExchangeOptionContractsMemberceva:DerivativesDesignatedAsCashFlowHedgingInstrumentsMember2023-01-012023-06-30 0001173489ceva:ForeignExchangeOptionContractsMemberceva:DerivativesDesignatedAsCashFlowHedgingInstrumentsMember2024-01-012024-06-30 0001173489us-gaap:CashFlowHedgingMember2023-04-012023-06-30 0001173489us-gaap:CashFlowHedgingMember2024-04-012024-06-30 0001173489us-gaap:CashFlowHedgingMember2023-01-012023-06-30 0001173489us-gaap:CashFlowHedgingMember2024-01-012024-06-30 0001173489us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2023-04-012023-06-30 0001173489us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2024-04-012024-06-30 0001173489us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2023-01-012023-06-30 0001173489us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2024-01-012024-06-30 0001173489us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMember2023-04-012023-06-30 0001173489us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMember2024-04-012024-06-30 0001173489us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMember2023-01-012023-06-30 0001173489us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMember2024-01-012024-06-30 0001173489us-gaap:CashFlowHedgingMember2023-12-31 0001173489us-gaap:CashFlowHedgingMember2024-06-30 0001173489us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMember2023-12-31 0001173489us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMember2024-06-30 0001173489us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2023-12-31 0001173489us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2024-06-30 00011734892023-12-31 utr:M 0001173489ceva:PurchaseRightsMemberceva:The2002EmployeeStockPurchasePlanMember2023-01-012023-06-30 0001173489ceva:PurchaseRightsMemberceva:The2002EmployeeStockPurchasePlanMember2024-01-012024-06-30 xbrli:pure 0001173489ceva:EquitybasedCompensationExpenseIncludedInDiscontinuedOperationsMember2023-04-012023-06-30 0001173489ceva:EquitybasedCompensationExpenseIncludedInDiscontinuedOperationsMember2024-04-012024-06-30 0001173489ceva:EquitybasedCompensationExpenseIncludedInDiscontinuedOperationsMember2023-01-012023-06-30 0001173489ceva:EquitybasedCompensationExpenseIncludedInDiscontinuedOperationsMember2024-01-012024-06-30 0001173489ceva:TotalEquitybasedCompensationExpenseFromContinuingOperationsMember2023-04-012023-06-30 0001173489ceva:TotalEquitybasedCompensationExpenseFromContinuingOperationsMember2024-04-012024-06-30 0001173489ceva:TotalEquitybasedCompensationExpenseFromContinuingOperationsMember2023-01-012023-06-30 0001173489ceva:TotalEquitybasedCompensationExpenseFromContinuingOperationsMember2024-01-012024-06-30 0001173489ceva:GeneralAndAdministrativeMember2023-04-012023-06-30 0001173489ceva:GeneralAndAdministrativeMember2024-04-012024-06-30 0001173489ceva:GeneralAndAdministrativeMember2023-01-012023-06-30 0001173489ceva:GeneralAndAdministrativeMember2024-01-012024-06-30 0001173489ceva:SalesAndMarketingMember2023-04-012023-06-30 0001173489ceva:SalesAndMarketingMember2024-04-012024-06-30 0001173489ceva:SalesAndMarketingMember2023-01-012023-06-30 0001173489ceva:SalesAndMarketingMember2024-01-012024-06-30 0001173489ceva:ResearchAndDevelopmentNetMember2023-04-012023-06-30 0001173489ceva:ResearchAndDevelopmentNetMember2024-04-012024-06-30 0001173489ceva:ResearchAndDevelopmentNetMember2023-01-012023-06-30 0001173489ceva:ResearchAndDevelopmentNetMember2024-01-012024-06-30 0001173489ceva:CostOfRevenuesMember2023-04-012023-06-30 0001173489ceva:CostOfRevenuesMember2024-04-012024-06-30 0001173489ceva:CostOfRevenuesMember2023-01-012023-06-30 0001173489ceva:CostOfRevenuesMember2024-01-012024-06-30 utr:Y 0001173489ceva:RSUsAndPSUsMember2024-01-012024-06-30 0001173489ceva:RSUsAndPSUsMember2024-06-30 0001173489ceva:RSUsAndPSUsMember2023-12-31 0001173489ceva:ShorttermExecutivePSUsMemberceva:VestingOnFebruary162027Member2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:VestingOnFebruary162026Member2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:VestingOnFebruary162025Member2024-02-122024-02-12 0001173489ceva:ChiefCommercialOfficerMember2024-02-122024-02-12 0001173489srt:ChiefOperatingOfficerMember2024-02-122024-02-12 0001173489srt:ChiefFinancialOfficerMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:CFOCOOAndCCOMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMembersrt:ChiefExecutiveOfficerMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:IncreaseInEligiblePSUsMembersrt:ChiefExecutiveOfficerMemberceva:GoalsThreeMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:IncreaseInEligiblePSUsMemberceva:GoalsThreeMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMembersrt:MaximumMemberceva:VestingBasedOnActualReturnInExcessof100PercentOfRussel2000IndexMemberceva:GoalsThreeMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMembersrt:MinimumMemberceva:VestingBasedOnActualReturnInExcessof100PercentOfRussel2000IndexMemberceva:GoalsThreeMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:VestingBasedOnActualReturnInExcessof100PercentOfRussel2000IndexMemberceva:GoalsThreeMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMembersrt:MaximumMemberceva:VestingBasedOnActualReturnBeingAtLeast90PercentOfRussel2000IndexMemberceva:GoalsThreeMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMembersrt:MinimumMemberceva:VestingBasedOnActualReturnBeingAtLeast90PercentOfRussel2000IndexMemberceva:GoalsThreeMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:VestingBasedOnActualReturnBeingAtLeast90PercentOfRussel2000IndexMemberceva:GoalsThreeMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:FullVestingBasedOnTheAchievementPositiveShareholderReturnMemberceva:GoalsThreeMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:GoalsThreeMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:IncreaseInEligiblePSUsMembersrt:ChiefExecutiveOfficerMemberceva:GoalsTwoMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:IncreaseInEligiblePSUsMemberceva:GoalsTwoMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMembersrt:MaximumMemberceva:VestingBasedOnActualReturnInExcessOf100PercentOfSP500IndexMemberceva:GoalsTwoMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMembersrt:MinimumMemberceva:VestingBasedOnActualReturnInExcessOf100PercentOfSP500IndexMemberceva:GoalsTwoMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:VestingBasedOnActualReturnInExcessOf100PercentOfSP500IndexMemberceva:GoalsTwoMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMembersrt:MaximumMemberceva:VestingBasedOnActualReturnBeingAtLeast90PercentOfSp500IndexMemberceva:GoalsTwoMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMembersrt:MinimumMemberceva:VestingBasedOnActualReturnBeingAtLeast90PercentOfSp500IndexMemberceva:GoalsTwoMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:VestingBasedOnActualReturnBeingAtLeast90PercentOfSp500IndexMemberceva:GoalsTwoMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:GoalsTwoMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:IncreaseInEligiblePSUsMembersrt:ChiefExecutiveOfficerMemberceva:GoalsOneMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:IncreaseInEligiblePSUsMemberceva:GoalsOneMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMembersrt:MaximumMemberceva:VestingBasedOnAchievementInExcessOf90PercentMemberceva:GoalsOneMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMembersrt:MinimumMemberceva:VestingBasedOnAchievementInExcessOf90PercentMemberceva:GoalsOneMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:GoalsOneMember2024-02-122024-02-12 0001173489ceva:ShorttermExecutivePSUsMemberceva:FullVestingBasedonTheAchievementof2022LicenseTargetMemberceva:GoalsOneMember2024-02-122024-02-12 0001173489us-gaap:RestrictedStockUnitsRSUMemberceva:The2011StockIncentivePlanMemberceva:NonEmployeeDirectorMemberceva:VestingAfterTheFirstAnniversaryGrantDateMember2024-02-122024-02-12 0001173489ceva:PerformanceShareUnitsMemberceva:The2011StockIncentivePlanMemberceva:ChiefCommercialOfficerMember2024-02-122024-02-12 0001173489ceva:PerformanceShareUnitsMemberceva:The2011StockIncentivePlanMembersrt:ChiefOperatingOfficerMember2024-02-122024-02-12 0001173489ceva:PerformanceShareUnitsMemberceva:The2011StockIncentivePlanMembersrt:ChiefFinancialOfficerMember2024-02-122024-02-12 0001173489ceva:PerformanceShareUnitsMemberceva:The2011StockIncentivePlanMembersrt:ChiefExecutiveOfficerMember2024-02-122024-02-12 0001173489us-gaap:RestrictedStockUnitsRSUMemberceva:VestingOnFebruary172026Member2024-02-122024-02-12 0001173489us-gaap:RestrictedStockUnitsRSUMemberceva:VestingOnFebruary172025Member2024-02-122024-02-12 0001173489us-gaap:RestrictedStockUnitsRSUMemberceva:VestingOnFebruary172024Member2024-02-122024-02-12 0001173489us-gaap:RestrictedStockUnitsRSUMemberceva:The2011StockIncentivePlanMemberceva:ChiefCommercialOfficerMember2024-02-122024-02-12 0001173489us-gaap:RestrictedStockUnitsRSUMemberceva:The2011StockIncentivePlanMembersrt:ChiefOperatingOfficerMember2024-02-122024-02-12 0001173489us-gaap:RestrictedStockUnitsRSUMemberceva:The2011StockIncentivePlanMembersrt:ChiefFinancialOfficerMember2024-02-122024-02-12 0001173489us-gaap:RestrictedStockUnitsRSUMemberceva:The2011StockIncentivePlanMembersrt:ChiefExecutiveOfficerMember2024-02-122024-02-12 0001173489us-gaap:RestrictedStockUnitsRSUMemberceva:NonEmployeeDirectorMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2024-06-302024-06-30 0001173489us-gaap:RestrictedStockUnitsRSUMemberceva:NonEmployeeDirectorMember2024-06-302024-06-30 0001173489us-gaap:RestrictedStockUnitsRSUMemberceva:EmployeesMember2024-03-302024-06-30 0001173489us-gaap:EmployeeStockOptionMember2024-01-012024-06-30 0001173489us-gaap:EmployeeStockOptionMember2024-06-30 00011734892023-01-012023-12-31 0001173489ceva:The2011StockIncentivePlanMembersrt:MaximumMember2024-01-012024-06-30 0001173489ceva:The2011StockIncentivePlanMember2024-01-012024-06-30 0001173489ceva:The2011StockIncentivePlanMember2024-06-30 0001173489us-gaap:ShareBasedPaymentArrangementEmployeeMember2023-12-31 0001173489us-gaap:ShareBasedPaymentArrangementEmployeeMember2024-06-30 0001173489us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberceva:CustomerEMember2023-04-012023-06-30 0001173489us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberceva:CustomerDMember2023-04-012023-06-30 0001173489us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberceva:CustomerCMember2024-04-012024-06-30 0001173489us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberceva:CustomerCMember2024-01-012024-06-30 0001173489us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberceva:CustomerBMember2024-04-012024-06-30 0001173489us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberceva:CustomerBMember2024-01-012024-06-30 0001173489us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberceva:CustomerAMember2023-04-012023-06-30 0001173489us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberceva:CustomerAMember2024-04-012024-06-30 0001173489us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberceva:CustomerAMember2024-01-012024-06-30 0001173489country:FI2024-04-012024-06-30 0001173489country:FI2024-01-012024-06-30 0001173489country:CN2023-04-012023-06-30 0001173489country:CN2024-04-012024-06-30 0001173489country:CN2023-01-012023-06-30 0001173489country:CN2024-01-012024-06-30 0001173489ceva:OtherMember2023-04-012023-06-30 0001173489ceva:OtherMember2024-04-012024-06-30 0001173489ceva:OtherMember2023-01-012023-06-30 0001173489ceva:OtherMember2024-01-012024-06-30 0001173489srt:AsiaPacificMember2023-04-012023-06-30 0001173489srt:AsiaPacificMember2024-04-012024-06-30 0001173489srt:AsiaPacificMember2023-01-012023-06-30 0001173489srt:AsiaPacificMember2024-01-012024-06-30 0001173489ceva:EuropeAndMiddleEastMember2023-04-012023-06-30 0001173489ceva:EuropeAndMiddleEastMember2024-04-012024-06-30 0001173489ceva:EuropeAndMiddleEastMember2023-01-012023-06-30 0001173489ceva:EuropeAndMiddleEastMember2024-01-012024-06-30 0001173489country:US2023-04-012023-06-30 0001173489country:US2024-04-012024-06-30 0001173489country:US2023-01-012023-06-30 0001173489country:US2024-01-012024-06-30 0001173489us-gaap:FairValueInputsLevel3Member2023-12-31 0001173489us-gaap:FairValueInputsLevel2Member2023-12-31 0001173489us-gaap:FairValueInputsLevel1Member2023-12-31 0001173489ceva:CorporateBondsMemberus-gaap:FairValueInputsLevel3Member2023-12-31 0001173489ceva:CorporateBondsMemberus-gaap:FairValueInputsLevel2Member2023-12-31 0001173489ceva:CorporateBondsMemberus-gaap:FairValueInputsLevel1Member2023-12-31 0001173489ceva:CorporateBondsMember2023-12-31 0001173489us-gaap:FairValueInputsLevel3Member2024-06-30 0001173489us-gaap:FairValueInputsLevel2Member2024-06-30 0001173489us-gaap:FairValueInputsLevel1Member2024-06-30 0001173489ceva:CorporateBondsMemberus-gaap:FairValueInputsLevel3Member2024-06-30 0001173489ceva:CorporateBondsMemberus-gaap:FairValueInputsLevel2Member2024-06-30 0001173489ceva:CorporateBondsMemberus-gaap:FairValueInputsLevel1Member2024-06-30 0001173489ceva:CorporateBondsMember2024-06-30 0001173489ceva:CorporateBondsMember2023-12-31 0001173489ceva:CorporateBondsMember2024-06-30 0001173489ceva:DeferredRevenueMember2023-12-31 0001173489ceva:DeferredRevenueMember2024-06-30 0001173489us-gaap:OtherNoncurrentAssetsMemberceva:LicensingAndOtherMember2023-12-31 0001173489us-gaap:OtherNoncurrentAssetsMemberceva:LicensingAndOtherMember2024-06-30 0001173489ceva:AccruedRevenuesMemberus-gaap:RoyaltyMember2023-12-31 0001173489ceva:AccruedRevenuesMemberus-gaap:RoyaltyMember2024-06-30 0001173489ceva:AccruedRevenuesMemberceva:LicensingAndOtherMember2023-12-31 0001173489ceva:AccruedRevenuesMemberceva:LicensingAndOtherMember2024-06-30 0001173489ceva:TradeReceivablesMember2023-12-31 0001173489ceva:TradeReceivablesMember2024-06-30 0001173489us-gaap:RoyaltyMember2023-04-012023-06-30 0001173489us-gaap:LicenseMember2023-04-012023-06-30 0001173489us-gaap:RoyaltyMember2023-01-012023-06-30 0001173489us-gaap:LicenseMember2023-01-012023-06-30 0001173489us-gaap:TransferredOverTimeMember2023-04-012023-06-30 0001173489us-gaap:RoyaltyMemberus-gaap:TransferredOverTimeMember2023-04-012023-06-30 0001173489us-gaap:LicenseMemberus-gaap:TransferredOverTimeMember2023-04-012023-06-30 0001173489us-gaap:TransferredOverTimeMember2023-01-012023-06-30 0001173489us-gaap:RoyaltyMemberus-gaap:TransferredOverTimeMember2023-01-012023-06-30 0001173489us-gaap:LicenseMemberus-gaap:TransferredOverTimeMember2023-01-012023-06-30 0001173489us-gaap:TransferredAtPointInTimeMember2023-04-012023-06-30 0001173489us-gaap:RoyaltyMemberus-gaap:TransferredAtPointInTimeMember2023-04-012023-06-30 0001173489us-gaap:LicenseMemberus-gaap:TransferredAtPointInTimeMember2023-04-012023-06-30 0001173489us-gaap:TransferredAtPointInTimeMember2023-01-012023-06-30 0001173489us-gaap:RoyaltyMemberus-gaap:TransferredAtPointInTimeMember2023-01-012023-06-30 0001173489us-gaap:LicenseMemberus-gaap:TransferredAtPointInTimeMember2023-01-012023-06-30 0001173489ceva:SmartSensingProductsMember2023-04-012023-06-30 0001173489us-gaap:RoyaltyMemberceva:SmartSensingProductsMember2023-04-012023-06-30 0001173489us-gaap:LicenseMemberceva:SmartSensingProductsMember2023-04-012023-06-30 0001173489ceva:SmartSensingProductsMember2023-01-012023-06-30 0001173489us-gaap:RoyaltyMemberceva:SmartSensingProductsMember2023-01-012023-06-30 0001173489us-gaap:LicenseMemberceva:SmartSensingProductsMember2023-01-012023-06-30 0001173489ceva:ConnectivityProductsMember2023-04-012023-06-30 0001173489us-gaap:RoyaltyMemberceva:ConnectivityProductsMember2023-04-012023-06-30 0001173489us-gaap:LicenseMemberceva:ConnectivityProductsMember2023-04-012023-06-30 0001173489ceva:ConnectivityProductsMember2023-01-012023-06-30 0001173489us-gaap:RoyaltyMemberceva:ConnectivityProductsMember2023-01-012023-06-30 0001173489us-gaap:LicenseMemberceva:ConnectivityProductsMember2023-01-012023-06-30 0001173489us-gaap:RoyaltyMemberceva:OtherMember2023-04-012023-06-30 0001173489us-gaap:LicenseMemberceva:OtherMember2023-04-012023-06-30 0001173489us-gaap:RoyaltyMemberceva:OtherMember2023-01-012023-06-30 0001173489us-gaap:LicenseMemberceva:OtherMember2023-01-012023-06-30 0001173489us-gaap:RoyaltyMembersrt:AsiaPacificMember2023-04-012023-06-30 0001173489us-gaap:LicenseMembersrt:AsiaPacificMember2023-04-012023-06-30 0001173489us-gaap:RoyaltyMembersrt:AsiaPacificMember2023-01-012023-06-30 0001173489us-gaap:LicenseMembersrt:AsiaPacificMember2023-01-012023-06-30 0001173489us-gaap:RoyaltyMemberceva:EuropeAndMiddleEastMember2023-04-012023-06-30 0001173489us-gaap:LicenseMemberceva:EuropeAndMiddleEastMember2023-04-012023-06-30 0001173489us-gaap:RoyaltyMemberceva:EuropeAndMiddleEastMember2023-01-012023-06-30 0001173489us-gaap:LicenseMemberceva:EuropeAndMiddleEastMember2023-01-012023-06-30 0001173489us-gaap:RoyaltyMembercountry:US2023-04-012023-06-30 0001173489us-gaap:LicenseMembercountry:US2023-04-012023-06-30 0001173489us-gaap:RoyaltyMembercountry:US2023-01-012023-06-30 0001173489us-gaap:LicenseMembercountry:US2023-01-012023-06-30 0001173489us-gaap:RoyaltyMember2024-04-012024-06-30 0001173489us-gaap:LicenseMember2024-04-012024-06-30 0001173489us-gaap:RoyaltyMember2024-01-012024-06-30 0001173489us-gaap:LicenseMember2024-01-012024-06-30 0001173489us-gaap:TransferredOverTimeMember2024-04-012024-06-30 0001173489us-gaap:LicenseMemberus-gaap:TransferredOverTimeMember2024-04-012024-06-30 0001173489us-gaap:TransferredOverTimeMember2024-01-012024-06-30 0001173489us-gaap:LicenseMemberus-gaap:TransferredOverTimeMember2024-01-012024-06-30 0001173489us-gaap:TransferredAtPointInTimeMember2024-04-012024-06-30 0001173489us-gaap:RoyaltyMemberus-gaap:TransferredAtPointInTimeMember2024-04-012024-06-30 0001173489us-gaap:LicenseMemberus-gaap:TransferredAtPointInTimeMember2024-04-012024-06-30 0001173489us-gaap:TransferredAtPointInTimeMember2024-01-012024-06-30 0001173489us-gaap:RoyaltyMemberus-gaap:TransferredAtPointInTimeMember2024-01-012024-06-30 0001173489us-gaap:LicenseMemberus-gaap:TransferredAtPointInTimeMember2024-01-012024-06-30 0001173489ceva:SmartSensingProductsMember2024-04-012024-06-30 0001173489us-gaap:RoyaltyMemberceva:SmartSensingProductsMember2024-04-012024-06-30 0001173489us-gaap:LicenseMemberceva:SmartSensingProductsMember2024-04-012024-06-30 0001173489ceva:SmartSensingProductsMember2024-01-012024-06-30 0001173489us-gaap:RoyaltyMemberceva:SmartSensingProductsMember2024-01-012024-06-30 0001173489us-gaap:LicenseMemberceva:SmartSensingProductsMember2024-01-012024-06-30 0001173489ceva:ConnectivityProductsMember2024-04-012024-06-30 0001173489us-gaap:RoyaltyMemberceva:ConnectivityProductsMember2024-04-012024-06-30 0001173489us-gaap:LicenseMemberceva:ConnectivityProductsMember2024-04-012024-06-30 0001173489ceva:ConnectivityProductsMember2024-01-012024-06-30 0001173489us-gaap:RoyaltyMemberceva:ConnectivityProductsMember2024-01-012024-06-30 0001173489us-gaap:LicenseMemberceva:ConnectivityProductsMember2024-01-012024-06-30 0001173489us-gaap:LicenseMemberceva:OtherMember2024-04-012024-06-30 0001173489us-gaap:LicenseMemberceva:OtherMember2024-01-012024-06-30 0001173489us-gaap:RoyaltyMembersrt:AsiaPacificMember2024-04-012024-06-30 0001173489us-gaap:LicenseMembersrt:AsiaPacificMember2024-04-012024-06-30 0001173489us-gaap:RoyaltyMembersrt:AsiaPacificMember2024-01-012024-06-30 0001173489us-gaap:LicenseMembersrt:AsiaPacificMember2024-01-012024-06-30 0001173489us-gaap:RoyaltyMemberceva:EuropeAndMiddleEastMember2024-04-012024-06-30 0001173489us-gaap:LicenseMemberceva:EuropeAndMiddleEastMember2024-04-012024-06-30 0001173489us-gaap:RoyaltyMemberceva:EuropeAndMiddleEastMember2024-01-012024-06-30 0001173489us-gaap:LicenseMemberceva:EuropeAndMiddleEastMember2024-01-012024-06-30 0001173489us-gaap:RoyaltyMembercountry:US2024-04-012024-06-30 0001173489us-gaap:LicenseMembercountry:US2024-04-012024-06-30 0001173489us-gaap:RoyaltyMembercountry:US2024-01-012024-06-30 0001173489us-gaap:LicenseMembercountry:US2024-01-012024-06-30 00011734892026-01-012024-06-30 00011734892025-01-012024-06-30 00011734892024-07-012024-06-30 0001173489us-gaap:SegmentDiscontinuedOperationsMember2023-01-012023-06-30 0001173489ceva:IntrinsixCorpMember2023-09-142023-09-14 0001173489ceva:IntrinsixCorpMember2023-09-142023-09-14 0001173489ceva:VisisonicsMember2024-01-31 0001173489ceva:VisisonicsMember2024-01-012024-01-31 00011734892023-06-30 00011734892022-12-31 0001173489us-gaap:RetainedEarningsMember2023-06-30 0001173489us-gaap:TreasuryStockCommonMember2023-06-30 0001173489us-gaap:AdditionalPaidInCapitalMember2023-06-30 0001173489ceva:CommonStockOutstandingMember2023-06-30 0001173489us-gaap:RetainedEarningsMember2023-04-012023-06-30 0001173489us-gaap:TreasuryStockCommonMember2023-04-012023-06-30 0001173489us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-30 0001173489ceva:CommonStockOutstandingMember2023-04-012023-06-30 00011734892023-03-31 0001173489us-gaap:RetainedEarningsMember2023-03-31 0001173489us-gaap:TreasuryStockCommonMember2023-03-31 0001173489us-gaap:AdditionalPaidInCapitalMember2023-03-31 0001173489ceva:CommonStockOutstandingMember2023-03-31 0001173489us-gaap:RetainedEarningsMember2023-01-012023-06-30 0001173489us-gaap:TreasuryStockCommonMember2023-01-012023-06-30 0001173489us-gaap:AdditionalPaidInCapitalMember2023-01-012023-06-30 0001173489ceva:CommonStockOutstandingMember2023-01-012023-06-30 0001173489us-gaap:RetainedEarningsMember2022-12-31 0001173489us-gaap:TreasuryStockCommonMember2022-12-31 0001173489us-gaap:AdditionalPaidInCapitalMember2022-12-31 0001173489ceva:CommonStockOutstandingMember2022-12-31 0001173489us-gaap:RetainedEarningsMember2024-06-30 0001173489us-gaap:TreasuryStockCommonMember2024-06-30 0001173489us-gaap:AdditionalPaidInCapitalMember2024-06-30 0001173489ceva:CommonStockOutstandingMember2024-06-30 0001173489us-gaap:RetainedEarningsMember2024-04-012024-06-30 0001173489us-gaap:TreasuryStockCommonMember2024-04-012024-06-30 0001173489us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-30 0001173489ceva:CommonStockOutstandingMember2024-04-012024-06-30 00011734892024-03-31 0001173489us-gaap:RetainedEarningsMember2024-03-31 0001173489us-gaap:TreasuryStockCommonMember2024-03-31 0001173489us-gaap:AdditionalPaidInCapitalMember2024-03-31 0001173489ceva:CommonStockOutstandingMember2024-03-31 0001173489us-gaap:RetainedEarningsMember2024-01-012024-06-30 0001173489us-gaap:TreasuryStockCommonMember2024-01-012024-06-30 0001173489us-gaap:AdditionalPaidInCapitalMember2024-01-012024-06-30 0001173489ceva:CommonStockOutstandingMember2024-01-012024-06-30 0001173489us-gaap:RetainedEarningsMember2023-12-31 0001173489us-gaap:TreasuryStockCommonMember2023-12-31 0001173489us-gaap:AdditionalPaidInCapitalMember2023-12-31 0001173489ceva:CommonStockOutstandingMember2023-12-31 00011734892024-08-05
 

 

Table of Contents

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

 

For the quarterly period ended: June 30, 2024

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

 

For the transition period from to

 

Commission file number: 000-49842

 


 

Ceva, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

77-0556376

(State or Other Jurisdiction of Incorporation or Organization)

(I.R.S. Employer Identification No.)

   

15245 Shady Grove Road, Suite 400, Rockville, MD 20850

20850

(Address of Principal Executive Offices)

(Zip Code)

 

(240)-308-8328

(Registrants Telephone Number, Including Area Code)

 


 

Securities registered pursuant to Section 12(b) of the Act

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 per share

CEVA

The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one).

 

Large accelerated filer

Accelerated filer

       

Non-accelerated filer

Smaller reporting company

       

Emerging growth company

   

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date: 23,685,941 of common stock, $0.001 par value, as of August 5, 2024.

 

 

 

TABLE OF CONTENTS

 

 

Page

PART I.

FINANCIAL INFORMATION

5

Item 1.

Interim Condensed Consolidated Balance Sheets at June 30, 2024 (unaudited) and December 31, 2023

5
 

Interim Condensed Consolidated Statements of Loss (unaudited) for the three and six months ended June 30, 2024 and 2023

6
 

Interim Condensed Consolidated Statements of Comprehensive Loss (unaudited) for the three and six months ended June 30, 2024 and 2023

7
 

Interim Condensed Consolidated Statements of Changes in Stockholders’ Equity (unaudited) for the three and six months ended June 30, 2024 and 2023

8
 

Interim Condensed Consolidated Statements of Cash Flows (unaudited) for the six months ended June 30, 2024 and 2023

10
 

Notes to the Interim Condensed Consolidated Financial Statements

11

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

27

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

35

Item 4.

Controls and Procedures

36
   

PART II.         

OTHER INFORMATION

36

Item 1.    

Legal Proceedings

36

Item 1A.

Risk Factors

36

Item 2.  

Unregistered Sales of Equity Securities and Use of Proceeds

37

Item 3

Defaults Upon Senior Securities

37

Item 4

Mine Safety Disclosures

37

Item 5

Other Information

37

Item 6        

Exhibits

38

SIGNATURES

38

 

 

FORWARD-LOOKING STATEMENTS

 

FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA

 

This Quarterly Report contains forward-looking statements that involve risks and uncertainties, as well as assumptions that if they materialize or prove incorrect, could cause the results of Ceva to differ materially from those expressed or implied by such forward-looking statements and assumptions.  All statements other than statements of historical fact are statements that could be deemed forward-looking statements.  Forward-looking statements are generally written in the future tense and/or are preceded by words such as “will,” “may,” “should,” “could,” “expect,” “suggest,” “believe,” “anticipate,” “intend,” “plan,” or other similar words.  Forward-looking statements include the following:

 

 

Our belief that our portfolio of wireless communications and sensing and edge AI technologies address some of the most important megatrends, including 5G, generative AI, industrial automation and vehicle electrification, and our belief in the continued interest in our IP portfolio due to these trends, in both traditional and new areas;

 

 

Our belief that our Bluetooth, Wi-Fi, Ultra Wide Band (UWB) and cellular IoT IPs allow us to address the high volume IoT industrial, consumer and smart home markets, and our expectation that the overall addressable market size will be more than 15 billion devices annually by 2027 based on research from ABI Research;

 

 

Our belief that Wi-Fi represents a significant royalty revenue opportunity in connection with our dominant market position in licensing Wi-Fi 6 and our leadership position in Wi-Fi 7 IP;

 

 

Our belief that our PentaG2 platform, including the recently announced CevaXC22 multi-thread DSP, ensures we offer the most comprehensive baseband processor IP platform in the industry today, and that our 5G IPs provide newcomers and incumbents with a customizable solution to address the need for 5G processing for smartphones, fixed wireless access, satellite communications and a range of connected devices such as robots, cars, smart cities and other devices for industrial applications;

 

 

Our belief that the high volume consumer audio markets, including True Wireless Stereo (TWS) earbuds, smartwatches, AR and VR headsets, and other wearable assisted devices, offers an incremental growth segment for our Bluetooth, Audio AI DSPs and software IPs, and our belief in the capabilities of our RealSpace Spatial Audio & Head Tracking Solution, WhisPro speech recognition technology and ClearVox voice input software to enhance the user experience and offer premium features;

 

 

Our belief that our SensPro2 sensor hub AI DSP family can address the growing demand for efficient, high-performance signal processing in sensor-based applications across various industries for applications such as smartphones, automotive safety (ADAS), autonomous driving, drones, robotics, security and surveillance, augmented reality (AR) and virtual reality (VR), natural language processing and voice recognition, which enables us to address the transformation in devices enabled by these applications and expand our footprint and content in smartphones, drones, consumer cameras, surveillance, ADAS, voice-enabled devices and industrial IoT applications;

 

 

Statements regarding third-party estimates of industry growth and future market conditions, including research from Bloomberg Intelligence which forecasts that hardware revenue associated with computer vision AI products and conversational AI devices will reach $61 billion and $108 billion, respectively, by 2030, indicating the size of the market opportunity;

 

 

Our belief that our newest generation family of AI neural processing units (NPUs) present a highly efficient and high-performance architecture to enable generative and classic AI on any device including communication gateways, optically connected networks, cars, notebooks and tablets, AR/VR headsets, smartphones, and any other cloud or edge use case from the edge all the way to the cloud, and that more than 2.5 billion Edge AI devices will ship annually by 2026 based on research from Yole Group;

 

 

Our belief that our recently announced NeuPro-Nano family of AI NPUs present a compelling position to add a cost- and power-efficient processor to microcontrollorer units and SoC designs to handle the complete AI workloads on-device, that based on research from ABI Research, by 2030, over 40% of TinyML shipments will be powered by dedicated TinyML hardware, representing billions of devices annually, and that NeuPro-Nano will allow us to expand on our strong position in IoT where we have a dominant position in wireless connectivity as customers increasingly look to add support for AI to their cost- and power-constrained chips for this market;

 

 

 

Our belief that our sensor fusion and spatial audio application software allows us to address an important technology piece used in personal computers, robotics, TWS earbuds, smart TVs and many other smart sensing IP products, in addition to our existing portfolio for camera-based computer vision and AI processing, and microphone-based sound processing;

 

 

Our belief that our customers can benefit from our capabilities as a complete, one-stop-shop for processing all classes and types of sensors;

 

 

Our belief that we are well positioned for long-term growth in shipments and royalty revenues derived from smart edge products as a result of our focus on silicon and software IP solutions that enable products to connect, sense and infer data;

 

 

Our belief that our ubiquitous technology and collaborative business model present a significant and secular growth prospect as the continuing digital transformation drives industries to become connected and intelligent;

 

 

Our intention to continue to capitalize on the semiconductor momentum with our portfolio of technologies to enable three main use cases associated with smart edge devices – connect, sense and infer, and to focus on four main markets which include consumer, automotive, industrial and infrastructure, and our belief that such markets are large, diversified and represent the greatest opportunities for long-term growth;

 

 

Any statements regarding sales trends and financial results for the third and fourth quarter of and full year 2024 and other future periods, including our expectations with respect to future customers, contracts, revenues and expenses, regarding our customer pipeline, that a significant portion of our future revenues will continue to be generated by a limited number of customers in part due to consolidation in the semiconductor industry, that international customers will continue to account for a significant portion of our revenues for the foreseeable future, that an increasing portion of our new customers and revenues will be derived from international customers generally and sales to the Asia Pacific and China in particular, that we can expand our customer base and revenues in Europe and the U.S., and that we will experience year-over-year revenue growth in 2024;

 

 

Our belief that our cash and cash equivalents, short-term bank deposits and marketable securities, along with cash from operations, will provide sufficient capital to fund our operations for at least the next 12 months; and

 

 

Our belief that fluctuations in high interest rates within our investment portfolio will not have a material effect on our financial position on an annual or quarterly basis.

 

Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. The forward-looking statements contained in this report are based on information that is currently available to us and expectations and assumptions that we deem reasonable at the time the statements were made. We do not undertake any obligation to update any forward-looking statements in this report or in any of our other communications, except as required by law. All such forward-looking statements should be read as of the time the statements were made and with the recognition that these forward-looking statements may not be complete or accurate at a later date.

 

Many factors may cause actual results to differ materially from those expressed or implied by the forward-looking statements contained in this report. These factors include, but are not limited to, those risks set forth in Part II – Item 1A – “Risk Factors” of this Form 10-Q.

 

This report contains market data prepared by third party research firm. Actual market results may differ from their projections.

 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. FINANCIAL STATEMENTS

 

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

 

 


U.S. dollars in thousands, except share and per share data

 

   

June 30,

2024

   

December 31,
2023

 
                 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 24,702     $ 23,287  

Short-term bank deposits

    2,107       10,556  

Marketable securities

    131,602       132,695  

Trade receivables (net of allowance for credit losses of $288 at both June 30, 2024 and December 31, 2023)

    35,655       30,307  

Prepaid expenses and other current assets

    13,201       12,526  

Total current assets

    207,267       209,371  

Long-term assets:

               

Severance pay fund

    6,762       7,070  

Deferred tax assets, net

    1,317       1,609  

Property and equipment, net

    6,843       6,732  

Operating lease right-of-use assets

    6,137       6,978  

Goodwill

    58,308       58,308  

Intangible assets, net

    2,411       2,967  

Investments in marketable equity securities

    288       406  

Other long-term assets

    11,069       10,644  

Total long-term assets

    93,135       94,714  

Total assets

  $ 300,402     $ 304,085  
                 

LIABILITIES AND STOCKHOLDERS EQUITY

               

Current liabilities:

               

Trade payables

  $ 1,092     $ 1,154  

Deferred revenues

    2,830       3,018  

Accrued expenses and other payables

    6,051       5,800  

Accrued payroll and related benefits

    12,394       14,402  

Operating lease liabilities

    2,615       2,513  

Total current liabilities

    24,982       26,887  

Long-term liabilities:

               

Accrued severance pay

    7,210       7,524  

Operating lease liabilities

    2,964       3,943  

Other accrued liabilities

    1,460       1,390  

Total long-term liabilities

    11,634       12,857  

Stockholders’ equity:

               

Preferred Stock: $0.001 par value: 5,000,000 shares authorized; none issued and outstanding

           

Common Stock: $0.001 par value: 45,000,000 shares authorized; 23,756,255 and 23,695,190 shares issued at June 30, 2024 and December 31, 2023, respectively. 23,659,925 and 23,440,848 shares outstanding at June 30, 2024 and December 31, 2023, respectively

    24       23  

Additional paid in-capital

    254,302       252,100  

Treasury stock at cost (96,330 and 254,342 shares of common stock at June 30, 2024, and December 31, 2023, respectively)

    (1,917 )     (5,620 )

Accumulated other comprehensive loss

    (2,894 )     (2,329 )

Retained earnings

    14,271       20,167  

Total stockholders’ equity

    263,786       264,341  

Total liabilities and stockholders’ equity

  $ 300,402     $ 304,085  

 

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

 

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF LOSS (UNAUDITED)

 

U.S. dollars in thousands, except per share data

 

 


 

   

Six months ended

   

Three months ended

 
   

June 30,

   

June 30,

 
   

2024

   

2023

   

2024

   

2023

 

Revenues:

                               

Licensing and related revenue

  $ 28,692     $ 31,799     $ 17,278     $ 13,551  

Royalties

    21,817       17,385       11,159       9,371  

Total revenues

    50,509       49,184       28,437       22,922  

Cost of revenues

    5,436       7,032       2,933       3,524  

Gross profit

    45,073       42,152       25,504       19,398  

Operating expenses:

                               

Research and development, net

    36,749       36,730       18,758       18,056  

Sales and marketing

    5,911       5,351       3,095       2,632  

General and administrative

    7,109       7,738       3,537       3,911  

Amortization of intangible assets

    299       296       149       142  

Total operating expenses

    50,068       50,115       25,539       24,741  

Operating loss

    (4,995 )     (7,963 )     (35 )     (5,343 )

Financial income, net

    2,663       2,573       1,406       1,118  

Remeasurement of marketable equity securities

    (118 )     (236 )     (58 )     (119 )

Income (loss) from continuing operation before taxes on income

    (2,450 )     (5,626 )     1,313       (4,344 )

Income tax expense

    3,289       1,963       1,604       546  

Net loss from continuing operation

    (5,739 )     (7,589 )     (291 )     (4,890 )

Discontinued operation (Note 4):

                               

Net loss from discontinued operation

          (3,101 )           (928 )

Net loss

  $ (5,739 )   $ (10,690 )   $ (291 )   $ (5,818 )
                                 

Basic and diluted net loss per share from continuing operation

  $ (0.24 )   $ (0.32 )   $ (0.01 )   $ (0.21 )

Basic and diluted net loss per share from discontinued operation

  $     $ (0.13 )   $     $ (0.04 )

Basic and diluted net loss per share

  $ (0.24 )   $ (0.45 )   $ (0.01 )   $ (0.25 )
                                 
                                 

Weighted-average shares used to compute net loss per share (in thousands):

                               

Basic and diluted

    23,568       23,405       23,628       23,476  

 

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

 

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)

 

U.S. dollars in thousands

 

 


 

   

Six months ended

   

Three months ended

 
   

June 30,

   

June 30,

 
   

2024

   

2023

   

2024

   

2023

 
                                 

Net loss:

  $ (5,739 )   $ (10,690 )   $ (291 )   $ (5,818 )

Other comprehensive income (loss) before tax:

                               

Available-for-sale securities:

                               

Changes in unrealized gains (losses)

    430       867       230       137  

Reclassification adjustments for (gains) losses included in net loss

    (10 )     (76 )     (6 )     16  

Net change

    420       791       224       153  

Cash flow hedges:

                               

Changes in unrealized gains (losses)

    (339 )     (630 )     (144 )     (205 )

Reclassification adjustments for losses included in net loss

    (607 )     574       (227 )     403  

Net change

    (946 )     (56 )     (371 )     198  

Other comprehensive income (loss) before tax

    (526 )     735       (147 )     351  

Income tax expense related to components of other comprehensive income (loss)

    39       69       27       24  

Other comprehensive income (loss), net of taxes

    (565 )     666       (174 )     327  

Comprehensive loss

  $ (6,304 )   $ (10,024 )   $ (465 )   $ (5,491 )

 

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

 

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (UNAUDITED)

 

U.S. dollars in thousands, except share data

 

 


 

   

Common stock

                                         

Six months ended June 30, 2024

 

Number of shares outstanding

   

Amount

    Additional
paid-in
capital
   

Treasury stock

   

Accumulated

other

comprehensive

income (loss)

    Retained
earnings
    Total
stockholders’
equity
 

Balance as of January 1, 2024

    23,440,848     $ 23     $ 252,100     $ (5,620 )   $ (2,329 )   $ 20,167     $ 264,341  

Net loss

                                  (5,739 )     (5,739 )

Other comprehensive loss, net

                            (565 )           (565 )

Equity-based compensation

                7,471                         7,471  

Purchase of treasury stock

    (157,303 )    

(*)

          (3,276 )                 (3,276 )

Issuance of common stock upon exercise of stock-based awards

    61,065      

(*)

                             

Issuance of treasury stock upon exercise of stock-based awards

    315,315       1       (5,269 )     6,979             (157 )     1,554  

Balance as of June 30, 2024

    23,659,925     $ 24     $ 254,302     $ (1,917 )   $ (2,894 )   $ 14,271     $ 263,786  

 

   

Common stock

                                         

Three months ended June 30, 2024

 

Number of shares outstanding

   

Amount

    Additional
paid-in
capital
   

Treasury stock

   

Accumulated

other

comprehensive

income (loss)

    Retained
earnings
    Total
stockholders’
equity
 

Balance as of April 1, 2024

    23,581,522     $ 24     $ 252,927     $ (2,528 )   $ (2,720 )   $ 14,646     $ 262,349  

Net loss

                                  (291 )     (291 )

Other comprehensive loss, net

                            (174 )           (174 )

Equity-based compensation

                3,900                         3,900  

Purchase of treasury stock

    (100,431 )    

(*)

          (1,998 )                 (1,998 )

Issuance of common stock upon exercise of stock-based awards

    61,065      

(*)

                             

Issuance of treasury stock upon exercise of stock-based awards

    117,769      

(*)

    (2,525 )     2,609             (84 )      

Balance as of June 30, 2024

    23,659,925     $ 24     $ 254,302     $ (1,917 )   $ (2,894 )   $ 14,271     $ 263,786  

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (UNAUDITED)

 

U.S. dollars in thousands, except share data

 

 


 

   

Common stock

                                         

Six months ended June 30, 2023

 

Number of shares outstanding

   

Amount

   

Additional
paid-in
capital

   

Treasury stock

   

Accumulated

other

comprehensive

income (loss)

   

Retained
earnings

   

Total
stockholders’
equity

 

Balance as of January 1, 2023

    23,215,439     $ 23     $ 242,841     $ (9,904 )   $ (6,249 )   $ 32,160     $ 258,871  

Net loss

                                  (10,690 )     (10,690 )

Other comprehensive income

                            666             666  

Equity-based compensation

                8,064                         8,064  

Issuance of treasury stock upon exercise of stock-based awards

    323,665       1       (6,655 )     8,442             (115 )     1,673  

Balance as of June 30, 2023

    23,539,104     $ 24     $ 244,250     $ (1,462 )   $ (5,583 )   $ 21,355     $ 258,584  

 

   

Common stock

                                         

Three months ended June 30, 2023

 

Number of shares outstanding

   

Amount

   

Additional
paid-in
capital

   

Treasury stock

   

Accumulated

other

comprehensive

income (loss)

   

Retained
earnings

   

Total
stockholders’
equity

 

Balance as of April 1, 2023

    23,416,026     $ 23     $ 243,141     $ (4,672 )   $ (5,910 )   $ 27,288     $ 259,870  

Net loss

                                  (5,818 )     (5,818 )

Other comprehensive income

                            327             327  

Equity-based compensation

                4,205                         4,205  

Issuance of treasury stock upon exercise of stock-based awards

    123,078       1       (3,096 )     3,210             (115 )      

Balance as of June 30, 2023

    23,539,104     $ 24     $ 244,250     $ (1,462 )   $ (5,583 )   $ 21,355     $ 258,584  

 

 

(*)         Amount less than $1.

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

 

U.S. dollars in thousands

 

 


 

   

Six months ended
June 30,

 
   

2024

   

2023

 

Cash flows from operating activities:

               

Net loss

  $ (5,739 )   $ (10,690 )

Adjustments required to reconcile net loss to net cash used in operating activities:

               

Depreciation

    1,444       1,462  

Amortization of intangible assets

    556       1,379  

Equity-based compensation

    7,471       8,064  

Realized gain on sale of available-for-sale marketable securities

    (10 )     (76 )

Amortization of premiums (accretion of discount) on available-for-sale marketable securities

    (386 )     40  

Unrealized foreign exchange (gain) loss

    167       (352 )

Remeasurement of marketable equity securities

    118       236  

Changes in operating assets and liabilities:

               

Trade receivables, net

    (4,989 )     (657 )

Prepaid expenses and other assets

    (2,210 )     (1,965 )

Operating lease right-of-use assets

    841       447  

Accrued interest on bank deposits

    449       (114 )

Deferred tax, net

    253       (406 )

Trade payables

    (105 )     (898 )

Deferred revenues

    (188 )     620  

Accrued expenses and other payables

    91       (1,177 )

Accrued payroll and related benefits

    (1,962 )     (5,545 )

Operating lease liability

    (781 )     (464 )

Accrued severance pay, net

    10       233  

Net cash used in operating activities

    (4,970 )     (9,863 )
                 

Cash flows from investing activities:

               

Purchase of property and equipment

    (1,512 )     (1,231 )

Acquisition of business

          (3,600 )

Proceeds from the sale of Intrinsix (see note 4)

    540        

Asset acquisition

    (753 )      

Proceeds from bank deposits

    8,000       4,000  

Investment in available-for-sale marketable securities

    (29,969 )     (2,455 )

Proceeds from maturity of available-for-sale marketable securities

    24,580       7,000  

Proceeds from sale of available-for-sale marketable securities

    7,298       10,659  

Net cash provided by investing activities

    8,184       14,373  
                 

Cash flows from financing activities:

               

Purchase of treasury stock

    (3,276 )      

Proceeds from exercise of stock-based awards

    1,554       1,673  

Net cash provided by (used in) financing activities

    (1,722 )     1,673  

Effect of exchange rate changes on cash and cash equivalents

    (77 )     43  

Increase in cash and cash equivalents

    1,415       6,226  

Cash and cash equivalents at the beginning of the period

    23,287       21,285  

Cash and cash equivalents at the end of the period

  $ 24,702     $ 27,511  
                 

Supplemental information of cash-flow activities:

               

Cash paid during the period for:

               

Income and withholding taxes

  $ 1,512     $ 3,871  

Non-cash transactions:

               

Property and equipment purchases incurred but unpaid at period end

  $ 22     $  

Right-of-use assets obtained in the exchange for operating lease liabilities

  $ 373     $ 1,028  

 

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

 

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

(in thousands, except share data)

 

 

 

NOTE 1:

BUSINESS

 

The financial information in this quarterly report includes the results of Ceva, Inc. and its subsidiaries (the “Company” or “Ceva”).

 

Ceva is the leader in innovative silicon and software IP solutions that enable smart edge products to connect, sense, and infer data more reliably and efficiently. With the industry’s only portfolio of comprehensive communications and scalable edge AI IP, Ceva powers the connectivity, sensing, and inference in today’s most advanced smart edge products across consumer IoT, mobile, automotive, infrastructure, industrial, and personal computing. More than 18 billion of the world’s most innovative smart edge products from AI-infused smartwatches, IoT devices and wearables to autonomous vehicles, 5G mobile networks and more are powered by Ceva.

 

Ceva is a trusted partner to many of the leading semiconductor and original equipment manufacturer (OEM) companies targeting a wide variety of cellular and IoT end markets, including mobile, PC, consumer, automotive, smart-home, surveillance, robotics, industrial and medical. The customers incorporate Ceva’s IP into application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs) that they manufacture, market and sell to consumer electronics companies. Ceva’s application software IP is licensed primarily to OEMs who embed it in their System on Chip (SoC) designs to enhance the user experience, and OEMs also license Ceva’s hardware IP products and solutions for their SoC designs to create power-efficient, intelligent, secure and connected devices. 

 

Ceva’s wireless communications, sensing and edge AI technologies are at the heart of some of today’s most advanced smart edge products. From Bluetooth connectivity, Wi-Fi, ultra-wide band (UWB) and 5G platform IP for ubiquitous, robust communications, to scalable edge AI neural processing unit (NPU) IPs, sensor fusion processors and embedded application software that make devices smarter.

 

Ceva licenses its portfolio of wireless communications and scalable edge AI IP to its customers, breaking down barriers to entry and enabling them to bring new cutting-edge products to market faster, more reliably, efficiently and economically.

 

 

 

NOTE 2:

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The interim condensed consolidated financial statements have been prepared according to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).

 

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2024, are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

 

The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2023, contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 7, 2024, have been applied consistently in these unaudited interim condensed consolidated financial statements.

 

 

11

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

Concentration of credit risk:

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, bank deposits, marketable securities, foreign exchange contracts and trade receivables. The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines relating to diversification and maturities to maintain safety and liquidity of the investments.

 

The majority of the Company’s cash and cash equivalents are invested in high grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits may be redeemed on demand and therefore minimal credit risk exists with respect to them. Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. Generally, these cash equivalents may be redeemed upon demand, and therefore management believes that they bear a lower risk. The short-term bank deposits are held in financial institutions that management believes are institutions with high credit standing and, accordingly, minimal credit risk from geographic or credit concentration. Furthermore, the Company holds an investment portfolio consisting principally of corporate bonds. The Company has the ability to hold such investments until recovery of temporary declines in market value or maturity.

 

The Company’s trade receivables are geographically diverse, mainly in the Asia Pacific region, and also in the United States and Europe. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers and to date has not experienced any material losses. The Company makes estimates of expected credit losses for based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers.

 

The Company has no off-balance-sheet concentration of credit risk.

 

Accounting Standards Recently Adopted by the Company

 

In June 2022, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The guidance is effective for annual periods beginning after December 15, 2023, with early adoption permitted. The Company adopted ASU 2022-03 as of January 1, 2024. The adoption did not result in a material impact on the Company's interim condensed financial statements.

 

Accounting Standards Recently Issued, Not Yet Adopted by the Company

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07.

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09.

 

Use of Estimates

 

The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, the reported amounts of revenues and expenses during the reporting period, and amounts classified as a discontinued operation. Actual results could differ from those estimates.

 

12

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

 

NOTE 3:

ACQUISITION

 

In January 2024, the Company acquired 100% of the equity shares of a privately held, Greek-based company, to extend the research and development resources in the Ceva group. Under the terms of the purchase agreement, the Company agreed to pay an aggregate of approximately $750 paid at closing and approximately $2,100 subject to continued employment and certain performance milestones. The Company has accounted for this acquisition as an asset acquisition. As such, the total purchase consideration was allocated to the assets acquired.

 

 

 

NOTE 4:

HELD FOR SALE AND DISCONTINUED OPERATION

 

On September 14, 2023, the Company and Intrinsix, then its wholly owned subsidiary, entered into a Share Purchase Agreement (the “Agreement”) with Cadence Design Systems, Inc. (“Cadence”), pursuant to which Cadence agreed to purchase all of the issued and outstanding capital shares of Intrinsix from the Company for $35,000 in cash, subject to other certain purchase price adjustments as provided for in the Agreement (the “Transaction”). The closing of the Transaction occurred on October 2, 2023. At the closing, an amount of $300 from the consideration was deposited with a third-party escrow agent for the purposes of satisfying any additional post-closing purchase price adjustments owed by the Company to Cadence, which was fully paid to the Company during the first quarter of 2024, a further amount of $3,500 of the consideration was deposited with the same escrow agent for a period of 18 months as security for the Company’s indemnification obligations to Cadence in accordance with the terms and conditions set forth in the Agreement, and after giving effect to post-closing adjustments resulting in a $240 repayment to the Company during the first quarter of 2024. The Agreement includes certain representations, warranties and covenants of the parties, and the Company also agreed to certain non-competition and non-solicitation terms, which are subject to certain exceptions.

 

Under ASC 205-20, "Discontinued Operation" when a component of an entity, as defined in ASC 205-20, has been disposed of or is classified as held for sale, the results of its operations, including the gain or loss on its component, are classified as discontinued operations and the assets and liabilities of such component are classified as assets and liabilities attributed to discontinued operations; that is, provided that the operations, assets and liabilities and cash flows of the component have been eliminated from the Company’s consolidated operations and the Company will have no significant continuing involvement in the operations of the component.

 

As a result of the Transaction, Intrinsix's results of operations and asset and liability balances are disclosed as a discontinued operation. All prior periods comparable results of operation, assets and liabilities have been retroactively included in discontinued operations.

 

The following table shows the Company's results of discontinued operation for the below presented period:

 

   

Six months ended June 30, 2023

(unaudited)

   

Three months ended June 30, 2023

(unaudited)

 

Revenues

  $ 5,723     $ 3,250  

Cost of revenue

    3,855       2,048  

Gross profit

    1,868       1,202  

Operating expenses:

               

Research and development, net

    3,655       1,538  

Sales and marketing

    489       163  

General and administrative

    479       258  

Amortization of intangible assets

    349       174  

Total operating expenses

    4,972       2,133  

Operating loss

    (3,104 )     (931 )

Financial income, net

    3       3  

Loss from discontinued operations before taxes on income

    (3,101 )     (928 )

Income tax expense

           

Net loss from discontinued operation

  $ (3,101 )   $ (928 )

 

13

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

The following table presents cash flows from discontinued operations:

 

   

Six months

ended

June 30, 2023

(unaudited)

 

Net cash flows used in operating activities (*)

  $ (1,902 )

 

(*) Amortization and depreciation allocated to discontinued operation for the six-month period ended June 30, 2023 amounted to $982.

 

 

 

NOTE 5:

REVENUE RECOGNITION

 

Under ASC No. 606, “Revenue from Contracts with Customers” (“ASC 606”), an entity recognizes revenue when or as it satisfies a performance obligation by transferring intellectual property (“IP”) licenses or services to the customer, either at a point in time or over time. The Company recognizes most of its revenues at a point in time upon delivery when the customer accepts control of the IP. The Company recognizes revenue over time on significant license customization contracts that are in the scope of ASC 606 by using cost inputs to measure progress toward completion of its performance obligations.

 

Revenues that are derived from the sale of a licensee’s products that incorporate the Company’s IP are classified as royalty revenues. Royalty revenues are recognized during the quarter in which the sale of the product incorporating the Company’s IP occurs. Royalties are calculated either as a percentage of the revenues received by the Company’s licensees on sales of products incorporating the Company’s IP or on a per unit basis, as specified in the agreements with the licensees. When the Company does not receive actual sales data from the customer prior to the finalization of its financial statements, royalty revenues are recognized based on the Company’s estimation of the customer’s sales during the quarter.

 

The following table includes estimated revenue expected to be recognized in future periods related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The estimated revenues do not include amounts of royalties or unexercised contract renewals:

 

   

Remainder of 2024

   

2025

   

2026 and

thereafter

 

Licensing and related revenues

  $ 9,352     $ 3,134     $ 449  

 

14

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

Disaggregation of revenue:

 

The following table provides information about disaggregated revenue by primary geographical, use cases for the Company's technology portfolio, and timing of revenue recognition:

 

   

Six months ended June 30, 2024 (unaudited)

   

Three months ended June 30, 2024 (unaudited)

 
   

Licensing and

related revenues

   

Royalties

   

Total

   

Licensing and

related revenues

   

Royalties

   

Total

 

Geography

                                               

United States

  $ 811     $ 3,092     $ 3,903     $ 428     $ 937     $ 1,365  

Europe and Middle East

    6,845       2,109       8,954       6,244       1,198       7,442  

Asia Pacific

    21,023       16,616       37,639       10,606       9,024       19,630  

Other

    13             13                    

Total

  $ 28,692     $ 21,817     $ 50,509     $ 17,278     $ 11,159     $ 28,437  
                                                 

Use cases for the Company’s technology portfolio

                                               

Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT)

  $ 26,323     $ 16,732     $ 43,055     $ 16,256     $ 8,793     $ 25,049  

Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI)

    2,369       5,085       7,454       1,022       2,366       3,388  

Total

  $ 28,692     $ 21,817     $ 50,509     $ 17,278     $ 11,159     $ 28,437  
                                                 

Timing of revenue recognition

                                               

Products transferred at a point in time

  $ 24,723     $ 21,817     $ 46,540     $ 15,270     $ 11,159     $ 26,429  

Products and services transferred over time

    3,969             3,969       2,008             2,008  

Total

  $ 28,692     $ 21,817     $ 50,509     $ 17,278     $ 11,159     $ 28,437  

  

   

Six months ended June 30, 2023 (unaudited)

   

Three months ended June 30, 2023 (unaudited)

 
   

Licensing and

related revenues

   

Royalties

   

Total

   

Licensing and

related revenues

   

Royalties

   

Total

 

Geography

                                               

United States

  $ 1,039     $ 3,061     $ 4,100     $ 337     $ 1,411     $ 1,748  

Europe and Middle East

    3,581       1,312       4,893       1,631       453       2,084  

Asia Pacific

    26,677       13,012       39,689       11,556       7,507       19,063  

Other

    502             502       27             27  

Total

  $ 31,799     $ 17,385     $ 49,184     $ 13,551     $ 9,371     $ 22,922  
                                                 

Use cases for the Company’s technology portfolio

                                               

Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT)

  $ 27,667     $ 12,445     $ 40,112     $ 11,743     $ 6,780     $ 18,523  

Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI)

    4,132       4,940       9,072       1,808       2,591       4,399  

Total

  $ 31,799     $ 17,385     $ 49,184     $ 13,551     $ 9,371     $ 22,922  
                                                 

Timing of revenue recognition

                                               

Products transferred at a point in time

  $ 25,024     $ 17,385     $ 42,409     $ 10,403     $ 9,371     $ 19,774  

Products and services transferred over time

    6,775             6,775       3,148             3,148  

Total

  $ 31,799     $ 17,385     $ 49,184     $ 13,551     $ 9,371     $ 22,922  

 

15

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

Contract balances:

 

The following table provides information about trade receivables, unbilled receivables and contract liabilities from contracts with customers:

 

   

June 30, 2024

   

December 31,

2023

 
                 

Currents assets (classified under Trade receivables):

               

Trade receivables

  $ 18,298     $ 8,433  

Unbilled receivables (associated with licensing and related revenue)

    6,497       9,735  

Unbilled receivables (associated with royalties)

    10,860       12,139  

Total current assets

    35,655       30,307  
                 

Long-term assets (classified under Other long-term assets)

               

Unbilled receivables (associated with licensing and related revenue)

    2,139        
                 

Deferred revenues (short-term contract liabilities)

    2,830       3,018  

 

The Company receives payments from customers based upon contractual payment schedules; trade receivables are recorded when the right to consideration becomes unconditional, and an invoice is issued to the customer. Unbilled receivables associated with licensing and other include amounts related to the Company’s contractual right to consideration for completed performance objectives not yet invoiced. Unbilled receivables associated with royalties are recorded as the Company recognizes revenues from royalties earned during the quarter, but not yet invoiced, either by actual sales data received from customers, or, when applicable, by the Company’s estimation. Contract liabilities (deferred revenue) include payments received in advance of performance under the contract, and are realized with the associated revenue recognized under the contract.

 

During the three and six months ended June 30, 2024, the Company recognized $744 and $1,924, respectively, that was included in deferred revenues (short-term contract liability) balance at January 1, 2024. 

 

 

 

NOTE 6:

LEASES

 

The Company leases substantially all of its office space and vehicles under operating leases. The Company's leases have original lease periods expiring between 2025 and 2034. Many leases include one or more options to renew. The Company does not assume renewals in its determination of the lease term unless the renewals are deemed to be reasonably certain. Lease payments included in the measurement of the lease liability comprise the following: the fixed non-cancelable lease payments, payments for optional renewal periods where it is reasonably certain the renewal period will be exercised, and payments for early termination options unless it is reasonably certain the lease will not be terminated early.

 

The following is a summary of weighted average remaining lease terms and discount rates for all of the Company’s operating leases:

 

   

June 30, 2024

(Unaudited)

 

Weighted average remaining lease term (years)

    3.87  

Weighted average discount rates

    3.94

%

 

Total operating lease cost and cash payments for operating leases were as follows:

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

   

2023

   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

   

(unaudited)

   

(unaudited)

 
                                 

Operating lease cost

  $ 1,357     $ 1,502     $ 694     $ 749  

Cash payments for operating leases

    1,309       1,484       687       757  

 

16

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

Maturities of lease liabilities are as follows:

 

The remainder of 2024

 

$

1,426  

2025

    2,037  

2026

    895  

2027

    638  

2028

    330  

2029 and thereafter

    618  

Total undiscounted cash flows

    5,944  

Less imputed interest

    365  

Present value of lease liabilities

  $ 5,579  

 

 

 

NOTE 7:

MARKETABLE SECURITIES

 

The following is a summary of available-for-sale marketable securities:

 

   

June 30, 2024 (Unaudited)

 
   

Amortized
cost

   

Gross
unrealized
gains

   

Gross
unrealized
losses

   

Fair
value

 

Available-for-sale - matures within one year:

                               

Corporate bonds

  $ 51,319     $ 19     $ (673 )   $ 50,665  
                                 

Available-for-sale - matures after one year through three years:

                               

Corporate bonds

    83,558       91       (2,712 )     80,937  

Total

                               
    $ 134,877     $ 110     $ (3,385 )   $ 131,602  

 

   

December 31, 2023

 
   

Amortized
cost

   

Gross
unrealized
gains

   

Gross
unrealized
losses

   

Fair
value

 

Available-for-sale - matures within one year:

                               

Corporate bonds

  $ 27,690     $ 4     $ (243 )   $ 27,451  
                                 

Available-for-sale - matures after one year through three years:

                               

Corporate bonds

    108,700       278       (3,734 )     105,244  
                                 

Total

  $ 136,390     $ 282     $ (3,977 )   $ 132,695  

 

17

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2024, and December 31, 2023, and the length of time that those investments have been in a continuous loss position:

 

   

Less than 12 months

   

12 months or greater

 
   

Fair value

   

Gross

unrealized

loss

   

Fair value

   

Gross

unrealized

loss

 

As of June 30, 2024 (unaudited)

  $ 37,893     $ (237 )   $ 73,923     $ (3,148 )

As of December 31, 2023

  $ 18,193     $ (49 )   $ 86,643     $ (3,928 )

  

As of June 30, 2024, the allowance for credit losses was not material.

 

The following table presents gross realized gains and losses from sale of available-for-sale marketable securities:

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

   

2023

   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

   

(unaudited)

   

(unaudited)

 
                                 

Gross realized gains from sale of available-for-sale marketable securities

  $ 15     $ 92     $ 6     $  

Gross realized losses from sale of available-for-sale marketable securities

  $ (5 )   $ (16 )   $     $ (16 )

 

 

 

NOTE 8:

FAIR VALUE MEASUREMENT

 

FASB ASC No. 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value. Fair value is an exit price, representing the amount that would be received for selling an asset or paid for the transfer of a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:

 

Level I

Unadjusted quoted prices in active markets that are accessible on the measurement date for identical, unrestricted assets or liabilities;

Level II

Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

Level III

Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

 

The Company measures its marketable securities, investments in marketable equity securities and foreign currency derivative contracts at fair value. The carrying amount of cash, cash equivalents, short-term bank deposits, trade receivables, other accounts receivable, trade payables and other accounts payables approximate fair value due to the short-term maturity of these instruments. Investments in marketable equity securities are classified within Level I as the securities are traded in an active market. Marketable securities and foreign currency derivative contracts are classified within Level II as the valuation inputs are based on quoted prices and market observable data of similar instruments.

 

18

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

The table below sets forth the Company’s assets and liabilities measured at fair value by level within the fair value hierarchy. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

Description

 

June 30, 2024

(unaudited)

   

Level I

(unaudited)

   

Level II (unaudited)

   

Level III (unaudited)

 

Assets:

                               

Marketable securities:

                               

Corporate bonds

  $ 131,602     $     $ 131,602     $  

Foreign exchange contracts

    51             51        

Investments in marketable equity securities

    288       288              
                                 

Liabilities:

                               

Foreign exchange contracts

  $ 9     $     $ 9     $  

 

Description

 

December 31, 2023

   

Level I

   

Level II

   

Level III

 

Assets:

                               

Marketable securities:

                               

Corporate bonds

  $ 132,695     $     $ 132,695     $  

Foreign exchange contracts

    988             988        

Investments in marketable equity securities

    406       406              

 

 

 

NOTE 9:

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA

 

 

a.

Summary information about geographic areas:

 

The Company manages its business on the basis of one reportable segment: the licensing of intellectual property to semiconductor companies and electronic equipment manufacturers (see Note 1 for a brief description of the Company’s business). The following is a summary of revenues within geographic areas:

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Revenues based on customer location:

                               

United States

  $ 3,903     $ 4,100     $ 1,365     $ 1,748  

Europe and Middle East (2)

    8,954       4,893       7,442       2,084  

Asia Pacific (1)

    37,639       39,689       19,630       19,063  

Other

    13       502             27  
    $ 50,509     $ 49,184     $ 28,437     $ 22,922  
                                 

(1) China

  $ 29,025     $ 30,477     $ 15,433     $ 12,714  

(2) Finland

  $ 6,645     $ * )   $ 6,455     $ * )

 

*) Less than 10%

 

 

b.

Major customer data as a percentage of total revenues:

 

The following table sets forth the customers that represented 10% or more of the Company’s total revenues in each of the periods set forth below. 

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 
                                 

Customer A

    13 %     * )     13 %     14 %

Customer B

    13 %     * )     23 %     * )

Customer C

    13 %     * )     21 %     * )

Customer D

    * )     * )     * )     14 %

Customer E

    * )     * )     * )     10 %

 

*) Less than 10%

 

19

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

 

NOTE 10:

NET LOSS PER SHARE OF COMMON STOCK

 

Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period, plus dilutive potential shares of common stock considered outstanding during the period, in accordance with FASB ASC No. 260, “Earnings Per Share.”

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Numerator:

                               

Net loss from continuing operations

  $ (5,739 )   $ (7,589 )   $ (291 )   $ (4,890 )

Net loss from discontinued operations

          (3,101 )           (928 )

Net loss

  $ (5,739 )   $ (10,690 )   $ (291 )   $ (5,818 )

Denominator (in thousands):

                               

Basic and diluted weighted-average common stock outstanding

    23,568       23,405       23,628       23,476  
                                 

Basic and diluted net loss per share from continuing operations

  $ (0.24 )   $ (0.32 )   $ (0.01 )   $ (0.21 )

Basic and diluted net loss per share from discontinued operations

  $       (0.13 )   $     $ (0.04 )

Basic and diluted net loss per share

  $ (0.24 )   $ (0.45 )   $ (0.01 )   $ (0.25 )

 

The total number of shares related to outstanding equity-based awards was 1,630,146 for both the three and six months ended June 30, 2024, and in each case was excluded from the calculation of diluted net loss per share. The total number of shares related to outstanding equity-based awards was 1,350,825 for both the three and six months ended June 30, 2023, and in each case was excluded from the calculation of diluted net loss per share. 

 

 

 

NOTE 11:

COMMON STOCK AND STOCK-BASED COMPENSATION PLANS

 

The Company has historically granted a mix of stock options, stock appreciation rights (“SARs”) capped with a ceiling and restricted stock units (“RSUs”) to employees and non‑employee directors of the Company and its subsidiaries under the Company’s equity plans and provides the right to purchase common stock pursuant to the Company’s 2002 employee stock purchase plan to employees of the Company and its subsidiaries. As of June 30, 2024, and December 31, 2023, there were no outstanding or exercisable SARs left.

 

The options granted under the Company’s stock incentive plans have been granted at the fair market value of the Company’s common stock on the grant date. Options granted to employees under stock incentive plans generally vest at a rate of 25% of the shares underlying the option after one year and the remaining shares vest in equal portions over the following 36 months, such that all shares are vested after four years. A summary of the Company’s stock option activities and related information for the six months ended June 30, 2024, are as follows:

 

   

Number of
options

   

Weighted
average

exercise
price

   

Weighted
average remaining
contractual

term

   

Aggregate
intrinsic

value

 

Outstanding as of December 31, 2023

    99,425     $ 20.74       2.5     $ 316  

Granted

    10,600       19.61                  

Exercised

    (26,000 )     14.77                  

Forfeited or expired

                           

Outstanding as of June 30, 2024 (unaudited)

    84,025     $ 22.45       3.2     $ 0  

Exercisable as of June 30, 2024 (unaudited)

    54,000     $ 23.30       1.5     $ 0  

 

20

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

As of June 30, 2024, there was $278 of unrecognized compensation expense related to unvested stock options. This amount is expected to be recognized over a weighted-average period of 2.2 years.

 

An RSU award is an agreement to issue shares of the Company’s common stock at the time the award or a portion thereof vests. RSUs granted to employees generally vest in three equal annual installments starting on the first anniversary of the grant date. RSUs granted to non-employee directors would generally vest in two equal annual installments starting on the first anniversary of the grant date.  

 

On February 12, 2024, the Compensation Committee of the Board (the “Committee”) granted 33,318, 20,043, 16,399 and 13,535 RSUs, effective as of February 16, 2024, to each of the Company’s Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), Chief Operating Officer (“COO”) and Chief Commercial Officer (“CCO”), respectively, pursuant to the Company’s 2011 Stock Incentive Plan (the “2011 Plan”). The RSU grants vest 33.4% on February 16, 2025, 33.3% on February 16, 2026 and 33.3% on February 16, 2027.

 

Also, on February 12, 2024, the Committee granted 49,978, 13,362, 10,932 and 9,023 performance-based restricted stock units (“PSUs”), effective as of February 16, 2024, to each of the Company’s CEO, CFO, COO and CCO, respectively, pursuant to the 2011 Plan. The performance goals for the PSUs with specified weighting are as follows:

 

Weighting

Goals

50% (*)

Vesting of the full 50% of the PSUs occurs if the Company achieves the 2024 license and related revenue target approved by the Board (the “2024 License Revenue Target”). The vesting threshold is achievement of 90% of the 2024 License Revenue Target. If the Company’s achievement of the 2024 License Revenue Target is above 90% but less than 99% of the 2024 License Revenue Target, 91% to 99% of the eligible PSUs would be subject to vesting. If the Company’s actual result exceeds 100% of the 2024 License Revenue Target, every 1% increase of the 2024 License Revenue Target, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO.

25%

Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2024 is greater than the S&P Semiconductors Select Industry index (the “S&P index”). The vesting threshold is if the return on the Company’s stock for 2024 is at least 90% of the S&P index. If the return on the Company’s stock, in comparison to the S&P index, is above 90% but less than 99% of the S&P index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company’s stock exceeds 100% of the S&P index, every 1% increase in comparison to the S&P index, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO.

25%

Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2024 is greater than the Russell 2000 index (the “Russell index”). The vesting threshold is if the return on the Company’s stock for 2024 is at least 90% of the Russell index. If the return on the Company’s stock, in comparison to the Russell index, is above 90% but less than 99% of the Russell index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company’s stock exceeds 100% of the Russell index, every 1% increase in comparison to the Russell index, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO.

 

(*) As of June 30, 2024, the Company's management estimates that it is not probable that the performance condition will be met by year end.

 

21

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

Accordingly, assuming maximum achievement of the performance goals set forth above, PSUs representing an additional 60%, meaning an additional 29,986, would be eligible for vesting of the Company’s CEO, and an additional 40%, meaning an additional 5,344, 4,372 and 3,609, would be eligible for vesting for each of the Company’s CFO, COO and CCO, respectively.

 

Subject to achievement of the thresholds the above performance goals for 2024, the PSUs vest 33.4% on February 16, 2025, 33.3% on February 16, 2026 and 33.3% on February 16, 2027. 

 

A summary of the Company’s RSU and PSU activities and related information for the six months ended June 30, 2024, are as follows:

 

   

Number of
RSUs and

PSUs

   

Weighted

Average Grant-

Date
Fair Value

 

Unvested as of December 31, 2023

    1,281,751     $ 24.97  

Granted

    693,378       18.18  

Vested

    (286,976

)

    32.22  

Forfeited or expired

    (142,032

)

    20.58  

Unvested as of June 30, 2024 (unaudited)

    1,546,121     $ 20.97  

 

As of June 30, 2024, there was $23,955 of unrecognized compensation expense related to unvested RSUs and PSUs. This amount is expected to be recognized over a weighted-average period of 1.6 years.

 

The following table shows the total equity-based compensation expense included in the interim condensed consolidated statements of loss:

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Cost of revenue

  $ 394     $ 420     $ 191     $ 214  

Research and development, net

    4,445       4,446       2,438       2,344  

Sales and marketing

    816       827       451       449  

General and administrative

    1,816       1,758       820       897  

Total equity-based compensation expense from continuing operations

    7,471       7,451       3,900       3,904  

Equity-based compensation expense included in discontinued operations

          613             301  

Total equity-based compensation expense

  $ 7,471     $ 8,064     $ 3,900     $ 4,205  

 

22

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

The fair value for rights to purchase shares of common stock under the Company’s employee stock purchase plan was estimated on the date of grant using the following assumptions:

 

   

Six months ended
June 30

 
   

2024

(unaudited)

   

2023

(unaudited)

 

Expected dividend yield

    0

%

    0

%

Expected volatility

    46

%

    45

%

Risk-free interest rate

    5.3

%

    4.8

%

Contractual term of up to (months)

    6       6  

 

 

 

NOTE 12:

DERIVATIVES AND HEDGING ACTIVITIES

 

The Company follows the requirements of FASB ASC No. 815,” Derivatives and Hedging” which requires companies to recognize all of their derivative instruments as either assets or liabilities in the statement of financial position at fair value. The accounting for changes in fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging transaction and further, on the type of hedging transaction. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. Due to the Company’s global operations, it is exposed to foreign currency exchange rate fluctuations in the normal course of its business. The Company’s treasury policy allows it to offset the risks associated with the effects of certain foreign currency exposures through the purchase of foreign exchange forward or option contracts (“Hedging Contracts”). The policy, however, prohibits the Company from speculating on such Hedging Contracts for profit. To protect against the increase in value of forecasted foreign currency cash flow resulting from salaries paid in currencies other than the U.S. dollar during the year, the Company instituted a foreign currency cash flow hedging program. The Company hedges portions of the anticipated payroll of its non-U.S. employees denominated in the currencies other than the U.S. dollar for a period of one to twelve months with Hedging Contracts. Accordingly, when the dollar strengthens against the foreign currencies, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the Hedging Contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency expenses is offset by gains in the fair value of the Hedging Contracts. These Hedging Contracts are designated as cash flow hedges.

 

For derivative instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. As of June 30, 2024, and December 31, 2023, the notional principal amount of the Hedging Contracts to sell U.S. dollars held by the Company was $5,900 and $16,500, respectively.

 

The fair value of the Company’s outstanding derivative instruments is as follows:

 

   

June 30, 2024

(unaudited)

   

December 31,

2023

 

Derivative assets:

               

Derivatives designated as cash flow hedging instruments:

               

Foreign exchange forward contracts

  $ 51     $ 988  

Total

  $ 51     $ 988  
                 

Derivative liabilities:

               

Derivatives designated as cash flow hedging instruments:

               

Foreign exchange option contracts

  $ 9     $  

Total

  $ 9     $  

 

23

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

The increase (decrease) in unrealized gains (losses) recognized in “accumulated other comprehensive gain (loss)” on derivatives, before tax effect, is as follows:

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Derivatives designated as cash flow hedging instruments:

                               

Foreign exchange option contracts

  $ 16     $ (198 )   $ 16     $ (93 )

Foreign exchange forward contracts

    (355 )     (432 )     (160 )     (112 )
    $ (339 )   $ (630 )   $ (144 )   $ (205 )

 

The net (gains) losses reclassified from “accumulated other comprehensive gain (loss)” into income are as follows:

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Derivatives designated as cash flow hedging instruments:

                               

Foreign exchange option contracts

  $ (25 )   $ 112     $ (25 )   $ 112  

Foreign exchange forward contracts

    (582 )     462       (202 )     291  
    $ (607 )   $ 574     $ (227 )   $ 403  

 

The Company recorded in cost of revenues and operating expenses a net gain of $227 and $607 during the three and six months ended June 30, 2024, respectively, and a net loss of $403 and $574 during the comparable periods of 2023, related to its Hedging Contracts. 

 

 

 

NOTE 13:

ACCUMULATED OTHER COMPREHENSIVE LOSS

 

The following tables summarize the changes in accumulated balances of other comprehensive income (loss), net of taxes:

 

   

Six months ended June 30, 2024 (unaudited)

   

Three months ended June 30, 2024 (unaudited)

 
   

Unrealized

gains

(losses) on

available-

for-

sale

marketable

securities

   

Unrealized

gains

(losses)

on cash

flow hedges

   

Total

   

Unrealized

gains

(losses) on

available-

for-

sale

marketable

securities

   

Unrealized

gains

(losses)

on cash

flow hedges

   

Total

 
                                                 

Beginning balance

  $ (3,317 )   $ 988     $ (2,329 )   $ (3,133 )   $ 413     $ (2,720 )

Other comprehensive income (loss) before reclassifications

    391       (340 )     51       203       (145 )     58  

Amounts reclassified from accumulated other comprehensive loss

    (10 )     (606 )     (616 )     (6 )     (226 )     (232 )

Net current period other comprehensive income (loss)

    381       (946 )     (565 )     197       (371 )     (174 )

Ending balance

  $ (2,936 )   $ 42     $ (2,894 )   $ (2,936 )   $ 42     $ (2,894 )

 

24

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

   

Six months ended June 30, 2023 (unaudited)

   

Three months ended June 30, 2023 (unaudited)

 
   

Unrealized

gains

(losses) on

available-

for-

sale

marketable

securities

   

Unrealized

gains

(losses)

on cash

flow hedges

   

Total

   

Unrealized

gains

(losses) on

available

for-

sale

marketable

securities

   

Unrealized

gains

(losses) on

cash

flow hedges

   

Total

 
                                                 

Beginning balance

  $ (6,142 )   $ (107 )   $ (6,249 )   $ (5,550 )   $ (360 )   $ (5,910 )

Other comprehensive income (loss) before reclassifications

    798       (631 )     167       114       (205 )    

(91

)

Amounts reclassified from accumulated other comprehensive loss

    (77 )     576       499       15       403       418  

Net current period other comprehensive income (loss)

    721       (55 )     666       129       198       327  

Ending balance

  $ (5,421 )   $ (162 )   $ (5,583 )   $ (5,421 )   $ (162 )   $ (5,583 )

 

 

The following table provides details about reclassifications out of accumulated other comprehensive income (loss):

 

Details about Accumulated

Other Comprehensive Income

(Loss) Components

 

Amount Reclassified from Accumulated Other

Comprehensive Income (Loss)

 

Affected Line Item in the

Statements of Income (Loss)

                                   
   

Six months ended June 30,

   

Three months ended June 30,

   
   

2024
(unaudited)

   

2023
(unaudited)

   

2024
(unaudited)

   

2023
(unaudited)

   

Unrealized gains (losses) on cash flow hedges

  $ 13     $ (11 )  

$

5     $ (7 )

Cost of revenues

      518       (495 )     194       (348 )

Research and development

      15       (13 )     6       (9 )

Sales and marketing

      61       (55 )     22       (39 )

General and administrative

      607       (574 )     227       (403 )

Total, before income taxes

      1       2       1        

Income tax expense (benefit)

      606       (576 )     226       (403 )

Total, net of income taxes

Unrealized gains (losses) on available-for-sale marketable securities

    10       76       6       (16 )

Financial income (loss), net

            (1

)

          (1 )

Income tax benefit

      10       77       6       (15 )

Total, net of income taxes

    $ 616     $ (499 )  

$

232     $ (418 )

Total, net of income taxes

 

25

 
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)
 
(in thousands, except share data)

 

 

NOTE 14:

SHARE REPURCHASE PROGRAM

 

During the three and six months ended June 30, 2024, the Company repurchased 100,431 and 157,303 shares of common stock at an average purchase price of $19.89 and $20.83 per share, respectively, for an aggregate purchase price of $1,998 and $3,276, respectively. The Company did not repurchase any shares of common stock during the three and six months ended June 30, 2023. As of June 30, 2024, 542,697 shares of common stock remained available for repurchase pursuant to the Company’s share repurchase program.

 

The repurchases of common stock are accounted for as treasury stock, and result in a reduction of stockholders’ equity. When treasury shares are reissued, the Company accounts for the reissuance in accordance with FASB ASC No. 505-30, “Treasury Stock” and charges the excess of the repurchase cost over issuance price using the weighted average method to retained earnings. The purchase cost is calculated based on the specific identified method. In the case where the repurchase cost over issuance price using the weighted average method is lower than the issuance price, the Company credits the difference to additional paid-in capital.

 

 

 

 

 

Item 2.

MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion together with the unaudited financial statements and related notes appearing elsewhere in this quarterly report. This discussion contains forward-looking statements that involve risks and uncertainties. Any or all of our forward-looking statements in this quarterly report may turn out to be wrong. These forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Factors which could cause actual results to differ materially include those set forth under in Part II Item 1A Risk Factors, as well as those discussed elsewhere in this quarterly report. See Forward-Looking Statements.

 

The financial information presented in this quarterly report includes the results of Ceva, Inc. and its subsidiaries.

 

BUSINESS OVERVIEW

 

Headquartered in Rockville, Maryland, Ceva is the leader in innovative silicon and software IP solutions that enable smart edge products to connect, sense, and infer data more reliably and efficiently. With the industry’s only portfolio of comprehensive communications and scalable edge AI IP, Ceva powers the connectivity, sensing, and inference in today’s most advanced smart edge products across consumer IoT, mobile, automotive, infrastructure, industrial, and personal computing. More than 18 billion of the world’s most innovative smart edge products from AI-infused smartwatches, IoT devices and wearables to autonomous vehicles, 5G mobile networks and more are powered by Ceva.

 

Ceva is a trusted partner to over 400 of the leading semiconductor and original equipment manufacturer (OEM) companies targeting a wide variety of cellular and IoT end markets, including mobile, PC, consumer, automotive, smart-home, surveillance, robotics, industrial and medical. The customers incorporate our IP into application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs) that they manufacture, market and sell to consumer electronics companies. Our application software IP is licensed primarily to OEMs who embed it in their System on Chip (SoC) designs to enhance the user experience, and OEMs also license our hardware IP products and solutions for their SoC designs to create power-efficient, intelligent, secure and connected devices.

 

Ceva’s wireless communications, sensing and edge AI technologies are at the heart of some of today’s most advanced smart edge products. From Bluetooth connectivity, Wi-Fi, ultra-wide band (UWB) and 5G platform IP for ubiquitous, robust communications, to scalable edge AI neural processing unit (NPU) IPs, sensor fusion processors and embedded application software that make devices smarter.

 

We license our portfolio of wireless communications and scalable edge AI IP to our customers, breaking down barriers to entry and enabling them to bring new cutting-edge products to market faster, more reliably, efficiently and economically.

 

Ceva is a sustainability and environmentally conscious company. We have adopted both a Code of Business Conduct and Ethics and a Sustainability Policy, in which we emphasize and focus on environmental preservation, recycling, the welfare of our employees and privacy – which we promote on a corporate level. At Ceva, we are committed to social responsibility, values of preservation and consciousness towards these purposes.

 

We believe our portfolio of wireless communications and sensing and edge AI technologies address some of the most important megatrends, including 5G, generative AI, industrial automation and vehicle electrification. We continue to experience strong interest across our IP portfolio due to these trends, in both traditional and new areas. In the second quarter of 2024, eleven IP licensing deals were concluded for a range of wireless and smart sensing use cases.

 

We believe the following key elements represent significant growth drivers for the company:

 

 

Our broad Bluetooth, Wi-Fi, UWB and cellular IoT IPs allow us to address the high volume IoT industrial, consumer and smart home markets. Our addressable market size for Bluetooth, Wi-Fi, UWB and cellular IoT is expected to be more than 15 billion devices annually by 2027 based on research from ABI Research. In the second quarter of 2024, we signed a strategic licensing deal with a leading U.S. analog semiconductor company for our Ceva-Waves Bluetooth portfolio expanding our market leading position for Bluetooth with more than 30% market share worldwide, excluding mobile. In addition, we believe that Wi-Fi presents a significant royalty revenue opportunity, given our dominant market position in licensing Wi-Fi 6 with more than 40 customers to date and leadership position in Wi-Fi 7 IP.

 

 

 

Our PentaG2 platform and digital signal processors (DSPs) for 5G mobile broadband and 5G RedCap is the most comprehensive baseband IP platform in the industry today and provides newcomers and incumbents with a comprehensive solution to address the need for 5G processing for fixed wireless access, satellite communications and a range of connected devices such as robots, cars, smart cities and other devices for industrial applications. Indicative of the demand for our 5G IPs, in the second quarter of 2024, we signed two deals for 5G new use cases, following on from three deals signed in the first quarter of 2024.

 

 

Our PentaG RAN platform for 5G RAN, including the recently announced Ceva-XC22 multi-thread DSP, ensures we offer the most comprehensive baseband processor IP in the industry today. Our 5G IPs provide newcomers and incumbents with a customizable solution to address the need for 5G and other communications in data centers and infrastructure. In the second quarter, we signed new agreements with our two large infrastructure OEM customers to deliver customized next-generation DSPs for their long-term roadmaps, reinforcing our position as the de-facto RAN DSP IP supplier for 5G-Advanced and beyond.

 

 

The high-volume consumer audio markets, including True Wireless Stereo (TWS) earbuds, smartwatches, AR and VR headsets, and other wearable assisted devices, offers an incremental growth segment for us for our Bluetooth, Audio AI DSPs and software IPs. For OEMs to better address this market, our RealSpace Spatial Audio & Head Tracking Solution and ClearVox voice input software are available to enhance the user experience and offer premium features.

 

 

Our SensPro2 sensor hub AI DSP family is designed to address the growing demand for efficient, high-performance signal processing in sensor-based applications across various industries and applications such as smartphones, automotive safety (ADAS), autonomous driving (AD), drones, robotics, security and surveillance, augmented reality (AR) and virtual reality (VR), natural language processing (NLP) and voice recognition. Research from Bloomberg Intelligence forecasts that hardware revenue associated with computer vision AI products and conversational AI devices will reach $61 billion and $108 billion, respectively by 2030, indicating the size of the market opportunity. This sensor hub AI DSP enables us to address the transformation in devices enabled by these applications, and expand our footprint and content in smartphones, drones, consumer cameras, surveillance, automotive ADAS, voice-enabled devices and industrial IoT applications.

 

 

Transformer and classic neural networks are increasingly being deployed in a wide range of devices in order to make these devices “smarter.”  Our newest generation family of AI NPUs present a highly-efficient and high performance architecture to enable generative and classic AI on any device including communication gateways, optically connected networks, cars, notebooks and tablets, AR/VR headsets, smartphones, and any other cloud or edge use case from the edge all the way to the cloud. Per research from Yole Group, 2.5 billion Edge AI devices will ship annually by 2026, illustrating the huge potential of the market.

 

 

AI is rapidly making its way into IoT devices, thanks in part to the emergence of tiny machine learning (“TinyML”) models, which enable small AI networks to be embedded in AIoT devices for sensing use cases including sound, vision, vibration and health monitoring. Our recently announced NeuPro-Nano family of AI NPUs present a compelling proposition to add a cost- and power-efficient processor to microcontroller units and SoC designs to handle the complete AI workloads, on-device. Per ABI Research, by 2030, over 40% of TinyML shipments will be powered by dedicated TinyML hardware such as NeuPro-Nano, representing billions of devices annually. NeuPro-Nano will allow us to expand on our strong position in IoT where we have a dominant position in wireless connectivity, as these customers increasingly look to add support for AI to their cost- and power-constrained chips for this market.

 

 

Our sensor fusion and spatial audio application software allows us to address an important technology piece used in personal computers, robotics, TWS earbuds, smart TVs and many other smart sensing IP products, in addition to our existing portfolio for camera-based computer vision and AI processing, and microphone-based sound processing. MEMS-based inertial and environmental sensors are used in an increasing number of devices, including robotics, smartphones, laptops, tablets, TWS earbuds, spatial audio headsets, remote controls and many other consumer and industrial devices. Our innovative and proven MotionEngine™ software supports a broad range of merchant sensor chips and is processor-agnostic in order to address the requirements of any OEM or semiconductor company that wishes to enhance their customer user experience. The MotionEngine software has already shipped in more than 300 million devices, indicative of its market traction and excellence. Along with our SensPro sensor hub AI DSPs, our licensees now benefit from our capabilities as a complete, one-stop-shop for processing all classes and types of sensors.

 

As a result of our focus on silicon and software IP solutions that enable products to connect, sense, and infer data, we believe we are well positioned for long-term growth in shipments and royalty revenues derived from smart edge products. Royalty rates from these products are comprised of a range of ASPs, spanning from high volume Bluetooth and Wi-Fi to high value sensor fusion and base station RAN. The royalty ASP of our other products will be in between the two ranges.

 

 

CURRENT TRENDS

 

We believe that as the continuing digital transformation drives industries to become connected and intelligent, our ubiquitous technology and collaborative business model present a significant and secular growth prospect. We intend to continue to capitalize on the semiconductor momentum with our portfolio of technologies to enable three main use cases associated with smart edge devices: connect, sense and infer. We intend to focus on four main markets, which are consumer, automotive, industrial and infrastructure, which we believe are large, diversified and represent the greatest opportunities for long-term growth. We will also continue to serve the mobile and PC markets where we have established customers and market presence. We believe our key customers are keenly receptive to our products roadmap around connect, sense and infer, and that they are willing to expand the scope of engagements with us as our roadmap aligns with their technology needs. Furthermore, we anticipate that we can expand our customer base and revenues in Europe and the U.S., complementing our strong presence in China, Taiwan, Japan and the remainder of the APAC region.

 

In 2024, we believe our strategy will return Ceva to year-over-year revenue growth, with overall revenue expected to grow 4% to 8% over 2023. Most of this growth is expected to be concentrated in the second half of the year. In 2024, we expect our licensing and related revenues business will continue to expand into new markets and use cases in the industrial IoT (IIoT) and consumer IoT, offering connectivity platforms, sensing platforms and software, AI solutions (including AI engines, NPUs and software) and more. On royalties, we expect our connectivity products to continue to show strength in 2024, particularly related to our Bluetooth, Wi-Fi and cellular IoT business lines, with the expected ramp of automotive ADAS royalties in the second half of the year.

 

Instability in the Middle East

 

Our operations in Israel remain largely unaffected by the war between Israel and Hamas that began on October 7, 2023, and we continue to drive our business and support our customers globally. However, a portion of our employees in Israel have been or are called to active reserve duty and additional employees may be called in the future, if needed. The Company has executed its business continuity plan with respect to those employees. It is possible that some of our operations in the region may be disrupted if this continues for a significant period of time or if the situation further deteriorates.

 

RESULTS OF OPERATIONS

 

Total Revenues

 

Total revenues were $28.4 million and $50.5 million for the second quarter and first half of 2024, respectively, representing an increase of 24% and 3% as compared to the corresponding periods in 2023. The increase in total revenues for the second quarter of 2024 was due to higher licensing and related revenues and higher royalty revenues, as further described below. The increase in total revenues for the first half of 2024 was due to higher royalty revenues, offset by lower licensing and related revenues, as further described below.

 

Our five largest customers accounted for 66% and 50% of our total revenues for the second quarter and first half of 2024, respectively, as compared to 49% and 33% for the comparable periods in 2023. Three customers accounted for 23%, 21% and 13% of our total revenues for the second quarter of 2024, as compared to three customers that accounted for 14%, 14% and 10% of our total revenues for the second quarter of 2023. Three customers accounted for 13%, 13% and 13% of our total revenues for the first half of 2024. There were no customers that accounted for more than 10% of our total revenues for the first half of 2023. Generally, the identity of our customers representing 10% or more of our total revenues varies from period to period, especially with respect to our IP licensing customers as we generate licensing revenues generally from new customers on a quarterly basis. With respect to our royalty revenues, two royalty paying customers represented 10% or more of our total royalty revenues for both the second quarter and first half of 2024, and collectively represented 45% and 43% of our total royalty revenues for the second quarter and first half of 2024, respectively. Two royalty paying customers represented 10% or more of our total royalty revenues for both the second quarter and first half of 2023, and collectively represented 47% and 38% of our total royalty revenues for the second quarter and first half of 2023, respectively. We expect that a significant portion of our future revenues will continue to be generated by a limited number of customers. The concentration of our customers is explainable in part by consolidation in the semiconductor industry.

 

The following table sets forth use cases for Ceva technology portfolio as percentages of our total revenues for each of the periods set forth below:

 

   

First Half
2024

   

First Half
2023

   

Second Quarter
2024

   

Second Quarter
2023

 
                                 

Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT)

    85 %     82 %     88 %     81 %

Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI)

    15 %     18 %     12 %     19 %

   

 

Licensing and Related Revenues

 

Licensing and related revenues were $17.3 million and $28.7 million for the second quarter and first half of 2024, respectively, representing an increase of 28% and a decrease of 10%, as compared to the corresponding periods in 2023. The increase in licensing and related revenues for the second quarter of 2024 was mainly due to the signing of a number of strategic deals in the second quarter of 2024, including two deals with our large OEM customers in wireless infrastructure for their development of next-generation ASICs to address the incredible growth in network traffic and performance improvements required to support Generative AI and Hybrid AI systems. The decrease in licensing and related revenues for the first half of 2024 was mainly due to a decrease from our wireless communications IP portfolio, partially offset by the strategic deals signed in the second quarter of 2024 as explained above. Our backlog heading into the third quarter is healthy, on the back of signing some significant deals in the quarter, including one with a leading U.S. analog semiconductor company for our Bluetooth portfolio.

 

During the second quarter of 2024, eleven IP licensing agreements were concluded, targeting a wide range of end markets and applications, including AI solutions for industrial and consumer edge AI devices, next-generation wireless infrastructure to enable ubiquitous AI, 5G satellite, 5G RedCap and Bluetooth connectivity for wearables and hearables. Five of the deals concluded in the second quarter of 2024 were with OEMs and one deal signed was with a first-time customer.

 

Licensing and related revenues accounted for 61% and 57% of our total revenues for the second quarter and first half of 2024, respectively, as compared to 59% and 65% for the comparable periods of 2023.

 

Royalty Revenues

 

Royalty revenues were $11.2 million and $21.8 million for the second quarter and first half of 2024, respectively, representing an increase of 19% and 25%, as compared to the corresponding periods in 2023. The second quarter and first half of 2024 included revenue of $0.3 million and $1.3 million, respectively, following the resolution of royalty audits. Excluding this amount, the second quarter and first half of 2024 would have been up by 16% and 18%, respectively, as compared to the comparable periods of 2023. Royalty revenues accounted for 39% and 43% of our total revenues for the second quarter and first half of 2024, respectively, as compared to 41% and 35% for the comparable periods of 2023. In the second quarter of 2024 we saw shipment volumes up 24% year-over-year, driven predominantly by our customers taking more market share in Bluetooth, Wi-Fi and cellular IoT in the growing industrial, healthcare and consumer IoT end markets. Smartphones recovered well from the first quarter of 2024, and our large customer addressing the low to mid-range market segment is expanding its customer base with new design wins. 

 

Our customers reported sales of 461 million and 832 million chipsets incorporating our technologies for the second quarter and first half of 2024, respectively, an increase of 24% and 25% from the corresponding periods in 2023 for actual shipments reported.

 

The five largest royalty-paying customers accounted for 63% and 59% of our total royalty revenues for the second quarter and first half of 2024, respectively, as compared to 64% and 53% for the comparable periods of 2023.

 

Geographic Revenue Analysis

 

   

First Half
2024

   

First Half
2023

   

Second Quarter
2024

   

Second Quarter
2023

 
   

(in millions, except percentages)

 

United States

  $ 3.9     8 %   $ 4.1     8 %   $ 1.4     5 %   $ 1.7     8 %

Europe and Middle East (2)

  $ 9.0     18 %   $ 4.9     10 %   $ 7.4     26 %   $ 2.1     9 %

Asia Pacific (1)

  $ 37.6     74 %   $ 39.7     81 %   $ 19.6     69 %   $ 19.1     83 %

Other

  $ * )   * )   $ 0.5     1 %   $           * )   * )
                                                         

(1) China

  $ 29.0     57 %   $ 30.5     62 %   $ 15.4     54 %   $ 12.7     55 %

(2) Finland

  $ 6.6     13 %   $ * )   * )   $ 6.5     23 %   $ * )   * )

 

*) Less than 10%

 

Due to the nature of our license agreements and the associated potential large individual contract amounts, the geographic split of revenues both in absolute dollars and percentage terms generally varies from quarter to quarter.

 

 

Cost of Revenues

 

Cost of revenues was $2.9 million and $5.4 million for the second quarter and first half of 2024, respectively, as compared to $3.5 million and $7.0 million for the comparable periods of 2023. Cost of revenues accounted for 10% and 11% of our total revenues for the second quarter and first half of 2024, respectively, as compared to 15% and 14% for the comparable periods of 2023. The decrease for the second quarter of 2024 principally reflected lower customization work for our licensees. The decrease for the first half of 2024 principally reflected lower customization work for our licensees and lower cost of unit shipments related to our sensor fusion chip business. Included in cost of revenues for the second quarter and first half of 2024 was a non-cash equity-based compensation expense of $191,000 and $394,000, respectively, as compared to $214,000 and $420,000 for the comparable periods of 2023.

 

Gross Margin

 

Gross margin for the second quarter and first half of 2024 was 90% and 89%, respectively, as compared to 85% and 86% for the comparable periods of 2023. The increase for both the second quarter and first half of 2024 mainly reflected lower cost of revenues as set forth above, as well as higher total revenues. The gross margin for the second quarter and first half of 2023 reflects historical period on a re-cast basis excluding the Intrisix business as a discontinued operation, is also illustrative of our decision to return to pure IP licensing and royalty business model.

 

Operating Expenses

 

Total operating expenses were $25.5 million and $50.1 million for the second quarter and first half of 2024, respectively, as compared to $24.7 million and $50.1 million for the comparable periods of 2023. The net increase for the second quarter of 2024 principally reflected lower research grants received, mainly from the Israeli Innovation Authority of the Ministry of Economy and Industry in Israel (IIA), and lower customization work for our licensees, partially offset by lower professional services cost.

 

Research and Development Expenses, Net

 

Total research and development expenses, net were $18.8 million and $36.7 million for the second quarter and first half of 2024, respectively, as compared to $18.1 million and $36.7 million for the comparable periods of 2023. The increase for the second quarter of 2024 principally reflected lower research grants received, mainly from the IIA, and lower customization work for our licensees, partially offset by lower salaries and related costs. Included in research and development expenses for the second quarter and first half of 2024 were non-cash equity-based compensation expenses of $2,438,000 and $4,445,000, respectively, as compared to $2,344,000 and $4,446,000 for the comparable periods of 2023. Research and development expenses as a percentage of our total revenues were 66% and 73% for the second quarter and first half of 2024, respectively, as compared to 79% and 75% for the comparable periods of 2023. The percentage decrease for both the second quarter and first half of 2024, as compared to the comparable periods of 2023, was mainly due to higher revenues.

 

The number of research and development personnel was 332 at June 30, 2024, as compared to 337 at June 30, 2023. 

 

Sales and Marketing Expenses

 

Our sales and marketing expenses were $3.1 million and $5.9 million for the second quarter and first half of 2024, respectively, as compared to $2.6 million and $5.4 million for the comparable periods of 2023. The increase for both the second quarter and first half of 2024 principally reflected higher commission expenses as well as higher sales training and higher marketing and trade shows events. Included in sales and marketing expenses for the second quarter and first half of 2024 were non-cash equity-based compensation expenses of $451,000 and $816,000, respectively, as compared to $449,000 and $827,000 for the comparable periods of 2023. Sales and marketing expenses as a percentage of our total revenues were 11% and 12% for the second quarter and first half of 2024, respectively, as compared to 11% for both the comparable periods of 2023.

 

The total number of sales and marketing personnel was 30 at June 30, 2024, as compared to 33 at June 30, 2023.

 

General and Administrative Expenses

 

Our general and administrative expenses were $3.5 million and $7.1 million for the second quarter and first half of 2024, respectively, as compared to $3.9 million and $7.7 million for the comparable periods of 2023. The decrease for both the second quarter and first half of 2024 primarily reflected lower professional services cost. Included in general and administrative expenses for the second quarter and first half of 2024 were non-cash equity-based compensation expenses of $820,000 and $1,816,000, respectively, as compared to $897,000 and $1,758,000 for the comparable periods of 2023. General and administrative expenses as a percentage of our total revenues were 12% and 14% for the second quarter and first half of 2024, respectively, as compared to 17% and 16% for the comparable periods of 2023.

 

 

The number of general and administrative personnel was 45 at June 30, 2024, as compared to 42 at June 30, 2023.

 

Amortization of Intangible Assets

 

Our amortization charges were $0.1 million and $0.3 million for the second quarter and first half of 2024, respectively, as compared to $0.1 million and $0.3 million for the comparable periods of 2023. The amortization charges for the second quarter and first half of 2024 and 2023 were incurred in connection with the amortization of intangible assets associated with the acquisitions of the Hillcrest Labs and VisiSonics business.

 

Financial Income, Net (in millions) 

 

   

First Half
2024

   

First Half
2023

   

Second

Quarter
2024

   

Second

Quarter
2023

 

Financial income, net

  $ 2.66     $ 2.58     $ 1.40     $ 1.12  

of which:

                               

Interest income and gains and losses from marketable securities, net

  $ 2.94     $ 2.22     $ 1.49     $ 1.03  

Foreign exchange gain (loss)

  $ (0.28 )   $ 0.36     $ (0.09 )   $ 0.09  

 

Financial income, net, consists of interest earned on investments, gains and losses from sale of marketable securities, accretion (amortization) of discounts (premiums) on marketable securities and foreign exchange movements.

 

The increase in interest income and gains and losses from marketable securities, net, during both the second quarter and first half of 2024 principally reflected higher combined bank deposits and marketable securities balances held (mainly because of cash received from the sale of Intrinsix in October 2023) and higher yields.

 

We review our monthly expected major non-U.S. dollar denominated expenditures and look to hold equivalent non-U.S. dollar cash balances to mitigate currency fluctuations. However, our Euro cash balances increase significantly on a quarterly basis beyond our Euro liabilities, mainly from applicable French research tax credits, which are generally refunded every three years. This has resulted in a foreign exchange loss of $0.09 million and $0.28 million for the second quarter and first half of 2024, respectively, as compared to foreign exchange gain of $0.09 million and $0.36 million for the comparable periods of 2023.

 

Remeasurement of Marketable Equity Securities

 

We recorded a loss of $0.1 million for both the second quarter and first half of 2024 as compared to a loss of $0.1 million and $0.2 million for the comparable periods of 2023, related to remeasurement of marketable equity securities, which we hold at cost. Over time, other income (expense), net, may be affected by market dynamics and other factors. Equity values generally change daily for marketable equity securities and upon the occurrence of observable price changes or upon impairment of marketable equity securities. In addition, volatility in the global economic climate and financial markets could result in a significant change in the value of our investments.

 

 

Provision for Income Taxes

 

Our income tax expenses was $1.6 million and $3.3 million for the second quarter and first half of 2024, respectively, as compared to $0.5 million and $2.0 million for the comparable periods of 2023. The increase for both the second quarter and first half of 2024 primarily reflected higher withholding tax expenses in our Israeli subsidiary for which we will not be able to obtain a refund from the tax authorities and the effect of the capitalization of R&D expenditures under IRC Section 174.

 

We are subject to income and other taxes in the United States and in numerous foreign jurisdictions. Our domestic and foreign tax liabilities are dependent on the jurisdictions in which profits are determined to be earned and taxed. Additionally, the amount of taxes paid is subject to our interpretation of applicable tax laws in the jurisdictions in which we operate. A number of factors influence our effective tax rate, including changes in tax laws and treaties as well as the interpretation of existing laws and rules. Federal, state, and local governments and administrative bodies within the United States, and other foreign jurisdictions have implemented, or are considering, a variety of broad tax, trade, and other regulatory reforms that may impact us. For example, the Tax Cuts and Jobs Act (the “U.S. Tax Reform”) enacted on December 22, 2017 resulted in changes in our corporate tax rate, our deferred income taxes, and the taxation of foreign earnings. It is not currently possible to accurately determine the potential comprehensive impact of these or future changes, but these changes could have a material impact on our business and financial condition.

 

We have significant operations in Israel and operations in France and the Republic of Ireland. A substantial portion of our taxable income is generated in Israel and France, as well as potentially in the U.S. due to global intangible low-taxed income (GILTI) and the requirement to capitalize R&D expenditures under IRC Section 174 over 5 years if sourced from the U.S. and over 15 years if sourced internationally. Although our Israeli and Irish subsidiaries, and, from 2022 onward, our French subsidiary, are taxed at rates substantially lower than U.S. tax rates, the tax rates in these jurisdictions could nevertheless result in a substantial increase as a result of withholding tax expenses with respect to which we are unable to obtain a refund from the relevant tax authorities.

 

Our Irish subsidiary qualified for a 12.5% tax rate on its trade. Interest income generated by our Irish subsidiary is taxed at a rate of 25%.

 

Our French subsidiary is entitled to a tax benefit of 10% applied to specific revenues under the French IP Box regime. The French IP Box regime applies to net income derived from the licensing, sublicensing or sale of several IP rights such as patents and copyrighted software, including royalty revenues. This elective regime requires a direct link between the income benefiting from the preferential treatment and the R&D expenditures incurred and contributing to that income. Qualifying income may be taxed at a favorable 10% CIT rate (plus social surtax, hence 10.3% in total).

 

Our Israeli subsidiary is entitled to various tax benefits as a technological enterprise. In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016, which includes the Amendment to the Law for the Encouragement of Capital Investments, 1959 (Amendment 73) (the “Amendment”), was published. The Amendment, among other things, prescribes special tax tracks for technological enterprises, which are subject to rules that were issued by the Minister of Finance in April 2017.

 

The new tax track under the Amendment, which is applicable to our Israeli subsidiary, is the “Technological Preferred Enterprise”. Technological Preferred Enterprise is an enterprise for which total consolidated revenues of its parent company and all subsidiaries are less than 10 billion New Israeli Shekel (NIS). A Technological Preferred Enterprise, as defined in the Amendment, that is located in the center of Israel (where our Israeli subsidiary is currently located), is taxed at a rate of 12% on profits deriving from intellectual property. Any dividends distributed to “foreign companies”, as defined in the Amendment, deriving from income from technological enterprises will be taxed at a rate of 4%. We are applying the Technological Preferred Enterprise tax track for our Israeli subsidiary from tax year 2020 and onwards.

 

Critical Accounting Policies and Estimates

 

Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates.

 

 

We believe that the assumptions and estimates associated with revenue recognition, fair value of financial instruments, equity-based compensation and income taxes have the greatest potential impact on our consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates.

 

See our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 7, 2024, for a discussion of additional critical accounting policies and estimates. There have been no changes in our critical accounting policies as compared to what was previously disclosed in the Annual Report on Form 10-K for the year ended December 31, 2023.

 

LIQUIDITY AND CAPITAL RESOURCES

 

As of June 30, 2024, we had approximately $24.7 million in cash and cash equivalents, $2.1 million in bank deposits, and $131.6 million in marketable securities, totaling $158.4 million, as compared to $166.5 million at December 31, 2023. The decrease for the first six months of 2024 principally reflected cash used in operating activities and funds used to repurchase 157,303 shares of common stock for an aggregate consideration of approximately $3.3 million, partially offset by cash proceeds from exercise of stock-based awards.

 

Out of total cash, cash equivalents, bank deposits and marketable securities of $158.4 million, $133.3 million was held by our foreign subsidiaries. Our intent is to permanently reinvest earnings of our foreign subsidiaries and our current operating plans do not demonstrate a need to repatriate foreign earnings to fund our U.S. operations. However, if these funds were needed for our operations in the United States, we would be required to accrue and pay taxes to repatriate these funds. The determination of the amount of additional taxes related to the repatriation of these earnings is not practicable, as it may vary based on various factors such as the location of the cash and the effect of regulation in the various jurisdictions from which the cash would be repatriated.

 

During the first six months of 2024, we invested $30.0 million of cash in marketable securities with maturities up to 33 months from the balance sheet date. In addition, during the same period, marketable securities were sold or redeemed for cash amounting to $31.9 million. All of our marketable securities are classified as available-for-sale. The purchase and sale or redemption of available-for-sale marketable securities are considered part of investing cash flow. Available-for-sale marketable securities are stated at fair value, with unrealized gains and losses reported in accumulated other comprehensive income (loss), a separate component of stockholders’ equity, net of taxes. Realized gains and losses on sales of investments, as determined on a specific identification basis, are included in the interim condensed consolidated statements of loss. The amount of credit losses recorded for the first six months of 2024 was immaterial. For more information about our marketable securities, see Note 7 to the interim condensed consolidated financial statements for the three and six months ended June 30, 2024.

 

Bank deposits are classified as short-term bank deposits and long-term bank deposits. Short-term bank deposits are deposits with maturities of more than three months but no longer than one year from the balance sheet date, whereas long-term bank deposits are deposits with maturities of more than one year as of the balance sheet date. Bank deposits are presented at their cost, including accrued interest, and purchases and sales are considered part of cash flows from investing activities.

 

Operating Activities

 

Cash used in operating activities for the first six months of 2024 was $5.0 million and consisted of net loss of $5.7 million, adjustments for non-cash items of $9.3 million, and changes in operating assets and liabilities of $8.6 million. Adjustments for non-cash items primarily consisted of $2.0 million of depreciation and amortization of intangible assets, and $7.5 million of equity-based compensation expenses. The decrease in operating assets and liabilities primarily consisted of an increase in trade receivables of $5.0 million, an increase in prepaid expenses and other assets of $2.2 million (mainly related to unbilled receivables of $2.1 million classified as “other long-term assets” in the Interim Condensed Consolidated Balance Sheets), and a decrease in accrued payroll and related benefits of $2.0 million (mainly as a result of a yearly bonus payments), partially offset by a decrease in accrued interest on bank deposits in the amount of $0.4 million.

 

Cash used in operating activities for the first six months of 2023 was $9.9 million and consisted of net loss of $10.7 million, adjustments for non-cash items of $10.7 million, and changes in operating assets and liabilities of $9.9 million. Adjustments for non-cash items primarily consisted of $2.8 million of depreciation and amortization of intangible assets, and $8.1 million of equity-based compensation expenses. The decrease in operating assets and liabilities primarily consisted of an increase in trade receivables of $0.7 million, an increase in prepaid expenses and other assets of $2.0 million (mainly as a result of payment of a yearly design tool subscription in the first quarter of 2023, and an increase in applicable French research tax credits), an increase in deferred taxes, net of $0.4 million, a decrease in trade payables of $0.9 million, a decrease in accrued expenses and other payables of $1.2 million, and a decrease in accrued payroll and related benefits of $5.5 million (mainly as a result of a yearly bonus payments), partially offset by an increase in deferred revenues of $0.6 million.

 

 

Cash flows from operating activities may vary significantly from quarter to quarter depending on the timing of our receipts and payments. Our ongoing cash outflows from operating activities principally relate to payroll-related costs and obligations under our property leases and design tool licenses. Our primary sources of cash inflows are receipts from our accounts receivable, to some extent, funding from research and development government grants and French research tax credits, and interest earned from our cash, deposits and marketable securities. The timing of receipts of accounts receivable from customers is based upon the completion of agreed milestones or agreed dates as set out in the contracts. 

 

Investing Activities

 

Net cash provided by investing activities for the first six months of 2024 was $8.2 million, compared to $14.4 million of net cash provided by investing activities for the comparable period of 2023. We had a cash outflow of $30.0 million and a cash inflow of $31.9 million with respect to investments in marketable securities during the six months of 2024, as compared to a cash outflow of $2.5 million and a cash inflow of $17.7 million with respect to investments in marketable securities during the first six months of 2023. For the first half of 2024, we had proceeds of $8.0 million from bank deposits, as compared to proceeds of $4.0 million from bank deposits for the comparable period of 2023. We had a cash outflow of $1.5 million and $1.2 million during the first six months of 2024 and 2023, respectively, from purchase of property and equipment. For the first six months of 2024, we had a cash inflow of $0.5 million in connection with the sale of Intrinsix, and a cash outflow of $0.8 million for the acquisition of a Greek-based company. For the first six months of 2023, we had a cash outflow of $3.6 million for the acquisition of the VisiSonics business.

 

Financing Activities

 

Net cash used in financing activities for the first six months of 2024 was $1.7 million, as compared to net cash provided by financing activities in the amount of $1.7 million for the comparable period of 2023.

 

In August 2008, we announced that our board of directors approved a share repurchase program for up to one million shares of common stock pursuant to Rule 10b-18 of the Exchange Act, which was extended by an additional 7,100,000 shares collectively across further approvals in 2010, 2013, 2014, 2018, 2020 and 2023. During the first six months ended June 30, 2024, we repurchased 157,303 shares of common stock at an average purchase price of $20.83 per share for an aggregate purchase price of $3,276. There were no repurchases of our common stock during the six months ended June 30, 2023. As of June 30, 2024, we had 542,697 shares available for repurchase.

 

During the first six months of 2024, we received $1.6 million from the exercise of stock-based awards, as compared to $1.7 million received for the comparable period of 2023.

 

We believe that our cash and cash equivalents, short-term bank deposits and marketable securities, along with cash from operations, will provide sufficient capital to fund our operations for at least the next 12 months. We cannot provide assurances, however, that the underlying assumed levels of revenues and expenses will prove to be accurate.

 

In addition, as part of our business strategy, we occasionally evaluate potential acquisitions of businesses, products and technologies and minority equity investments. Accordingly, a portion of our available cash may be used at any time for the acquisition of complementary products or businesses or minority equity investments. Such potential transactions may require substantial capital resources, which may require us to seek additional debt or equity financing. We cannot assure you that we will be able to successfully identify suitable acquisition or investment candidates, complete acquisitions or investments, integrate acquired businesses into our current operations, or expand into new markets. Furthermore, we cannot provide assurances that additional financing will be available to us in any required time frame and on commercially reasonable terms, if at all.

 

Item 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

A majority of our revenues and a portion of our expenses are transacted in U.S. dollars and our assets and liabilities together with our cash holdings are predominately denominated in U.S. dollars. However, the majority of our expenses are denominated in currencies other than the U.S. dollar, principally the NIS and the Euro. Increases in volatility of the exchange rates of currencies other than the U.S. dollar versus the U.S. dollar could have an adverse effect on the expenses and liabilities that we incur when remeasured into U.S. dollars. We review our monthly expected non-U.S. dollar denominated expenditures and look to hold equivalent non-U.S. dollar cash balances to mitigate currency fluctuations. However, our Euro cash balances increase significantly on a quarterly basis beyond our Euro liabilities, mainly from French research tax benefits applicable to the CIR, which is generally refunded every three years. This has resulted in a foreign exchange loss of $86,000 and $279,000 for the second quarter and first half of 2024, respectively, and a foreign exchange gain of $93,000 and $356,000 for the comparable periods of 2023.

 

 

As a result of currency fluctuations and the remeasurement of non-U.S. dollar denominated expenditures to U.S. dollars for financial reporting purposes, we may experience fluctuations in our operating results on an annual and quarterly basis. To protect against the increase in value of forecasted foreign currency cash flow resulting from salaries paid in currencies other than the U.S. dollar during the year, we follow a foreign currency cash flow hedging program. We hedge portions of the anticipated payroll for our non-U.S. employees denominated in currencies other than the U.S. dollar for a period of one to twelve months with forward and option contracts. During the second quarter and first half of 2024, we recorded accumulated other comprehensive loss of $371,000 and $946,000, respectively, from our forward and option contracts, net of taxes, with respect to anticipated payroll expenses for our non-U.S. employees. During the second quarter and first half of 2023, we recorded accumulated other comprehensive gain of $198,000 and accumulated other comprehensive loss of $55,000, respectively, from our forward and option contracts, net of taxes, with respect to anticipated payroll expenses for our non-U.S. employees. As of June 30, 2024, the amount of other comprehensive gain from our forward and option contracts, net of taxes, was $42,000, which will be recorded in the consolidated statements of income (loss) during the following three months. We recognized a net gain of $227,000 and $607,000 for the second quarter and first half of 2024, respectively, and a net loss of $403,000 and $574,000 for the comparable periods of 2023, related to forward and options contracts. We note that hedging transactions may not successfully mitigate losses caused by currency fluctuations. We expect to continue to experience the effect of exchange rate and currency fluctuations on an annual and quarterly basis. 

 

The majority of our cash and cash equivalents are invested in high-grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits may be redeemed and therefore minimal credit risk exists with respect to them. Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation (FDIC) insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. While we monitor on a systematic basis the cash and cash equivalent balances in the operating accounts and adjust the balances as appropriate, these balances could be impacted if one or more of the financial institutions with which we deposit our funds fails or is subject to other adverse conditions in the financial or credit markets. To date, we have experienced no loss of principal or lack of access to our invested cash or cash equivalents; however, we can provide no assurance that access to our invested cash and cash equivalents will not be affected if the financial institutions that we hold our cash and cash equivalents fail.

 

We hold an investment portfolio consisting principally of corporate bonds. We have the ability to hold such investments until recovery of temporary declines in market value or maturity. As of June 30, 2024, the unrealized losses associated with our investments were approximately $3.3 million due to the dramatic changes in the interest rate environment that took place in 2022. As we tend to hold such bonds with unrealized losses to recovery, the allowance for credit losses was not material during the second quarter and first half of 2024. However, we can provide no assurance that we will recover present declines in the market value of our investments. 

 

Interest income and gains and losses from marketable securities, net, were $1.49 million and $2.94 million for the second quarter and first half of 2024, respectively, as compared to $1.03 million and $2.22 million for the comparable periods of 2023. The increase in interest income, and gains and losses from marketable securities, net, during both the second quarter and first half of 2024 reflected higher combined bank deposits and marketable securities balances held (mainly because of cash received from the sale of Intrinsix in October 2023) and higher yields.

 

We are exposed primarily to fluctuations in the level of U.S. interest rates. To the extent that interest rates rise, fixed interest investments may be adversely impacted, whereas a decline in interest rates may decrease the anticipated interest income for variable rate investments. We typically do not attempt to reduce or eliminate our market exposures on our investment securities because the majority of our investments are short-term. We currently do not have any derivative instruments but may put them in place in the future. Fluctuations in interest rates within our investment portfolio have not had, and we do not currently anticipate such fluctuations will have, a material effect on our financial position on an annual or quarterly basis.

 

Item 4.

CONTROLS AND PROCEDURES

 

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2024.

 

There has been no change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

 

PART II    OTHER INFORMATION

 

Item 1

LEGAL PROCEEDINGS

 

We are not a party to any litigation or other legal proceedings that we believe could reasonably be expected to have a material effect on our business, results of operations and financial condition.

 

Item 1A

RISK FACTORS

 

We have not identified any material changes to the Risk Factors previously disclosed in Part I—Item IA—“Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, any one or more of which could, directly or indirectly, cause our actual financial condition and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any of those factors, in whole or in part, could materially and adversely affect our business, financial condition, operating results and stock price. You should carefully consider the risks and uncertainties described in our Annual Report filed on Form 10-K for the fiscal year ended December 31, 2023, together with all of the other information in this Quarterly Report on Form 10-Q, including in “Part I—Item 2—”Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the condensed consolidated financial statements and related notes.

 

 

Item 2

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

The table below sets forth the information with respect to repurchases of our common stock during the three months ended June 30, 2024.

 

Period

 

(a) Total

Number of

Shares

Purchased

   

(b) Average Price

Paid per Share

   

(c) Total Number

of Shares

Purchased as Part

of Publicly

Announced Plans

or Programs

   

(d) Maximum

Number of Shares

that May Yet Be

Purchased Under

the Plans or

Programs (1)

 

Month #1 (April 1, 2024 to April 30, 2024)

 

__

   

__

   

__

      643,128  

Month #2 (May 1, 2024 to May 31, 2024)

    77,359     $ 19.86       77,359       565,769  

Month #3 (June 1, 2024 to June 30, 2024)

    23,072     $ 20.02       23,072       542,697  

TOTAL

    100,431     $ 19.89       100,431       542, 697 (2)

 

 

(1)

In August 2008, we announced that our board of directors approved a share repurchase program for up to one million shares of common stock pursuant to Rule 10b-18 of the Exchange Act, which was extended by an additional 7,100,000 shares collectively across further approvals in 2010, 2013, 2014, 2018, 2020 and 2023.

 

 

(2)

The number represents the number of shares of our common stock that remain available for repurchase pursuant to our share repurchase program.

 

Item 3

DEFAULTS UPON SENIOR SECURITIES

 

Not applicable.

 

Item 4

MINE SAFETY DISCLOSURES

 

Not applicable.

 

 

Item 5

OTHER INFORMATION

 

During the three months ended June 30, 2024, no director or officer (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

 

 

 

Item 6

EXHIBITS

 

Exhibit
No.

Description

10.1*†

Fourth Amendment to Employment Agreement, dated April 1, 2024, between Ceva Technologies, Ltd. and Yaniv Arieli (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on April 5, 2024).

31.1

Rule 13a14(a)/15d14(a) Certification of Chief Executive Officer.

31.2

Rule 13a14(a)/15d14(a) Certification of Chief Financial Officer.

32

Section 1350 Certification of Chief Executive Officer and Chief Financial Officer.

   

101

The following materials from CEVA, Inc.’s Quarterly report on Form 10-Q for the quarter ended September 30, 2023, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Statements of Loss, (ii) the Condensed Consolidated Balance Sheet, (iii) the Condensed Consolidated Statements of Cash Flows, (iv) the Condensed Consolidated Statements of Comprehensive Loss, (v) Condensed Consolidated Statements of Changes in Stockholders’ Equity, and (vi) Notes to Condensed Consolidated Financial Statements.

   

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

* Portions of exhibit are redacted.

† Indicates management compensatory plan or arrangement.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Ceva, INC.

   

Date: August 8, 2024

By:    /s/    AMIR PANUSH

 

Amir Panush
Chief Executive Officer
(principal executive officer)

   

Date: August 8, 2024

By:    /s/    YANIV ARIELI

 

Yaniv Arieli
Chief Financial Officer
(principal financial officer and principal accounting officer)

 

 

38

 

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

 

SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

 

I, Amir Panush, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of CEVA, Inc. (the “Company”);

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a15(e) and 15d15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a15(f) and 15d15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

   

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

   

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

   

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

   

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 8, 2024

 

 

/s/    AMIR PANUSH

Amir Panush

Chief Executive Officer

 

 

 

 

EXHIBIT 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

 

SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

 

I, Yaniv Arieli, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of CEVA, Inc. (the “Company”);

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a15(e) and 15d15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a15(f) and 15d15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

   

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

   

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

   

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

   

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 8, 2024

 

 

/s/    YANIV ARIELI

Yaniv Arieli

Chief Financial Officer

 

 

 

 

Exhibit 32

 

CERTIFICATION

 

PURSUANT TO 18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report on Form 10-Q of CEVA, Inc. (the “Company”) for the quarter ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Amir Panush, Chief Executive Officer of the Company, and Yaniv Arieli, Chief Financial Officer of the Company, each hereby certifies, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.

 

Date: August 8, 2024

 
 

/s/    AMIR PANUSH

 

Amir Panush

 

Chief Executive Officer

   
   
 

/s/    YANIV ARIELI

 

Yaniv Arieli

 

Chief Financial Officer

 

 
v3.24.2.u1
Document And Entity Information - shares
6 Months Ended
Jun. 30, 2024
Aug. 05, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2024  
Document Transition Report false  
Entity File Number 000-49842  
Entity Registrant Name Ceva, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 77-0556376  
Entity Address, Address Line One 15245 Shady Grove Road, Suite 400  
Entity Address, City or Town Rockville  
Entity Address, State or Province MD  
Entity Address, Postal Zip Code 20850  
City Area Code 240  
Local Phone Number 308-8328  
Title of 12(b) Security Common Stock, $.001 per share  
Trading Symbol CEVA  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   23,685,941
Entity Central Index Key 0001173489  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Amendment Flag false  
v3.24.2.u1
Interim Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 24,702 $ 23,287
Short-term bank deposits 2,107 10,556
Marketable securities 131,602 132,695
Trade receivables (net of allowance for credit losses of $288 at both March 31, 2024 and December 31, 2023) 35,655 30,307
Prepaid expenses and other current assets 13,201 12,526
Total current assets 207,267 209,371
Long-term assets:    
Severance pay fund 6,762 7,070
Deferred tax assets, net 1,317 1,609
Property and equipment, net 6,843 6,732
Operating lease right-of-use assets 6,137 6,978
Goodwill 58,308 58,308
Intangible assets, net 2,411 2,967
Investments in marketable equity securities 288 406
Other long-term assets 11,069 10,644
Total long-term assets 93,135 94,714
Total assets 300,402 304,085
Current liabilities:    
Trade payables 1,092 1,154
Deferred revenues 2,830 3,018
Accrued expenses and other payables 6,051 5,800
Accrued payroll and related benefits 12,394 14,402
Operating lease liabilities 2,615 2,513
Total current liabilities 24,982 26,887
Long-term liabilities:    
Accrued severance pay 7,210 7,524
Operating lease liabilities 2,964 3,943
Other accrued liabilities 1,460 1,390
Total long-term liabilities 11,634 12,857
Stockholders’ equity:    
Preferred Stock: $0.001 par value: 5,000,000 shares authorized; none issued and outstanding 0 0
Common Stock: $0.001 par value: 45,000,000 shares authorized; 23,756,255 and 23,695,190 shares issued at June 30, 2024 and December 31, 2023, respectively. 23,659,925 and 23,440,848 shares outstanding at June 30, 2024 and December 31, 2023, respectively 24 23
Additional paid in-capital 254,302 252,100
Treasury stock at cost (96,330 and 254,342 shares of common stock at June 30, 2024, and December 31, 2023, respectively) (1,917) (5,620)
Accumulated other comprehensive loss (2,894) (2,329)
Retained earnings 14,271 20,167
Total stockholders’ equity 263,786 264,341
Total liabilities and stockholders’ equity $ 300,402 $ 304,085
v3.24.2.u1
Interim Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Accounts Receivable, Allowance for Credit Loss $ 288 $ 288
Preferred Stock, Par or Stated Value Per Share (in dollars per share) $ 0.001 $ 0.001
Preferred Stock, Shares Authorized (in shares) 5,000,000 5,000,000
Preferred Stock, Shares Issued (in shares) 0 0
Preferred Stock, Shares Outstanding (in shares) 0 0
Common Stock, Par or Stated Value Per Share (in dollars per share) $ 0.001 $ 0.001
Common Stock, Shares Authorized (in shares) 45,000,000 45,000,000
Common Stock, Shares, Issued (in shares) 23,756,255 23,695,190
Common Stock, Shares, Issued (in shares) 23,756,255 23,695,190
Common Stock, Shares, Outstanding (in shares) 23,659,925 23,440,848
Treasury Stock, Common, Shares (in shares) 96,330 254,342
v3.24.2.u1
Interim Condensed Consolidated Statements of Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
us-gaap_RevenuesAbstract        
Revenue $ 28,437 $ 22,922 $ 50,509 $ 49,184
Cost of revenues 2,933 3,524 5,436 7,032
Gross profit 25,504 19,398 45,073 42,152
Operating expenses:        
Research and development, net 18,758 18,056 36,749 36,730
Sales and marketing 3,095 2,632 5,911 5,351
General and administrative 3,537 3,911 7,109 7,738
Amortization of intangible assets 149 142 299 296
Total operating expenses 25,539 24,741 50,068 50,115
Operating income (loss) (35) (5,343) (4,995) (7,963)
Financial income, net 1,406 1,118 2,663 2,573
Remeasurement of marketable equity securities (58) (119) (118) (236)
Loss before taxes on income 1,313 (4,344) (2,450) (5,626)
Income tax expense 1,604 546 3,289 1,963
Net loss (291) (4,890) (5,739) (7,589)
Net loss from discontinued operation 0 (928) 0 (3,101)
Net loss $ (291) $ (5,818) $ (5,739) $ (10,690)
Basic and diluted (in dollars per share) $ (0.01) $ (0.21) $ (0.24) $ (0.32)
Basic and diluted net loss per share from discontinued operation (in dollars per share) 0 (0.04) 0 (0.13)
Basic and diluted net loss per share (in dollars per share) $ (0.01) $ (0.25) $ (0.24) $ (0.45)
Weighted-average shares used to compute net loss per share (in thousands):        
Basic and diluted (in shares) 23,628 23,476 23,568 23,405
License [Member]        
us-gaap_RevenuesAbstract        
Revenue $ 17,278 $ 13,551 $ 28,692 $ 31,799
Royalty [Member]        
us-gaap_RevenuesAbstract        
Revenue $ 11,159 $ 9,371 $ 21,817 $ 17,385
v3.24.2.u1
Interim Condensed Consolidated Statements of Comprehensive (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Net loss: $ (291) $ (5,818) $ (5,739) $ (10,690)
Available-for-sale securities:        
Changes in unrealized losses 230 137 430 867
Reclassification adjustments for (gains) losses included in net loss (6) 16 (10) (76)
Net change 224 153 420 791
Cash flow hedges:        
Changes in unrealized gains (losses) (144) (205) (339) (630)
Reclassification adjustments for losses included in net loss (227) 403 (607) 574
Net change (371) 198 (946) (56)
Other comprehensive income (loss) before tax (147) 351 (526) 735
Income tax expense (benefit) related to components of other comprehensive income (loss) 27 24 39 69
Other comprehensive income (loss), net of taxes (174) 327 (565) 666
Comprehensive loss $ (465) $ (5,491) $ (6,304) $ (10,024)
v3.24.2.u1
Interim Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock Outstanding [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2022 23,215,439          
Balance at Dec. 31, 2022 $ 23 $ 242,841 $ (9,904) $ (6,249) $ 32,160 $ 258,871
Net loss 0 0 0 0 (10,690) (10,690)
Other comprehensive loss, net 0 0 0 666 0 666
Equity-based compensation $ 0 8,064 0 0 0 $ 8,064
Purchase of treasury stock (in shares)           0
Issuance of treasury stock upon exercise of stock-based awards (in shares) 323,665          
Issuance of treasury stock upon exercise of stock-based awards $ 1 (6,655) 8,442 0 (115) $ 1,673
Other comprehensive income 0 0 0 666 0 666
Equity-based compensation $ 0 8,064 0 0 0 8,064
Balance (in shares) at Jun. 30, 2023 23,539,104          
Balance at Jun. 30, 2023 $ 24 244,250 (1,462) (5,583) 21,355 258,584
Balance (in shares) at Mar. 31, 2023 23,416,026          
Balance at Mar. 31, 2023 $ 23 243,141 (4,672) (5,910) 27,288 259,870
Net loss 0 0 0 0 (5,818) (5,818)
Other comprehensive loss, net 0 0 0 327 0 327
Equity-based compensation $ 0 4,205 0 0 0 $ 4,205
Purchase of treasury stock (in shares)           0
Issuance of treasury stock upon exercise of stock-based awards (in shares) 123,078          
Issuance of treasury stock upon exercise of stock-based awards $ 1 (3,096) 3,210 0 (115) $ 0
Other comprehensive income 0 0 0 327 0 327
Equity-based compensation $ 0 4,205 0 0 0 4,205
Balance (in shares) at Jun. 30, 2023 23,539,104          
Balance at Jun. 30, 2023 $ 24 244,250 (1,462) (5,583) 21,355 258,584
Balance (in shares) at Dec. 31, 2023 23,440,848          
Balance at Dec. 31, 2023 $ 23 252,100 (5,620) (2,329) 20,167 264,341
Net loss 0 0 0 0 (5,739) (5,739)
Other comprehensive loss, net 0 0 0 (565) 0 (565)
Equity-based compensation $ 0 7,471 0 0 0 $ 7,471
Purchase of treasury stock (in shares) (157,303)         (157,303)
Purchase of treasury stock $ 0 0 (3,276) 0 0 $ (3,276)
Issuance of common stock upon exercise of stock-based awards (in shares) 61,065          
Issuance of common stock upon exercise of stock-based awards $ 0 0 0 0 0 0
Issuance of treasury stock upon exercise of stock-based awards (in shares) 315,315          
Issuance of treasury stock upon exercise of stock-based awards $ 1 (5,269) 6,979 0 (157) 1,554
Other comprehensive income 0 0 0 (565) 0 (565)
Equity-based compensation $ 0 7,471 0 0 0 7,471
Balance (in shares) at Jun. 30, 2024 23,659,925          
Balance at Jun. 30, 2024 $ 24 254,302 (1,917) (2,894) 14,271 263,786
Balance (in shares) at Mar. 31, 2024 23,581,522          
Balance at Mar. 31, 2024 $ 24 252,927 (2,528) (2,720) 14,646 262,349
Net loss 0 0 0 0 (291) (291)
Other comprehensive loss, net 0 0 0 (174) 0 (174)
Equity-based compensation $ 0 3,900 0 0 0 $ 3,900
Purchase of treasury stock (in shares) (100,431)         (100,431)
Purchase of treasury stock $ 0 0 (1,998) 0 0 $ (1,998)
Issuance of common stock upon exercise of stock-based awards (in shares) 61,065          
Issuance of common stock upon exercise of stock-based awards $ 0 0 0 0 0 0
Issuance of treasury stock upon exercise of stock-based awards (in shares) 117,769          
Issuance of treasury stock upon exercise of stock-based awards $ 0 (2,525) 2,609 0 (84) 0
Other comprehensive income 0 0 0 (174) 0 (174)
Equity-based compensation $ 0 3,900 0 0 0 3,900
Balance (in shares) at Jun. 30, 2024 23,659,925          
Balance at Jun. 30, 2024 $ 24 $ 254,302 $ (1,917) $ (2,894) $ 14,271 $ 263,786
v3.24.2.u1
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net loss: $ (5,739) $ (10,690)
Adjustments required to reconcile net loss to net cash used in operating activities:    
Depreciation 1,444 1,462
Amortization of intangible assets 556 1,379
Equity-based compensation 7,471 8,064
Realized gain on sale of available-for-sale marketable securities (10) (76)
Amortization of premiums (accretion of discount) on available-for-sale marketable securities (386) (40)
Amortization of premiums (accretion of discount) on available-for-sale marketable securities 386 40
Unrealized foreign exchange (gain) loss 167 (352)
Remeasurement of marketable equity securities 118 236
Changes in operating assets and liabilities:    
Trade receivables, net (4,989) (657)
Prepaid expenses and other assets (2,210) (1,965)
Operating lease right-of-use assets 841 447
Accrued interest on bank deposits 449 (114)
Deferred tax, net 253 (406)
Trade payables (105) (898)
Deferred revenues (188) 620
Accrued expenses and other payables 91 (1,177)
Accrued payroll and related benefits (1,962) (5,545)
Operating lease liability (781) (464)
Accrued severance pay, net 10 233
Net cash used in operating activities (4,970) (9,863)
Cash flows from investing activities:    
Purchase of property and equipment 1,512 1,231
Acquisition of business 0 (3,600)
Proceeds from the sale of Intrinsix (see note 4) 540 0
Asset acquisition (753) 0
Proceeds from bank deposits 8,000 4,000
Investment in available-for-sale marketable securities (29,969) (2,455)
Proceeds from maturity of available-for-sale marketable securities 24,580 7,000
Proceeds from sale of available-for-sale marketable securities 7,298 10,659
Net cash provided by investing activities 8,184 14,373
Cash flows from financing activities:    
Purchase of treasury stock (3,276) 0
Proceeds from exercise of stock-based awards 1,554 1,673
Net cash provided by (used in) financing activities (1,722) 1,673
Effect of exchange rate changes on cash and cash equivalents (77) 43
Increase (decrease) in cash and cash equivalents 1,415 6,226
Cash and cash equivalents at the beginning of the period 23,287 21,285
Cash and cash equivalents at the end of the period 24,702 27,511
Supplemental information of cash-flow activities:    
Income and withholding taxes 1,512 3,871
Non-cash transactions:    
Property and equipment purchases incurred but unpaid at period end 22 0
Right-of-use assets obtained in the exchange for operating lease liabilities $ 373 $ 1,028
v3.24.2.u1
Note 1 - Business
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Nature of Operations [Text Block]

NOTE 1:

BUSINESS

 

The financial information in this quarterly report includes the results of Ceva, Inc. and its subsidiaries (the “Company” or “Ceva”).

 

Ceva is the leader in innovative silicon and software IP solutions that enable smart edge products to connect, sense, and infer data more reliably and efficiently. With the industry’s only portfolio of comprehensive communications and scalable edge AI IP, Ceva powers the connectivity, sensing, and inference in today’s most advanced smart edge products across consumer IoT, mobile, automotive, infrastructure, industrial, and personal computing. More than 18 billion of the world’s most innovative smart edge products from AI-infused smartwatches, IoT devices and wearables to autonomous vehicles, 5G mobile networks and more are powered by Ceva.

 

Ceva is a trusted partner to many of the leading semiconductor and original equipment manufacturer (OEM) companies targeting a wide variety of cellular and IoT end markets, including mobile, PC, consumer, automotive, smart-home, surveillance, robotics, industrial and medical. The customers incorporate Ceva’s IP into application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs) that they manufacture, market and sell to consumer electronics companies. Ceva’s application software IP is licensed primarily to OEMs who embed it in their System on Chip (SoC) designs to enhance the user experience, and OEMs also license Ceva’s hardware IP products and solutions for their SoC designs to create power-efficient, intelligent, secure and connected devices. 

 

Ceva’s wireless communications, sensing and edge AI technologies are at the heart of some of today’s most advanced smart edge products. From Bluetooth connectivity, Wi-Fi, ultra-wide band (UWB) and 5G platform IP for ubiquitous, robust communications, to scalable edge AI neural processing unit (NPU) IPs, sensor fusion processors and embedded application software that make devices smarter.

 

Ceva licenses its portfolio of wireless communications and scalable edge AI IP to its customers, breaking down barriers to entry and enabling them to bring new cutting-edge products to market faster, more reliably, efficiently and economically.

v3.24.2.u1
Note 2 - Basis of Presentation and Summary Significant Accounting Policies
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]

NOTE 2:

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The interim condensed consolidated financial statements have been prepared according to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).

 

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2024, are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

 

The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2023, contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 7, 2024, have been applied consistently in these unaudited interim condensed consolidated financial statements.

 

 

Concentration of credit risk:

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, bank deposits, marketable securities, foreign exchange contracts and trade receivables. The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines relating to diversification and maturities to maintain safety and liquidity of the investments.

 

The majority of the Company’s cash and cash equivalents are invested in high grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits may be redeemed on demand and therefore minimal credit risk exists with respect to them. Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. Generally, these cash equivalents may be redeemed upon demand, and therefore management believes that they bear a lower risk. The short-term bank deposits are held in financial institutions that management believes are institutions with high credit standing and, accordingly, minimal credit risk from geographic or credit concentration. Furthermore, the Company holds an investment portfolio consisting principally of corporate bonds. The Company has the ability to hold such investments until recovery of temporary declines in market value or maturity.

 

The Company’s trade receivables are geographically diverse, mainly in the Asia Pacific region, and also in the United States and Europe. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers and to date has not experienced any material losses. The Company makes estimates of expected credit losses for based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers.

 

The Company has no off-balance-sheet concentration of credit risk.

 

Accounting Standards Recently Adopted by the Company

 

In June 2022, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The guidance is effective for annual periods beginning after December 15, 2023, with early adoption permitted. The Company adopted ASU 2022-03 as of January 1, 2024. The adoption did not result in a material impact on the Company's interim condensed financial statements.

 

Accounting Standards Recently Issued, Not Yet Adopted by the Company

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07.

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09.

 

Use of Estimates

 

The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, the reported amounts of revenues and expenses during the reporting period, and amounts classified as a discontinued operation. Actual results could differ from those estimates.

 

 

v3.24.2.u1
Note 3 - Acquisition
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Business Combination Disclosure [Text Block]

NOTE 3:

ACQUISITION

 

In January 2024, the Company acquired 100% of the equity shares of a privately held, Greek-based company, to extend the research and development resources in the Ceva group. Under the terms of the purchase agreement, the Company agreed to pay an aggregate of approximately $750 paid at closing and approximately $2,100 subject to continued employment and certain performance milestones. The Company has accounted for this acquisition as an asset acquisition. As such, the total purchase consideration was allocated to the assets acquired.

v3.24.2.u1
Note 4 - Held for Sale and Discontinued Operation
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

NOTE 4:

HELD FOR SALE AND DISCONTINUED OPERATION

 

On September 14, 2023, the Company and Intrinsix, then its wholly owned subsidiary, entered into a Share Purchase Agreement (the “Agreement”) with Cadence Design Systems, Inc. (“Cadence”), pursuant to which Cadence agreed to purchase all of the issued and outstanding capital shares of Intrinsix from the Company for $35,000 in cash, subject to other certain purchase price adjustments as provided for in the Agreement (the “Transaction”). The closing of the Transaction occurred on October 2, 2023. At the closing, an amount of $300 from the consideration was deposited with a third-party escrow agent for the purposes of satisfying any additional post-closing purchase price adjustments owed by the Company to Cadence, which was fully paid to the Company during the first quarter of 2024, a further amount of $3,500 of the consideration was deposited with the same escrow agent for a period of 18 months as security for the Company’s indemnification obligations to Cadence in accordance with the terms and conditions set forth in the Agreement, and after giving effect to post-closing adjustments resulting in a $240 repayment to the Company during the first quarter of 2024. The Agreement includes certain representations, warranties and covenants of the parties, and the Company also agreed to certain non-competition and non-solicitation terms, which are subject to certain exceptions.

 

Under ASC 205-20, "Discontinued Operation" when a component of an entity, as defined in ASC 205-20, has been disposed of or is classified as held for sale, the results of its operations, including the gain or loss on its component, are classified as discontinued operations and the assets and liabilities of such component are classified as assets and liabilities attributed to discontinued operations; that is, provided that the operations, assets and liabilities and cash flows of the component have been eliminated from the Company’s consolidated operations and the Company will have no significant continuing involvement in the operations of the component.

 

As a result of the Transaction, Intrinsix's results of operations and asset and liability balances are disclosed as a discontinued operation. All prior periods comparable results of operation, assets and liabilities have been retroactively included in discontinued operations.

 

The following table shows the Company's results of discontinued operation for the below presented period:

 

   

Six months ended June 30, 2023

(unaudited)

   

Three months ended June 30, 2023

(unaudited)

 

Revenues

  $ 5,723     $ 3,250  

Cost of revenue

    3,855       2,048  

Gross profit

    1,868       1,202  

Operating expenses:

               

Research and development, net

    3,655       1,538  

Sales and marketing

    489       163  

General and administrative

    479       258  

Amortization of intangible assets

    349       174  

Total operating expenses

    4,972       2,133  

Operating loss

    (3,104 )     (931 )

Financial income, net

    3       3  

Loss from discontinued operations before taxes on income

    (3,101 )     (928 )

Income tax expense

           

Net loss from discontinued operation

  $ (3,101 )   $ (928 )

 

The following table presents cash flows from discontinued operations:

 

   

Six months

ended

June 30, 2023

(unaudited)

 

Net cash flows used in operating activities (*)

  $ (1,902 )

 

(*) Amortization and depreciation allocated to discontinued operation for the six-month period ended June 30, 2023 amounted to $982.

v3.24.2.u1
Note 5 - Revenue Recognition
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]

NOTE 5:

REVENUE RECOGNITION

 

Under ASC No. 606, “Revenue from Contracts with Customers” (“ASC 606”), an entity recognizes revenue when or as it satisfies a performance obligation by transferring intellectual property (“IP”) licenses or services to the customer, either at a point in time or over time. The Company recognizes most of its revenues at a point in time upon delivery when the customer accepts control of the IP. The Company recognizes revenue over time on significant license customization contracts that are in the scope of ASC 606 by using cost inputs to measure progress toward completion of its performance obligations.

 

Revenues that are derived from the sale of a licensee’s products that incorporate the Company’s IP are classified as royalty revenues. Royalty revenues are recognized during the quarter in which the sale of the product incorporating the Company’s IP occurs. Royalties are calculated either as a percentage of the revenues received by the Company’s licensees on sales of products incorporating the Company’s IP or on a per unit basis, as specified in the agreements with the licensees. When the Company does not receive actual sales data from the customer prior to the finalization of its financial statements, royalty revenues are recognized based on the Company’s estimation of the customer’s sales during the quarter.

 

The following table includes estimated revenue expected to be recognized in future periods related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The estimated revenues do not include amounts of royalties or unexercised contract renewals:

 

   

Remainder of 2024

   

2025

   

2026 and

thereafter

 

Licensing and related revenues

  $ 9,352     $ 3,134     $ 449  

 

Disaggregation of revenue:

 

The following table provides information about disaggregated revenue by primary geographical, use cases for the Company's technology portfolio, and timing of revenue recognition:

 

   

Six months ended June 30, 2024 (unaudited)

   

Three months ended June 30, 2024 (unaudited)

 
   

Licensing and

related revenues

   

Royalties

   

Total

   

Licensing and

related revenues

   

Royalties

   

Total

 

Geography

                                               

United States

  $ 811     $ 3,092     $ 3,903     $ 428     $ 937     $ 1,365  

Europe and Middle East

    6,845       2,109       8,954       6,244       1,198       7,442  

Asia Pacific

    21,023       16,616       37,639       10,606       9,024       19,630  

Other

    13             13                    

Total

  $ 28,692     $ 21,817     $ 50,509     $ 17,278     $ 11,159     $ 28,437  
                                                 

Use cases for the Company’s technology portfolio

                                               

Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT)

  $ 26,323     $ 16,732     $ 43,055     $ 16,256     $ 8,793     $ 25,049  

Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI)

    2,369       5,085       7,454       1,022       2,366       3,388  

Total

  $ 28,692     $ 21,817     $ 50,509     $ 17,278     $ 11,159     $ 28,437  
                                                 

Timing of revenue recognition

                                               

Products transferred at a point in time

  $ 24,723     $ 21,817     $ 46,540     $ 15,270     $ 11,159     $ 26,429  

Products and services transferred over time

    3,969             3,969       2,008             2,008  

Total

  $ 28,692     $ 21,817     $ 50,509     $ 17,278     $ 11,159     $ 28,437  

  

   

Six months ended June 30, 2023 (unaudited)

   

Three months ended June 30, 2023 (unaudited)

 
   

Licensing and

related revenues

   

Royalties

   

Total

   

Licensing and

related revenues

   

Royalties

   

Total

 

Geography

                                               

United States

  $ 1,039     $ 3,061     $ 4,100     $ 337     $ 1,411     $ 1,748  

Europe and Middle East

    3,581       1,312       4,893       1,631       453       2,084  

Asia Pacific

    26,677       13,012       39,689       11,556       7,507       19,063  

Other

    502             502       27             27  

Total

  $ 31,799     $ 17,385     $ 49,184     $ 13,551     $ 9,371     $ 22,922  
                                                 

Use cases for the Company’s technology portfolio

                                               

Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT)

  $ 27,667     $ 12,445     $ 40,112     $ 11,743     $ 6,780     $ 18,523  

Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI)

    4,132       4,940       9,072       1,808       2,591       4,399  

Total

  $ 31,799     $ 17,385     $ 49,184     $ 13,551     $ 9,371     $ 22,922  
                                                 

Timing of revenue recognition

                                               

Products transferred at a point in time

  $ 25,024     $ 17,385     $ 42,409     $ 10,403     $ 9,371     $ 19,774  

Products and services transferred over time

    6,775             6,775       3,148             3,148  

Total

  $ 31,799     $ 17,385     $ 49,184     $ 13,551     $ 9,371     $ 22,922  

 

Contract balances:

 

The following table provides information about trade receivables, unbilled receivables and contract liabilities from contracts with customers:

 

   

June 30, 2024

   

December 31,

2023

 
                 

Currents assets (classified under Trade receivables):

               

Trade receivables

  $ 18,298     $ 8,433  

Unbilled receivables (associated with licensing and related revenue)

    6,497       9,735  

Unbilled receivables (associated with royalties)

    10,860       12,139  

Total current assets

    35,655       30,307  
                 

Long-term assets (classified under Other long-term assets)

               

Unbilled receivables (associated with licensing and related revenue)

    2,139        
                 

Deferred revenues (short-term contract liabilities)

    2,830       3,018  

 

The Company receives payments from customers based upon contractual payment schedules; trade receivables are recorded when the right to consideration becomes unconditional, and an invoice is issued to the customer. Unbilled receivables associated with licensing and other include amounts related to the Company’s contractual right to consideration for completed performance objectives not yet invoiced. Unbilled receivables associated with royalties are recorded as the Company recognizes revenues from royalties earned during the quarter, but not yet invoiced, either by actual sales data received from customers, or, when applicable, by the Company’s estimation. Contract liabilities (deferred revenue) include payments received in advance of performance under the contract, and are realized with the associated revenue recognized under the contract.

 

During the three and six months ended June 30, 2024, the Company recognized $744 and $1,924, respectively, that was included in deferred revenues (short-term contract liability) balance at January 1, 2024. 

v3.24.2.u1
Note 6 - Leases
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Lessee, Operating Leases [Text Block]

NOTE 6:

LEASES

 

The Company leases substantially all of its office space and vehicles under operating leases. The Company's leases have original lease periods expiring between 2025 and 2034. Many leases include one or more options to renew. The Company does not assume renewals in its determination of the lease term unless the renewals are deemed to be reasonably certain. Lease payments included in the measurement of the lease liability comprise the following: the fixed non-cancelable lease payments, payments for optional renewal periods where it is reasonably certain the renewal period will be exercised, and payments for early termination options unless it is reasonably certain the lease will not be terminated early.

 

The following is a summary of weighted average remaining lease terms and discount rates for all of the Company’s operating leases:

 

   

June 30, 2024

(Unaudited)

 

Weighted average remaining lease term (years)

    3.87  

Weighted average discount rates

    3.94

%

 

Total operating lease cost and cash payments for operating leases were as follows:

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

   

2023

   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

   

(unaudited)

   

(unaudited)

 
                                 

Operating lease cost

  $ 1,357     $ 1,502     $ 694     $ 749  

Cash payments for operating leases

    1,309       1,484       687       757  

 

Maturities of lease liabilities are as follows:

 

The remainder of 2024

 

$

1,426  

2025

    2,037  

2026

    895  

2027

    638  

2028

    330  

2029 and thereafter

    618  

Total undiscounted cash flows

    5,944  

Less imputed interest

    365  

Present value of lease liabilities

  $ 5,579  

 

v3.24.2.u1
Note 7 - Marketable Securities
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Cash, Cash Equivalents, and Marketable Securities [Text Block]

NOTE 7:

MARKETABLE SECURITIES

 

The following is a summary of available-for-sale marketable securities:

 

   

June 30, 2024 (Unaudited)

 
   

Amortized
cost

   

Gross
unrealized
gains

   

Gross
unrealized
losses

   

Fair
value

 

Available-for-sale - matures within one year:

                               

Corporate bonds

  $ 51,319     $ 19     $ (673 )   $ 50,665  
                                 

Available-for-sale - matures after one year through three years:

                               

Corporate bonds

    83,558       91       (2,712 )     80,937  

Total

                               
    $ 134,877     $ 110     $ (3,385 )   $ 131,602  

 

   

December 31, 2023

 
   

Amortized
cost

   

Gross
unrealized
gains

   

Gross
unrealized
losses

   

Fair
value

 

Available-for-sale - matures within one year:

                               

Corporate bonds

  $ 27,690     $ 4     $ (243 )   $ 27,451  
                                 

Available-for-sale - matures after one year through three years:

                               

Corporate bonds

    108,700       278       (3,734 )     105,244  
                                 

Total

  $ 136,390     $ 282     $ (3,977 )   $ 132,695  

 

The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2024, and December 31, 2023, and the length of time that those investments have been in a continuous loss position:

 

   

Less than 12 months

   

12 months or greater

 
   

Fair value

   

Gross

unrealized

loss

   

Fair value

   

Gross

unrealized

loss

 

As of June 30, 2024 (unaudited)

  $ 37,893     $ (237 )   $ 73,923     $ (3,148 )

As of December 31, 2023

  $ 18,193     $ (49 )   $ 86,643     $ (3,928 )

  

As of June 30, 2024, the allowance for credit losses was not material.

 

The following table presents gross realized gains and losses from sale of available-for-sale marketable securities:

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

   

2023

   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

   

(unaudited)

   

(unaudited)

 
                                 

Gross realized gains from sale of available-for-sale marketable securities

  $ 15     $ 92     $ 6     $  

Gross realized losses from sale of available-for-sale marketable securities

  $ (5 )   $ (16 )   $     $ (16 )

 

v3.24.2.u1
Note 8 - Fair Value Measurement
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

NOTE 8:

FAIR VALUE MEASUREMENT

 

FASB ASC No. 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value. Fair value is an exit price, representing the amount that would be received for selling an asset or paid for the transfer of a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:

 

Level I

Unadjusted quoted prices in active markets that are accessible on the measurement date for identical, unrestricted assets or liabilities;

Level II

Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

Level III

Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

 

The Company measures its marketable securities, investments in marketable equity securities and foreign currency derivative contracts at fair value. The carrying amount of cash, cash equivalents, short-term bank deposits, trade receivables, other accounts receivable, trade payables and other accounts payables approximate fair value due to the short-term maturity of these instruments. Investments in marketable equity securities are classified within Level I as the securities are traded in an active market. Marketable securities and foreign currency derivative contracts are classified within Level II as the valuation inputs are based on quoted prices and market observable data of similar instruments.

 

The table below sets forth the Company’s assets and liabilities measured at fair value by level within the fair value hierarchy. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

Description

 

June 30, 2024

(unaudited)

   

Level I

(unaudited)

   

Level II (unaudited)

   

Level III (unaudited)

 

Assets:

                               

Marketable securities:

                               

Corporate bonds

  $ 131,602     $     $ 131,602     $  

Foreign exchange contracts

    51             51        

Investments in marketable equity securities

    288       288              
                                 

Liabilities:

                               

Foreign exchange contracts

  $ 9     $     $ 9     $  

 

Description

 

December 31, 2023

   

Level I

   

Level II

   

Level III

 

Assets:

                               

Marketable securities:

                               

Corporate bonds

  $ 132,695     $     $ 132,695     $  

Foreign exchange contracts

    988             988        

Investments in marketable equity securities

    406       406              

 

v3.24.2.u1
Note 9 - Geographic Information and Major Customer Data
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

NOTE 9:

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA

 

 

a.

Summary information about geographic areas:

 

The Company manages its business on the basis of one reportable segment: the licensing of intellectual property to semiconductor companies and electronic equipment manufacturers (see Note 1 for a brief description of the Company’s business). The following is a summary of revenues within geographic areas:

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Revenues based on customer location:

                               

United States

  $ 3,903     $ 4,100     $ 1,365     $ 1,748  

Europe and Middle East (2)

    8,954       4,893       7,442       2,084  

Asia Pacific (1)

    37,639       39,689       19,630       19,063  

Other

    13       502             27  
    $ 50,509     $ 49,184     $ 28,437     $ 22,922  
                                 

(1) China

  $ 29,025     $ 30,477     $ 15,433     $ 12,714  

(2) Finland

  $ 6,645     $ * )   $ 6,455     $ * )

 

*) Less than 10%

 

 

b.

Major customer data as a percentage of total revenues:

 

The following table sets forth the customers that represented 10% or more of the Company’s total revenues in each of the periods set forth below. 

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 
                                 

Customer A

    13 %     * )     13 %     14 %

Customer B

    13 %     * )     23 %     * )

Customer C

    13 %     * )     21 %     * )

Customer D

    * )     * )     * )     14 %

Customer E

    * )     * )     * )     10 %

 

*) Less than 10%

 

 

v3.24.2.u1
Note 10 - Net Loss Per Share of Common Stock
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 10:

NET LOSS PER SHARE OF COMMON STOCK

 

Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period, plus dilutive potential shares of common stock considered outstanding during the period, in accordance with FASB ASC No. 260, “Earnings Per Share.”

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Numerator:

                               

Net loss from continuing operations

  $ (5,739 )   $ (7,589 )   $ (291 )   $ (4,890 )

Net loss from discontinued operations

          (3,101 )           (928 )

Net loss

  $ (5,739 )   $ (10,690 )   $ (291 )   $ (5,818 )

Denominator (in thousands):

                               

Basic and diluted weighted-average common stock outstanding

    23,568       23,405       23,628       23,476  
                                 

Basic and diluted net loss per share from continuing operations

  $ (0.24 )   $ (0.32 )   $ (0.01 )   $ (0.21 )

Basic and diluted net loss per share from discontinued operations

  $       (0.13 )   $     $ (0.04 )

Basic and diluted net loss per share

  $ (0.24 )   $ (0.45 )   $ (0.01 )   $ (0.25 )

 

The total number of shares related to outstanding equity-based awards was 1,630,146 for both the three and six months ended June 30, 2024, and in each case was excluded from the calculation of diluted net loss per share. The total number of shares related to outstanding equity-based awards was 1,350,825 for both the three and six months ended June 30, 2023, and in each case was excluded from the calculation of diluted net loss per share. 

v3.24.2.u1
Note 11 - Common Stock and Stock-based Compensation Plans
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

NOTE 11:

COMMON STOCK AND STOCK-BASED COMPENSATION PLANS

 

The Company has historically granted a mix of stock options, stock appreciation rights (“SARs”) capped with a ceiling and restricted stock units (“RSUs”) to employees and non‑employee directors of the Company and its subsidiaries under the Company’s equity plans and provides the right to purchase common stock pursuant to the Company’s 2002 employee stock purchase plan to employees of the Company and its subsidiaries. As of June 30, 2024, and December 31, 2023, there were no outstanding or exercisable SARs left.

 

The options granted under the Company’s stock incentive plans have been granted at the fair market value of the Company’s common stock on the grant date. Options granted to employees under stock incentive plans generally vest at a rate of 25% of the shares underlying the option after one year and the remaining shares vest in equal portions over the following 36 months, such that all shares are vested after four years. A summary of the Company’s stock option activities and related information for the six months ended June 30, 2024, are as follows:

 

   

Number of
options

   

Weighted
average

exercise
price

   

Weighted
average remaining
contractual

term

   

Aggregate
intrinsic

value

 

Outstanding as of December 31, 2023

    99,425     $ 20.74       2.5     $ 316  

Granted

    10,600       19.61                  

Exercised

    (26,000 )     14.77                  

Forfeited or expired

                           

Outstanding as of June 30, 2024 (unaudited)

    84,025     $ 22.45       3.2     $ 0  

Exercisable as of June 30, 2024 (unaudited)

    54,000     $ 23.30       1.5     $ 0  

 

As of June 30, 2024, there was $278 of unrecognized compensation expense related to unvested stock options. This amount is expected to be recognized over a weighted-average period of 2.2 years.

 

An RSU award is an agreement to issue shares of the Company’s common stock at the time the award or a portion thereof vests. RSUs granted to employees generally vest in three equal annual installments starting on the first anniversary of the grant date. RSUs granted to non-employee directors would generally vest in two equal annual installments starting on the first anniversary of the grant date.  

 

On February 12, 2024, the Compensation Committee of the Board (the “Committee”) granted 33,318, 20,043, 16,399 and 13,535 RSUs, effective as of February 16, 2024, to each of the Company’s Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), Chief Operating Officer (“COO”) and Chief Commercial Officer (“CCO”), respectively, pursuant to the Company’s 2011 Stock Incentive Plan (the “2011 Plan”). The RSU grants vest 33.4% on February 16, 2025, 33.3% on February 16, 2026 and 33.3% on February 16, 2027.

 

Also, on February 12, 2024, the Committee granted 49,978, 13,362, 10,932 and 9,023 performance-based restricted stock units (“PSUs”), effective as of February 16, 2024, to each of the Company’s CEO, CFO, COO and CCO, respectively, pursuant to the 2011 Plan. The performance goals for the PSUs with specified weighting are as follows:

 

Weighting

Goals

50% (*)

Vesting of the full 50% of the PSUs occurs if the Company achieves the 2024 license and related revenue target approved by the Board (the “2024 License Revenue Target”). The vesting threshold is achievement of 90% of the 2024 License Revenue Target. If the Company’s achievement of the 2024 License Revenue Target is above 90% but less than 99% of the 2024 License Revenue Target, 91% to 99% of the eligible PSUs would be subject to vesting. If the Company’s actual result exceeds 100% of the 2024 License Revenue Target, every 1% increase of the 2024 License Revenue Target, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO.

25%

Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2024 is greater than the S&P Semiconductors Select Industry index (the “S&P index”). The vesting threshold is if the return on the Company’s stock for 2024 is at least 90% of the S&P index. If the return on the Company’s stock, in comparison to the S&P index, is above 90% but less than 99% of the S&P index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company’s stock exceeds 100% of the S&P index, every 1% increase in comparison to the S&P index, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO.

25%

Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2024 is greater than the Russell 2000 index (the “Russell index”). The vesting threshold is if the return on the Company’s stock for 2024 is at least 90% of the Russell index. If the return on the Company’s stock, in comparison to the Russell index, is above 90% but less than 99% of the Russell index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company’s stock exceeds 100% of the Russell index, every 1% increase in comparison to the Russell index, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO.

 

(*) As of June 30, 2024, the Company's management estimates that it is not probable that the performance condition will be met by year end.

 

Accordingly, assuming maximum achievement of the performance goals set forth above, PSUs representing an additional 60%, meaning an additional 29,986, would be eligible for vesting of the Company’s CEO, and an additional 40%, meaning an additional 5,344, 4,372 and 3,609, would be eligible for vesting for each of the Company’s CFO, COO and CCO, respectively.

 

Subject to achievement of the thresholds the above performance goals for 2024, the PSUs vest 33.4% on February 16, 2025, 33.3% on February 16, 2026 and 33.3% on February 16, 2027. 

 

A summary of the Company’s RSU and PSU activities and related information for the six months ended June 30, 2024, are as follows:

 

   

Number of
RSUs and

PSUs

   

Weighted

Average Grant-

Date
Fair Value

 

Unvested as of December 31, 2023

    1,281,751     $ 24.97  

Granted

    693,378       18.18  

Vested

    (286,976

)

    32.22  

Forfeited or expired

    (142,032

)

    20.58  

Unvested as of June 30, 2024 (unaudited)

    1,546,121     $ 20.97  

 

As of June 30, 2024, there was $23,955 of unrecognized compensation expense related to unvested RSUs and PSUs. This amount is expected to be recognized over a weighted-average period of 1.6 years.

 

The following table shows the total equity-based compensation expense included in the interim condensed consolidated statements of loss:

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Cost of revenue

  $ 394     $ 420     $ 191     $ 214  

Research and development, net

    4,445       4,446       2,438       2,344  

Sales and marketing

    816       827       451       449  

General and administrative

    1,816       1,758       820       897  

Total equity-based compensation expense from continuing operations

    7,471       7,451       3,900       3,904  

Equity-based compensation expense included in discontinued operations

          613             301  

Total equity-based compensation expense

  $ 7,471     $ 8,064     $ 3,900     $ 4,205  

 

The fair value for rights to purchase shares of common stock under the Company’s employee stock purchase plan was estimated on the date of grant using the following assumptions:

 

   

Six months ended
June 30

 
   

2024

(unaudited)

   

2023

(unaudited)

 

Expected dividend yield

    0

%

    0

%

Expected volatility

    46

%

    45

%

Risk-free interest rate

    5.3

%

    4.8

%

Contractual term of up to (months)

    6       6  

 

v3.24.2.u1
Note 12 - Derivatives and Hedging Activities
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Derivative Instruments and Hedging Activities Disclosure [Text Block]

NOTE 12:

DERIVATIVES AND HEDGING ACTIVITIES

 

The Company follows the requirements of FASB ASC No. 815,” Derivatives and Hedging” which requires companies to recognize all of their derivative instruments as either assets or liabilities in the statement of financial position at fair value. The accounting for changes in fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging transaction and further, on the type of hedging transaction. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. Due to the Company’s global operations, it is exposed to foreign currency exchange rate fluctuations in the normal course of its business. The Company’s treasury policy allows it to offset the risks associated with the effects of certain foreign currency exposures through the purchase of foreign exchange forward or option contracts (“Hedging Contracts”). The policy, however, prohibits the Company from speculating on such Hedging Contracts for profit. To protect against the increase in value of forecasted foreign currency cash flow resulting from salaries paid in currencies other than the U.S. dollar during the year, the Company instituted a foreign currency cash flow hedging program. The Company hedges portions of the anticipated payroll of its non-U.S. employees denominated in the currencies other than the U.S. dollar for a period of one to twelve months with Hedging Contracts. Accordingly, when the dollar strengthens against the foreign currencies, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the Hedging Contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency expenses is offset by gains in the fair value of the Hedging Contracts. These Hedging Contracts are designated as cash flow hedges.

 

For derivative instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. As of June 30, 2024, and December 31, 2023, the notional principal amount of the Hedging Contracts to sell U.S. dollars held by the Company was $5,900 and $16,500, respectively.

 

The fair value of the Company’s outstanding derivative instruments is as follows:

 

   

June 30, 2024

(unaudited)

   

December 31,

2023

 

Derivative assets:

               

Derivatives designated as cash flow hedging instruments:

               

Foreign exchange forward contracts

  $ 51     $ 988  

Total

  $ 51     $ 988  
                 

Derivative liabilities:

               

Derivatives designated as cash flow hedging instruments:

               

Foreign exchange option contracts

  $ 9     $  

Total

  $ 9     $  

 

The increase (decrease) in unrealized gains (losses) recognized in “accumulated other comprehensive gain (loss)” on derivatives, before tax effect, is as follows:

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Derivatives designated as cash flow hedging instruments:

                               

Foreign exchange option contracts

  $ 16     $ (198 )   $ 16     $ (93 )

Foreign exchange forward contracts

    (355 )     (432 )     (160 )     (112 )
    $ (339 )   $ (630 )   $ (144 )   $ (205 )

 

The net (gains) losses reclassified from “accumulated other comprehensive gain (loss)” into income are as follows:

 

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Derivatives designated as cash flow hedging instruments:

                               

Foreign exchange option contracts

  $ (25 )   $ 112     $ (25 )   $ 112  

Foreign exchange forward contracts

    (582 )     462       (202 )     291  
    $ (607 )   $ 574     $ (227 )   $ 403  

 

The Company recorded in cost of revenues and operating expenses a net gain of $227 and $607 during the three and six months ended June 30, 2024, respectively, and a net loss of $403 and $574 during the comparable periods of 2023, related to its Hedging Contracts. 

v3.24.2.u1
Note 13 - Accumulated Other Comprehensive Loss
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Comprehensive Income (Loss) Note [Text Block]

NOTE 13:

ACCUMULATED OTHER COMPREHENSIVE LOSS

 

The following tables summarize the changes in accumulated balances of other comprehensive income (loss), net of taxes:

 

   

Six months ended June 30, 2024 (unaudited)

   

Three months ended June 30, 2024 (unaudited)

 
   

Unrealized

gains

(losses) on

available-

for-

sale

marketable

securities

   

Unrealized

gains

(losses)

on cash

flow hedges

   

Total

   

Unrealized

gains

(losses) on

available-

for-

sale

marketable

securities

   

Unrealized

gains

(losses)

on cash

flow hedges

   

Total

 
                                                 

Beginning balance

  $ (3,317 )   $ 988     $ (2,329 )   $ (3,133 )   $ 413     $ (2,720 )

Other comprehensive income (loss) before reclassifications

    391       (340 )     51       203       (145 )     58  

Amounts reclassified from accumulated other comprehensive loss

    (10 )     (606 )     (616 )     (6 )     (226 )     (232 )

Net current period other comprehensive income (loss)

    381       (946 )     (565 )     197       (371 )     (174 )

Ending balance

  $ (2,936 )   $ 42     $ (2,894 )   $ (2,936 )   $ 42     $ (2,894 )

 

   

Six months ended June 30, 2023 (unaudited)

   

Three months ended June 30, 2023 (unaudited)

 
   

Unrealized

gains

(losses) on

available-

for-

sale

marketable

securities

   

Unrealized

gains

(losses)

on cash

flow hedges

   

Total

   

Unrealized

gains

(losses) on

available

for-

sale

marketable

securities

   

Unrealized

gains

(losses) on

cash

flow hedges

   

Total

 
                                                 

Beginning balance

  $ (6,142 )   $ (107 )   $ (6,249 )   $ (5,550 )   $ (360 )   $ (5,910 )

Other comprehensive income (loss) before reclassifications

    798       (631 )     167       114       (205 )    

(91

)

Amounts reclassified from accumulated other comprehensive loss

    (77 )     576       499       15       403       418  

Net current period other comprehensive income (loss)

    721       (55 )     666       129       198       327  

Ending balance

  $ (5,421 )   $ (162 )   $ (5,583 )   $ (5,421 )   $ (162 )   $ (5,583 )

 

 

The following table provides details about reclassifications out of accumulated other comprehensive income (loss):

 

Details about Accumulated

Other Comprehensive Income

(Loss) Components

 

Amount Reclassified from Accumulated Other

Comprehensive Income (Loss)

 

Affected Line Item in the

Statements of Income (Loss)

                                   
   

Six months ended June 30,

   

Three months ended June 30,

   
   

2024
(unaudited)

   

2023
(unaudited)

   

2024
(unaudited)

   

2023
(unaudited)

   

Unrealized gains (losses) on cash flow hedges

  $ 13     $ (11 )  

$

5     $ (7 )

Cost of revenues

      518       (495 )     194       (348 )

Research and development

      15       (13 )     6       (9 )

Sales and marketing

      61       (55 )     22       (39 )

General and administrative

      607       (574 )     227       (403 )

Total, before income taxes

      1       2       1        

Income tax expense (benefit)

      606       (576 )     226       (403 )

Total, net of income taxes

Unrealized gains (losses) on available-for-sale marketable securities

    10       76       6       (16 )

Financial income (loss), net

            (1

)

          (1 )

Income tax benefit

      10       77       6       (15 )

Total, net of income taxes

    $ 616     $ (499 )  

$

232     $ (418 )

Total, net of income taxes

 

 

v3.24.2.u1
Note 14 - Share Repurchase Program
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Treasury Stock [Text Block]

NOTE 14:

SHARE REPURCHASE PROGRAM

 

During the three and six months ended June 30, 2024, the Company repurchased 100,431 and 157,303 shares of common stock at an average purchase price of $19.89 and $20.83 per share, respectively, for an aggregate purchase price of $1,998 and $3,276, respectively. The Company did not repurchase any shares of common stock during the three and six months ended June 30, 2023. As of June 30, 2024, 542,697 shares of common stock remained available for repurchase pursuant to the Company’s share repurchase program.

 

The repurchases of common stock are accounted for as treasury stock, and result in a reduction of stockholders’ equity. When treasury shares are reissued, the Company accounts for the reissuance in accordance with FASB ASC No. 505-30, “Treasury Stock” and charges the excess of the repurchase cost over issuance price using the weighted average method to retained earnings. The purchase cost is calculated based on the specific identified method. In the case where the repurchase cost over issuance price using the weighted average method is lower than the issuance price, the Company credits the difference to additional paid-in capital.

 

 

 

 

v3.24.2.u1
Insider Trading Arrangements
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Insider Trading Arr Line Items    
Material Terms of Trading Arrangement [Text Block]  

Item 5

OTHER INFORMATION

 

During the three months ended June 30, 2024, no director or officer (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

 

 

Rule 10b5-1 Arrangement Adopted [Flag] false  
Rule 10b5-1 Arrangement Terminated [Flag] false  
Non-Rule 10b5-1 Arrangement Adopted [Flag] false  
Non-Rule 10b5-1 Arrangement Terminated [Flag] false  
v3.24.2.u1
Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation

 

The interim condensed consolidated financial statements have been prepared according to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).

 

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2024, are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

 

The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2023, contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 7, 2024, have been applied consistently in these unaudited interim condensed consolidated financial statements.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

Concentration of credit risk:

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, bank deposits, marketable securities, foreign exchange contracts and trade receivables. The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines relating to diversification and maturities to maintain safety and liquidity of the investments.

 

The majority of the Company’s cash and cash equivalents are invested in high grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits may be redeemed on demand and therefore minimal credit risk exists with respect to them. Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. Generally, these cash equivalents may be redeemed upon demand, and therefore management believes that they bear a lower risk. The short-term bank deposits are held in financial institutions that management believes are institutions with high credit standing and, accordingly, minimal credit risk from geographic or credit concentration. Furthermore, the Company holds an investment portfolio consisting principally of corporate bonds. The Company has the ability to hold such investments until recovery of temporary declines in market value or maturity.

 

The Company’s trade receivables are geographically diverse, mainly in the Asia Pacific region, and also in the United States and Europe. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers and to date has not experienced any material losses. The Company makes estimates of expected credit losses for based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers.

 

The Company has no off-balance-sheet concentration of credit risk.

New Accounting Pronouncements, Policy [Policy Text Block]

Accounting Standards Recently Adopted by the Company

 

In June 2022, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The guidance is effective for annual periods beginning after December 15, 2023, with early adoption permitted. The Company adopted ASU 2022-03 as of January 1, 2024. The adoption did not result in a material impact on the Company's interim condensed financial statements.

 

Accounting Standards Recently Issued, Not Yet Adopted by the Company

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07.

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

 

The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, the reported amounts of revenues and expenses during the reporting period, and amounts classified as a discontinued operation. Actual results could differ from those estimates.

v3.24.2.u1
Note 4 - Held for Sale and Discontinued Operation (Tables)
6 Months Ended
Jun. 30, 2024
Notes Tables  
Disposal Groups, Including Discontinued Operations [Table Text Block]
   

Six months ended June 30, 2023

(unaudited)

   

Three months ended June 30, 2023

(unaudited)

 

Revenues

  $ 5,723     $ 3,250  

Cost of revenue

    3,855       2,048  

Gross profit

    1,868       1,202  

Operating expenses:

               

Research and development, net

    3,655       1,538  

Sales and marketing

    489       163  

General and administrative

    479       258  

Amortization of intangible assets

    349       174  

Total operating expenses

    4,972       2,133  

Operating loss

    (3,104 )     (931 )

Financial income, net

    3       3  

Loss from discontinued operations before taxes on income

    (3,101 )     (928 )

Income tax expense

           

Net loss from discontinued operation

  $ (3,101 )   $ (928 )
   

Six months

ended

June 30, 2023

(unaudited)

 

Net cash flows used in operating activities (*)

  $ (1,902 )
v3.24.2.u1
Note 5 - Revenue Recognition (Tables)
6 Months Ended
Jun. 30, 2024
Notes Tables  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]
   

Remainder of 2024

   

2025

   

2026 and

thereafter

 

Licensing and related revenues

  $ 9,352     $ 3,134     $ 449  
Disaggregation of Revenue [Table Text Block]
   

Six months ended June 30, 2024 (unaudited)

   

Three months ended June 30, 2024 (unaudited)

 
   

Licensing and

related revenues

   

Royalties

   

Total

   

Licensing and

related revenues

   

Royalties

   

Total

 

Geography

                                               

United States

  $ 811     $ 3,092     $ 3,903     $ 428     $ 937     $ 1,365  

Europe and Middle East

    6,845       2,109       8,954       6,244       1,198       7,442  

Asia Pacific

    21,023       16,616       37,639       10,606       9,024       19,630  

Other

    13             13                    

Total

  $ 28,692     $ 21,817     $ 50,509     $ 17,278     $ 11,159     $ 28,437  
                                                 

Use cases for the Company’s technology portfolio

                                               

Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT)

  $ 26,323     $ 16,732     $ 43,055     $ 16,256     $ 8,793     $ 25,049  

Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI)

    2,369       5,085       7,454       1,022       2,366       3,388  

Total

  $ 28,692     $ 21,817     $ 50,509     $ 17,278     $ 11,159     $ 28,437  
                                                 

Timing of revenue recognition

                                               

Products transferred at a point in time

  $ 24,723     $ 21,817     $ 46,540     $ 15,270     $ 11,159     $ 26,429  

Products and services transferred over time

    3,969             3,969       2,008             2,008  

Total

  $ 28,692     $ 21,817     $ 50,509     $ 17,278     $ 11,159     $ 28,437  
   

Six months ended June 30, 2023 (unaudited)

   

Three months ended June 30, 2023 (unaudited)

 
   

Licensing and

related revenues

   

Royalties

   

Total

   

Licensing and

related revenues

   

Royalties

   

Total

 

Geography

                                               

United States

  $ 1,039     $ 3,061     $ 4,100     $ 337     $ 1,411     $ 1,748  

Europe and Middle East

    3,581       1,312       4,893       1,631       453       2,084  

Asia Pacific

    26,677       13,012       39,689       11,556       7,507       19,063  

Other

    502             502       27             27  

Total

  $ 31,799     $ 17,385     $ 49,184     $ 13,551     $ 9,371     $ 22,922  
                                                 

Use cases for the Company’s technology portfolio

                                               

Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT)

  $ 27,667     $ 12,445     $ 40,112     $ 11,743     $ 6,780     $ 18,523  

Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI)

    4,132       4,940       9,072       1,808       2,591       4,399  

Total

  $ 31,799     $ 17,385     $ 49,184     $ 13,551     $ 9,371     $ 22,922  
                                                 

Timing of revenue recognition

                                               

Products transferred at a point in time

  $ 25,024     $ 17,385     $ 42,409     $ 10,403     $ 9,371     $ 19,774  

Products and services transferred over time

    6,775             6,775       3,148             3,148  

Total

  $ 31,799     $ 17,385     $ 49,184     $ 13,551     $ 9,371     $ 22,922  
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]
   

June 30, 2024

   

December 31,

2023

 
                 

Currents assets (classified under Trade receivables):

               

Trade receivables

  $ 18,298     $ 8,433  

Unbilled receivables (associated with licensing and related revenue)

    6,497       9,735  

Unbilled receivables (associated with royalties)

    10,860       12,139  

Total current assets

    35,655       30,307  
                 

Long-term assets (classified under Other long-term assets)

               

Unbilled receivables (associated with licensing and related revenue)

    2,139        
                 

Deferred revenues (short-term contract liabilities)

    2,830       3,018  
v3.24.2.u1
Note 6 - Leases (Tables)
6 Months Ended
Jun. 30, 2024
Notes Tables  
Lease, Cost [Table Text Block]
   

June 30, 2024

(Unaudited)

 

Weighted average remaining lease term (years)

    3.87  

Weighted average discount rates

    3.94

%

   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

   

2023

   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

   

(unaudited)

   

(unaudited)

 
                                 

Operating lease cost

  $ 1,357     $ 1,502     $ 694     $ 749  

Cash payments for operating leases

    1,309       1,484       687       757  
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]

The remainder of 2024

 

$

1,426  

2025

    2,037  

2026

    895  

2027

    638  

2028

    330  

2029 and thereafter

    618  

Total undiscounted cash flows

    5,944  

Less imputed interest

    365  

Present value of lease liabilities

  $ 5,579  
v3.24.2.u1
Note 7 - Marketable Securities (Tables)
6 Months Ended
Jun. 30, 2024
Notes Tables  
Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]
   

June 30, 2024 (Unaudited)

 
   

Amortized
cost

   

Gross
unrealized
gains

   

Gross
unrealized
losses

   

Fair
value

 

Available-for-sale - matures within one year:

                               

Corporate bonds

  $ 51,319     $ 19     $ (673 )   $ 50,665  
                                 

Available-for-sale - matures after one year through three years:

                               

Corporate bonds

    83,558       91       (2,712 )     80,937  

Total

                               
    $ 134,877     $ 110     $ (3,385 )   $ 131,602  
   

December 31, 2023

 
   

Amortized
cost

   

Gross
unrealized
gains

   

Gross
unrealized
losses

   

Fair
value

 

Available-for-sale - matures within one year:

                               

Corporate bonds

  $ 27,690     $ 4     $ (243 )   $ 27,451  
                                 

Available-for-sale - matures after one year through three years:

                               

Corporate bonds

    108,700       278       (3,734 )     105,244  
                                 

Total

  $ 136,390     $ 282     $ (3,977 )   $ 132,695  
Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]
   

Less than 12 months

   

12 months or greater

 
   

Fair value

   

Gross

unrealized

loss

   

Fair value

   

Gross

unrealized

loss

 

As of June 30, 2024 (unaudited)

  $ 37,893     $ (237 )   $ 73,923     $ (3,148 )

As of December 31, 2023

  $ 18,193     $ (49 )   $ 86,643     $ (3,928 )
Schedule of Realized Gain (Loss) [Table Text Block]
   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

   

2023

   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

   

(unaudited)

   

(unaudited)

 
                                 

Gross realized gains from sale of available-for-sale marketable securities

  $ 15     $ 92     $ 6     $  

Gross realized losses from sale of available-for-sale marketable securities

  $ (5 )   $ (16 )   $     $ (16 )
v3.24.2.u1
Note 8 - Fair Value Measurement (Tables)
6 Months Ended
Jun. 30, 2024
Notes Tables  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

Description

 

June 30, 2024

(unaudited)

   

Level I

(unaudited)

   

Level II (unaudited)

   

Level III (unaudited)

 

Assets:

                               

Marketable securities:

                               

Corporate bonds

  $ 131,602     $     $ 131,602     $  

Foreign exchange contracts

    51             51        

Investments in marketable equity securities

    288       288              
                                 

Liabilities:

                               

Foreign exchange contracts

  $ 9     $     $ 9     $  

Description

 

December 31, 2023

   

Level I

   

Level II

   

Level III

 

Assets:

                               

Marketable securities:

                               

Corporate bonds

  $ 132,695     $     $ 132,695     $  

Foreign exchange contracts

    988             988        

Investments in marketable equity securities

    406       406              
v3.24.2.u1
Note 9 - Geographic Information and Major Customer Data (Tables)
6 Months Ended
Jun. 30, 2024
Notes Tables  
Revenue from External Customers by Geographic Areas [Table Text Block]
   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Revenues based on customer location:

                               

United States

  $ 3,903     $ 4,100     $ 1,365     $ 1,748  

Europe and Middle East (2)

    8,954       4,893       7,442       2,084  

Asia Pacific (1)

    37,639       39,689       19,630       19,063  

Other

    13       502             27  
    $ 50,509     $ 49,184     $ 28,437     $ 22,922  
                                 

(1) China

  $ 29,025     $ 30,477     $ 15,433     $ 12,714  

(2) Finland

  $ 6,645     $ * )   $ 6,455     $ * )
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 
                                 

Customer A

    13 %     * )     13 %     14 %

Customer B

    13 %     * )     23 %     * )

Customer C

    13 %     * )     21 %     * )

Customer D

    * )     * )     * )     14 %

Customer E

    * )     * )     * )     10 %
v3.24.2.u1
Note 10 - Net Loss Per Share of Common Stock (Tables)
6 Months Ended
Jun. 30, 2024
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Numerator:

                               

Net loss from continuing operations

  $ (5,739 )   $ (7,589 )   $ (291 )   $ (4,890 )

Net loss from discontinued operations

          (3,101 )           (928 )

Net loss

  $ (5,739 )   $ (10,690 )   $ (291 )   $ (5,818 )

Denominator (in thousands):

                               

Basic and diluted weighted-average common stock outstanding

    23,568       23,405       23,628       23,476  
                                 

Basic and diluted net loss per share from continuing operations

  $ (0.24 )   $ (0.32 )   $ (0.01 )   $ (0.21 )

Basic and diluted net loss per share from discontinued operations

  $       (0.13 )   $     $ (0.04 )

Basic and diluted net loss per share

  $ (0.24 )   $ (0.45 )   $ (0.01 )   $ (0.25 )
v3.24.2.u1
Note 11 - Common Stock and Stock-based Compensation Plans (Tables)
6 Months Ended
Jun. 30, 2024
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
   

Number of
options

   

Weighted
average

exercise
price

   

Weighted
average remaining
contractual

term

   

Aggregate
intrinsic

value

 

Outstanding as of December 31, 2023

    99,425     $ 20.74       2.5     $ 316  

Granted

    10,600       19.61                  

Exercised

    (26,000 )     14.77                  

Forfeited or expired

                           

Outstanding as of June 30, 2024 (unaudited)

    84,025     $ 22.45       3.2     $ 0  

Exercisable as of June 30, 2024 (unaudited)

    54,000     $ 23.30       1.5     $ 0  
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
   

Number of
RSUs and

PSUs

   

Weighted

Average Grant-

Date
Fair Value

 

Unvested as of December 31, 2023

    1,281,751     $ 24.97  

Granted

    693,378       18.18  

Vested

    (286,976

)

    32.22  

Forfeited or expired

    (142,032

)

    20.58  

Unvested as of June 30, 2024 (unaudited)

    1,546,121     $ 20.97  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Cost of revenue

  $ 394     $ 420     $ 191     $ 214  

Research and development, net

    4,445       4,446       2,438       2,344  

Sales and marketing

    816       827       451       449  

General and administrative

    1,816       1,758       820       897  

Total equity-based compensation expense from continuing operations

    7,471       7,451       3,900       3,904  

Equity-based compensation expense included in discontinued operations

          613             301  

Total equity-based compensation expense

  $ 7,471     $ 8,064     $ 3,900     $ 4,205  
Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]
   

Six months ended
June 30

 
   

2024

(unaudited)

   

2023

(unaudited)

 

Expected dividend yield

    0

%

    0

%

Expected volatility

    46

%

    45

%

Risk-free interest rate

    5.3

%

    4.8

%

Contractual term of up to (months)

    6       6  
v3.24.2.u1
Note 12 - Derivatives and Hedging Activities (Tables)
6 Months Ended
Jun. 30, 2024
Notes Tables  
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]
   

June 30, 2024

(unaudited)

   

December 31,

2023

 

Derivative assets:

               

Derivatives designated as cash flow hedging instruments:

               

Foreign exchange forward contracts

  $ 51     $ 988  

Total

  $ 51     $ 988  
                 

Derivative liabilities:

               

Derivatives designated as cash flow hedging instruments:

               

Foreign exchange option contracts

  $ 9     $  

Total

  $ 9     $  
   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Derivatives designated as cash flow hedging instruments:

                               

Foreign exchange option contracts

  $ 16     $ (198 )   $ 16     $ (93 )

Foreign exchange forward contracts

    (355 )     (432 )     (160 )     (112 )
    $ (339 )   $ (630 )   $ (144 )   $ (205 )
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]
   

Six months ended
June 30,

   

Three months ended
June 30,

 
   

2024

(unaudited)

   

2023

(unaudited)

   

2024

(unaudited)

   

2023

(unaudited)

 

Derivatives designated as cash flow hedging instruments:

                               

Foreign exchange option contracts

  $ (25 )   $ 112     $ (25 )   $ 112  

Foreign exchange forward contracts

    (582 )     462       (202 )     291  
    $ (607 )   $ 574     $ (227 )   $ 403  
v3.24.2.u1
Note 13 - Accumulated Other Comprehensive Loss (Tables)
6 Months Ended
Jun. 30, 2024
Notes Tables  
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
   

Six months ended June 30, 2024 (unaudited)

   

Three months ended June 30, 2024 (unaudited)

 
   

Unrealized

gains

(losses) on

available-

for-

sale

marketable

securities

   

Unrealized

gains

(losses)

on cash

flow hedges

   

Total

   

Unrealized

gains

(losses) on

available-

for-

sale

marketable

securities

   

Unrealized

gains

(losses)

on cash

flow hedges

   

Total

 
                                                 

Beginning balance

  $ (3,317 )   $ 988     $ (2,329 )   $ (3,133 )   $ 413     $ (2,720 )

Other comprehensive income (loss) before reclassifications

    391       (340 )     51       203       (145 )     58  

Amounts reclassified from accumulated other comprehensive loss

    (10 )     (606 )     (616 )     (6 )     (226 )     (232 )

Net current period other comprehensive income (loss)

    381       (946 )     (565 )     197       (371 )     (174 )

Ending balance

  $ (2,936 )   $ 42     $ (2,894 )   $ (2,936 )   $ 42     $ (2,894 )
   

Six months ended June 30, 2023 (unaudited)

   

Three months ended June 30, 2023 (unaudited)

 
   

Unrealized

gains

(losses) on

available-

for-

sale

marketable

securities

   

Unrealized

gains

(losses)

on cash

flow hedges

   

Total

   

Unrealized

gains

(losses) on

available

for-

sale

marketable

securities

   

Unrealized

gains

(losses) on

cash

flow hedges

   

Total

 
                                                 

Beginning balance

  $ (6,142 )   $ (107 )   $ (6,249 )   $ (5,550 )   $ (360 )   $ (5,910 )

Other comprehensive income (loss) before reclassifications

    798       (631 )     167       114       (205 )    

(91

)

Amounts reclassified from accumulated other comprehensive loss

    (77 )     576       499       15       403       418  

Net current period other comprehensive income (loss)

    721       (55 )     666       129       198       327  

Ending balance

  $ (5,421 )   $ (162 )   $ (5,583 )   $ (5,421 )   $ (162 )   $ (5,583 )
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]

Details about Accumulated

Other Comprehensive Income

(Loss) Components

 

Amount Reclassified from Accumulated Other

Comprehensive Income (Loss)

 

Affected Line Item in the

Statements of Income (Loss)

                                   
   

Six months ended June 30,

   

Three months ended June 30,

   
   

2024
(unaudited)

   

2023
(unaudited)

   

2024
(unaudited)

   

2023
(unaudited)

   

Unrealized gains (losses) on cash flow hedges

  $ 13     $ (11 )  

$

5     $ (7 )

Cost of revenues

      518       (495 )     194       (348 )

Research and development

      15       (13 )     6       (9 )

Sales and marketing

      61       (55 )     22       (39 )

General and administrative

      607       (574 )     227       (403 )

Total, before income taxes

      1       2       1        

Income tax expense (benefit)

      606       (576 )     226       (403 )

Total, net of income taxes

Unrealized gains (losses) on available-for-sale marketable securities

    10       76       6       (16 )

Financial income (loss), net

            (1

)

          (1 )

Income tax benefit

      10       77       6       (15 )

Total, net of income taxes

    $ 616     $ (499 )  

$

232     $ (418 )

Total, net of income taxes

v3.24.2.u1
Note 3 - Acquisition (Details Textual) - VisiSonics [Member]
$ in Thousands
1 Months Ended
Jan. 31, 2024
USD ($)
Asset Acquisition, Percentage of Equity Shares Acquired 100.00%
Asset Acquisition, Consideration Transferred $ 750
Asset Acquisition, Contingent Consideration, Liability $ 2,100
v3.24.2.u1
Note 4 - Held for Sale and Discontinued Operation (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 14, 2023
Jun. 30, 2023
Jun. 30, 2023
Amortization of intangible assets   $ 174 $ 349
Discontinued Operations [Member]      
Amortization of intangible assets     $ 982
Intrinsix Corp. [Member]      
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred $ 240    
Intrinsix Corp. [Member]      
Sale of Stock, Consideration 35,000    
Sale of Stock, Amount Held for Post Closing Price Adjustment 300    
Sale of Stock, Amount Held for Indemnification Obligations $ 3,500    
v3.24.2.u1
Note 4 - Held for Sale and Discontinued Operation - Schedule of Disposal Groups Including Discontinued Operations (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenues   $ 3,250   $ 5,723
Net cash flows used in operating activities [1]       (1,902)
Cost of revenue   2,048   3,855
Gross profit   1,202   1,868
Research and development, net   1,538   3,655
Sales and marketing   163   489
General and administrative   258   479
Amortization of intangible assets   174   349
Total operating expenses   2,133   4,972
Operating loss   (931)   (3,104)
Financial income, net   3   3
Loss from discontinued operations before taxes on income   (928)   (3,101)
Income tax expense   0   0
Net loss from discontinued operation $ 0 $ (928) $ 0 $ (3,101)
[1] (*) Amortization and depreciation allocated to discontinued operation for the six-month period ended June 30, 2023 amounted to $982.
v3.24.2.u1
Note 5 - Revenue Recognition (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Contract with Customer, Liability, Revenue Recognized $ 744 $ 1,924
v3.24.2.u1
Note 5 - Revenue Recognition - Remaining Performance Obligation 2 (Details)
$ in Thousands
Jun. 30, 2024
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year) 6 months
Licensing, NRE and related revenues $ 9,352
Revenue, Remaining Performance Obligation, Amount $ 9,352
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year) 1 year
Licensing, NRE and related revenues $ 3,134
Revenue, Remaining Performance Obligation, Amount $ 3,134
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year) 1 year
Licensing, NRE and related revenues $ 449
Revenue, Remaining Performance Obligation, Amount $ 449
v3.24.2.u1
Note 5 - Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenue $ 28,437 $ 22,922 $ 50,509 $ 49,184
Transferred at Point in Time [Member]        
Revenue 26,429 19,774 46,540 42,409
Transferred over Time [Member]        
Revenue 2,008 3,148 3,969 6,775
Connectivity Products [Member]        
Revenue 25,049 18,523 43,055 40,112
Smart Sensing Products [Member]        
Revenue 3,388 4,399 7,454 9,072
UNITED STATES        
Revenue 1,365 1,748 3,903 4,100
Europe and Middle East [Member]        
Revenue [1] 7,442 2,084 8,954 4,893
Asia Pacific [Member]        
Revenue [2] 19,630 19,063 37,639 39,689
Other [Member]        
Revenue 0 27 13 502
License [Member]        
Revenue 17,278 13,551 28,692 31,799
License [Member] | Transferred at Point in Time [Member]        
Revenue 15,270 10,403 24,723 25,024
License [Member] | Transferred over Time [Member]        
Revenue 2,008 3,148 3,969 6,775
License [Member] | Connectivity Products [Member]        
Revenue 16,256 11,743 26,323 27,667
License [Member] | Smart Sensing Products [Member]        
Revenue 1,022 1,808 2,369 4,132
License [Member] | UNITED STATES        
Revenue 428 337 811 1,039
License [Member] | Europe and Middle East [Member]        
Revenue 6,244 1,631 6,845 3,581
License [Member] | Asia Pacific [Member]        
Revenue 10,606 11,556 21,023 26,677
License [Member] | Other [Member]        
Revenue 0 27 13 502
Royalty [Member]        
Revenue 11,159 9,371 21,817 17,385
Royalty [Member] | Transferred at Point in Time [Member]        
Revenue 11,159 9,371 21,817 17,385
Royalty [Member] | Transferred over Time [Member]        
Revenue   0   0
Royalty [Member] | Connectivity Products [Member]        
Revenue 8,793 6,780 16,732 12,445
Royalty [Member] | Smart Sensing Products [Member]        
Revenue 2,366 2,591 5,085 4,940
Royalty [Member] | UNITED STATES        
Revenue 937 1,411 3,092 3,061
Royalty [Member] | Europe and Middle East [Member]        
Revenue 1,198 453 2,109 1,312
Royalty [Member] | Asia Pacific [Member]        
Revenue $ 9,024 7,507 $ 16,616 13,012
Royalty [Member] | Other [Member]        
Revenue   $ 0   $ 0
[1] Finland
[2] China
v3.24.2.u1
Note 5 - Revenue Recognition - Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Total current assets $ 35,655 $ 30,307
Deferred revenues 2,830 3,018
Trade Receivables [Member]    
Trade receivables 18,298 8,433
Accrued Revenues [Member] | Licensing and Other [Member]    
Trade receivables 6,497 9,735
Accrued Revenues [Member] | Royalty [Member]    
Trade receivables 10,860 12,139
Other Noncurrent Assets [Member] | Licensing and Other [Member]    
Trade receivables 2,139 0
Deferred Revenue [Member]    
Deferred revenues $ 2,830 $ 3,018
v3.24.2.u1
Note 6 - Leases -Lease Cost (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Weighted average remaining lease term (years) (Year) 3 years 10 months 13 days   3 years 10 months 13 days  
Operating lease cost $ 694 $ 749 $ 1,357 $ 1,502
Weighted average discount rates 3.94%   3.94%  
Cash payments for operating leases $ 687 $ 757 $ 1,309 $ 1,484
v3.24.2.u1
Note 6 - Leases - Maturities of Lease Liabilities (Details)
$ in Thousands
Jun. 30, 2024
USD ($)
The remainder of 2024 $ 1,426
2024 2,037
2025 895
2026 638
2027 330
2028 and thereafter 618
Total undiscounted cash flows 5,944
Less imputed interest 365
Present value of lease liabilities $ 5,579
v3.24.2.u1
Note 7 - Marketable Securities - Available-for-sale Marketable Securities (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Marketable securities $ 131,602 $ 132,695
Corporate Bonds [Member]    
Available For Sale Securities Debt Maturities Within One Year Amortized Cost 51,319 27,690
Available-for-sale - matures within one year, Gross unrealized gains 19 4
Available-for-sale - matures within one year, Gross unrealized losses (673) (243)
Available-for-sale- matures within one year, Fair Value 50,665 27,451
Available-for-sale - matures after one year through five years, amortized cost 83,558 108,700
Available-for-sale - matures after one year through five years, Gross unrealized gains 91 278
Available for Sale Matures after One Year Through Five Years, Gross Unrealized Loss (2,712) (3,734)
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value 80,937 105,244
Debt Securities, Available-for-Sale, Amortized Cost 134,877 136,390
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax 110 282
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax (3,385) (3,977)
Marketable securities $ 131,602 $ 132,695
v3.24.2.u1
Note 7 - Marketable Securities - Summary of Gross Unrealized Losses and Fair Values on Investments (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Less than 12 months, Fair value $ 37,893 $ 18,193
Less than 12 months, Gross unrealized loss 237 49
12 months or greater, Fair value 73,923 86,643
12 months or greater, Gross unrealized loss $ 3,148 $ 3,928
v3.24.2.u1
Note 7 - Marketable Securities - Summary of Gross Realized Gains and Losses from Sale of Available-for-sale Marketable Securities (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Gross realized gains from sale of available-for-sale marketable securities $ 6 $ 0 $ 15 $ 92
Gross realized losses from sale of available-for-sale marketable securities $ 0 $ (16) $ (5) $ (16)
v3.24.2.u1
Note 8 - Fair Value Measurement - Assets and Liabilities Measured at Fair Value (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Corporate bonds $ 131,602 $ 132,695
Foreign exchange contracts 51 988
Investments in marketable equity securities 288 406
Foreign exchange contracts 9  
Fair Value, Inputs, Level 1 [Member]    
Foreign exchange contracts 0 0
Investments in marketable equity securities 288 406
Foreign exchange contracts 0  
Fair Value, Inputs, Level 2 [Member]    
Foreign exchange contracts 51 988
Investments in marketable equity securities 0 0
Foreign exchange contracts 9  
Fair Value, Inputs, Level 3 [Member]    
Foreign exchange contracts 0 0
Investments in marketable equity securities 0 0
Foreign exchange contracts 0  
Corporate Bonds [Member]    
Corporate bonds 131,602 132,695
Corporate Bonds [Member] | Fair Value, Inputs, Level 1 [Member]    
Corporate bonds 0 0
Corporate Bonds [Member] | Fair Value, Inputs, Level 2 [Member]    
Corporate bonds 131,602 132,695
Corporate Bonds [Member] | Fair Value, Inputs, Level 3 [Member]    
Corporate bonds $ 0 $ 0
v3.24.2.u1
Note 9 - Geographic Information and Major Customer Data (Details Textual)
6 Months Ended
Jun. 30, 2024
Number of Reportable Segments 1
v3.24.2.u1
Note 9 - Geographic Information and Major Customer Data - Revenues Based On Customer Location (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenue $ 28,437 $ 22,922 $ 50,509 $ 49,184
UNITED STATES        
Revenue 1,365 1,748 3,903 4,100
Europe and Middle East [Member]        
Revenue [1] 7,442 2,084 8,954 4,893
Asia Pacific [Member]        
Revenue [2] 19,630 19,063 37,639 39,689
Other [Member]        
Revenue 0 27 13 502
CHINA        
Revenue 15,433 $ 12,714 29,025 $ 30,477
FINLAND        
Revenue $ 6,455   $ 6,645  
[1] Finland
[2] China
v3.24.2.u1
Note 9 - Geographic Information and Major Customer Data - Major Customers Data As Percentage of Total Revenues (Details) - Revenue from Contract with Customer Benchmark [Member] - Customer Concentration Risk [Member]
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Customer A [Member]      
Percentage of total revenues 13.00% 14.00% 13.00%
Customer B [Member]      
Percentage of total revenues 23.00%   13.00%
Customer C [Member]      
Percentage of total revenues 21.00%   13.00%
Customer D [Member]      
Percentage of total revenues   14.00%  
Customer E [Member]      
Percentage of total revenues   10.00%  
v3.24.2.u1
Note 10 - Net Loss Per Share of Common Stock (Details Textual) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 1,630,146 1,350,825 1,630,146 1,350,825
v3.24.2.u1
Note 10 - Net Loss Per Share of Common Stock - Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Net loss from continuing operations $ (291) $ (4,890) $ (5,739) $ (7,589)
Net loss from discontinued operations 0 (928) 0 (3,101)
Net loss: $ (291) $ (5,818) $ (5,739) $ (10,690)
Basic and diluted (in shares) 23,628 23,476 23,568 23,405
Basic and diluted (in dollars per share) $ (0.01) $ (0.21) $ (0.24) $ (0.32)
Basic and diluted net loss per share from discontinued operation (in dollars per share) 0 (0.04) 0 (0.13)
Basic and diluted net loss per share (in dollars per share) $ (0.01) $ (0.25) $ (0.24) $ (0.45)
v3.24.2.u1
Note 11 - Common Stock and Stock-based Compensation Plans (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Feb. 12, 2024
Jun. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Options and Stock Appreciation Rights, Outstanding Number (in shares) 84,025   84,025 84,025 99,425
Chief Financial Officer [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded   5,344      
Chief Operating Officer [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded   4,372      
Chief Commercial Officer [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded   3,609      
Share-Based Payment Arrangement, Option [Member]          
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 278   $ 278 $ 278  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition       2 years 2 months 12 days  
Restricted Stock Units (RSUs) [Member] | Vesting on February 17, 2024 [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   33.40%      
Restricted Stock Units (RSUs) [Member] | Vesting on February 17, 2025 [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   33.30%      
Restricted Stock Units (RSUs) [Member] | Vesting on February 17, 2026 [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   33.30%      
Restricted Stock Units (RSUs) [Member] | Employees [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period     3 years    
Restricted Stock Units (RSUs) [Member] | Non-employee Director [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 2 years        
Restricted Stock Units (RSUs) [Member] | Non-employee Director [Member] | Share-Based Payment Arrangement, Tranche One [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 1 year        
Short-Term Executive PSUs [Member] | Goals One [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage   90.00%      
Short-Term Executive PSUs [Member] | Goals One [Member] | Full Vesting Based on The Achievement of 2022 License Target [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   50.00%      
Short-Term Executive PSUs [Member] | Goals One [Member] | Increase in Eligible PSUs, Percent [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage   2.00%      
Short-Term Executive PSUs [Member] | Goals Two [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   25.00%      
Short-Term Executive PSUs [Member] | Goals Two [Member] | Increase in Eligible PSUs, Percent [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage   2.00%      
Short-Term Executive PSUs [Member] | Goals Two [Member] | Vesting Based on Actual Return Being at Least 90 Percent of S&P500 Index [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   25.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage   90.00%      
Short-Term Executive PSUs [Member] | Goals Two [Member] | Vesting Based on Actual Return In Excess of 100 Percent of S&P500 Index [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage   100.00%      
Short-Term Executive PSUs [Member] | Goals Three [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   25.00%      
Short-Term Executive PSUs [Member] | Goals Three [Member] | Increase in Eligible PSUs, Percent [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage   2.00%      
Short-Term Executive PSUs [Member] | Goals Three [Member] | Full Vesting Based on The Achievement of Positive Shareholder Return [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   25.00%      
Short-Term Executive PSUs [Member] | Goals Three [Member] | Vesting Based on Actual Return Being at Least 90 Percent of Russel 2000 Index [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage   90.00%      
Short-Term Executive PSUs [Member] | Goals Three [Member] | Vesting Based on Actual Return In Excess of 100 Percent of Russel 2000 Index [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage   100.00%      
Short-Term Executive PSUs [Member] | Vesting on February 16, 2025 [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   33.40%      
Short-Term Executive PSUs [Member] | Vesting on February 16, 2026 [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   33.30%      
Short-Term Executive PSUs [Member] | Vesting on February 16, 2027 [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   33.30%      
Short-Term Executive PSUs [Member] | Chief Executive Officer [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded, Percentage   60.00%      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded   29,986      
Short-Term Executive PSUs [Member] | Chief Executive Officer [Member] | Goals One [Member] | Increase in Eligible PSUs, Percent [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage   3.00%      
Short-Term Executive PSUs [Member] | Chief Executive Officer [Member] | Goals Two [Member] | Increase in Eligible PSUs, Percent [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage   3.00%      
Short-Term Executive PSUs [Member] | Chief Executive Officer [Member] | Goals Three [Member] | Increase in Eligible PSUs, Percent [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage   3.00%      
Short-Term Executive PSUs [Member] | CFO, COO, and CCO [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded, Percentage   40.00%      
RSUs and PSUs [Member]          
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 23,955   $ 23,955 $ 23,955  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition       1 year 7 months 6 days  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period       693,378  
Maximum [Member] | Short-Term Executive PSUs [Member] | Goals One [Member] | Vesting Based on Achievement In Excess of 90 Percent [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   99.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage   99.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage   120.00%      
Maximum [Member] | Short-Term Executive PSUs [Member] | Goals Two [Member] | Vesting Based on Actual Return Being at Least 90 Percent of S&P500 Index [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   99.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage   99.00%      
Maximum [Member] | Short-Term Executive PSUs [Member] | Goals Two [Member] | Vesting Based on Actual Return In Excess of 100 Percent of S&P500 Index [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage   120.00%      
Maximum [Member] | Short-Term Executive PSUs [Member] | Goals Three [Member] | Vesting Based on Actual Return Being at Least 90 Percent of Russel 2000 Index [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   99.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage   99.00%      
Maximum [Member] | Short-Term Executive PSUs [Member] | Goals Three [Member] | Vesting Based on Actual Return In Excess of 100 Percent of Russel 2000 Index [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage   120.00%      
Minimum [Member] | Short-Term Executive PSUs [Member] | Goals One [Member] | Vesting Based on Achievement In Excess of 90 Percent [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   91.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage   1.00%      
Minimum [Member] | Short-Term Executive PSUs [Member] | Goals Two [Member] | Vesting Based on Actual Return Being at Least 90 Percent of S&P500 Index [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   91.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage   90.00%      
Minimum [Member] | Short-Term Executive PSUs [Member] | Goals Two [Member] | Vesting Based on Actual Return In Excess of 100 Percent of S&P500 Index [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage   1.00%      
Minimum [Member] | Short-Term Executive PSUs [Member] | Goals Three [Member] | Vesting Based on Actual Return Being at Least 90 Percent of Russel 2000 Index [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   91.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage   90.00%      
Minimum [Member] | Short-Term Executive PSUs [Member] | Goals Three [Member] | Vesting Based on Actual Return In Excess of 100 Percent of Russel 2000 Index [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage   1.00%      
The2011 Stock Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Options and Stock Appreciation Rights Vesting Percentage, Year One 25.00%   25.00% 25.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Remaining Vesting Period       36 months  
The2011 Stock Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Non-employee Director [Member] | Vesting After the First Anniversary Grant Date [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   50.00%      
The2011 Stock Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Chief Executive Officer [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period   33,318      
The2011 Stock Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Chief Financial Officer [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period   20,043      
The2011 Stock Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Chief Operating Officer [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period   16,399      
The2011 Stock Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Chief Commercial Officer [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period   13,535      
The2011 Stock Incentive Plan [Member] | Performance Share Units [Member] | Chief Executive Officer [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period   49,978      
The2011 Stock Incentive Plan [Member] | Performance Share Units [Member] | Chief Financial Officer [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period   13,362      
The2011 Stock Incentive Plan [Member] | Performance Share Units [Member] | Chief Operating Officer [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period   10,932      
The2011 Stock Incentive Plan [Member] | Performance Share Units [Member] | Chief Commercial Officer [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period   9,023      
The2011 Stock Incentive Plan [Member] | Maximum [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period       4 years  
Share-Based Payment Arrangement, Employee [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Options and Stock Appreciation Rights, Outstanding Number (in shares) 0   0 0 0
v3.24.2.u1
Note 11 - Common Stock and Stock-based Compensation Plans - Summary of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Outstanding, Number of shares (in shares) 99,425  
Outstanding, Weighted average exercise price (in dollars per share) $ 20.74  
Outstanding, Weighted average remaining contractual term (Year) 3 years 2 months 12 days 2 years 6 months
Outstanding, Aggregated intrinsic value $ 0 $ 316
Granted (in shares) 10,600,000  
Granted (in dollars per share) $ 19.61  
Exercised, Number of shares (in shares) (26,000)  
Exercised, Weighted average exercise price (in dollars per share) $ 14.77  
Outstanding, Number of shares (in shares) 84,025 99,425
Outstanding, Weighted average exercise price (in dollars per share) $ 22.45 $ 20.74
Exercisable, Number of shares (in shares) 54,000  
Exercisable, Weighted average exercise price (in dollars per share) $ 23.3  
Exercisable, Weighted average remaining contractual term (Year) 1 year 6 months  
Exercisable, Aggregated intrinsic value $ 0  
v3.24.2.u1
Note 11 - Common Stock and Stock-based Compensation Plans - Summary of Restricted Stock Units Activity (Details) - RSUs and PSUs [Member]
6 Months Ended
Jun. 30, 2024
$ / shares
shares
Unvested, number (in shares) | shares 1,281,751
Unvested, weighted average fair value (in dollars per share) | $ / shares $ 24.97
Granted, number (in shares) | shares 693,378
Granted, weighted average fair value (in dollars per share) | $ / shares $ 18.18
Vested, number (in shares) | shares (286,976)
Vested, weighted average fair value (in dollars per share) | $ / shares $ 32.22
Forfeited or expired, number (in shares) | shares (142,032)
Forfeited or expired, weighted average fair value (in dollars per share) | $ / shares $ 20.58
Unvested, number (in shares) | shares 1,546,121
Unvested, weighted average fair value (in dollars per share) | $ / shares $ 20.97
v3.24.2.u1
Note 11 - Common Stock and Stock-based Compensation Plans - Equity-based Compensation Expense Included in Interim Condensed Consolidated Statements of Income (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Total equity-based compensation expense $ 3,900 $ 4,205 $ 7,471 $ 8,064
Cost of Revenues [Member]        
Total equity-based compensation expense 191 214 394 420
Research and Development, Net [Member]        
Total equity-based compensation expense 2,438 2,344 4,445 4,446
Sales and Marketing [Member]        
Total equity-based compensation expense 451 449 816 827
General and Administrative [Member]        
Total equity-based compensation expense 820 897 1,816 1,758
Total Equity-based Compensation Expense From Continuing Operations [Member]        
Total equity-based compensation expense 3,900 3,904 7,471 7,451
Equity-based Compensation Expense Included in Discontinued Operations [Member]        
Total equity-based compensation expense $ 0 $ 301 $ 0 $ 613
v3.24.2.u1
Note 11 - Common Stock and Stock-based Compensation Plans - Valuation Assumptions (Details) - The 2002 Employee Stock Purchase Plan [Member] - Purchase Rights [Member]
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Expected dividend yield   0.00%
Expected volatility 46.00%  
Expected volatility   45.00%
Risk-free interest rate 5.30%  
Risk-free interest rate   4.80%
Contractual term of (months) (Month) 6 months 6 months
v3.24.2.u1
Note 12 - Derivatives and Hedging Activities (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Derivative, Notional Amount $ 5,900   $ 5,900   $ 16,500
Derivative, Gain (Loss) on Derivative, Net $ 227 $ 403 $ 607 $ 574  
v3.24.2.u1
Note 12 - Derivatives and Hedging Activities - Effective Portion of the Gains and Losses on Derivative Instruments Designated (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Changes in unrealized gains (losses) $ (144) $ (205) $ (339) $ (630)  
Foreign exchange forward contracts 51   51   $ 988
Foreign exchange option contracts 9   9    
Cash Flow Hedging [Member]          
Changes in unrealized gains (losses) (144) (205) (339) (630)  
Derivative assets 51   51   988
Derivative liabilities 9   9   0
Cash Flow Hedging [Member] | Foreign Exchange Option [Member]          
Changes in unrealized gains (losses) 16 (93) 16 (198)  
Foreign exchange option contracts 9   9   0
Cash Flow Hedging [Member] | Foreign Exchange Forward [Member]          
Changes in unrealized gains (losses) (160) $ (112) (355) $ (432)  
Foreign exchange forward contracts $ 51   $ 51   $ 988
v3.24.2.u1
Note 12 - Derivatives and Hedging Activities - Net (Gains) Losses Reclassified from Accumulated Other Comprehensive Loss (Details) - Derivatives Designated as Cash Flow Hedging Instruments [Member] - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Gain (loss) reclassified from accumulated OCI into income, Effective portion, Net, Total $ (227) $ 403 $ (607) $ 574
Foreign Exchange Option Contracts [Member]        
Gain (loss) reclassified from accumulated OCI into income, Effective portion, Net, Total (25) 112 (25) 112
Foreign Exchange Forward Contracts [Member]        
Gain (loss) reclassified from accumulated OCI into income, Effective portion, Net, Total $ (202) $ 291 $ (582) $ 462
v3.24.2.u1
Note 13 - Accumulated Other Comprehensive Loss - Changes in Accumulated Balances of Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Balance $ 262,349 $ 259,870 $ 264,341 $ 258,871
Balance 263,786 258,584 263,786 258,584
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]        
Balance (3,133) (5,550) (3,317) (6,142)
Other comprehensive income (loss) before reclassifications 203 114 391 798
Amounts reclassified from accumulated other comprehensive loss (6) (15) (10) 77
Amounts reclassified from accumulated other comprehensive loss 6 15 10 (77)
Net current period other comprehensive income (loss) 197 129 381 721
Balance (2,936) (5,421) (2,936) (5,421)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]        
Balance 413 (360) 988 (107)
Other comprehensive income (loss) before reclassifications (145) (205) (340) (631)
Amounts reclassified from accumulated other comprehensive loss (226) (403) (606) (576)
Amounts reclassified from accumulated other comprehensive loss 226 403 606 576
Net current period other comprehensive income (loss) (371) 198 (946) (55)
Balance 42 (162) 42 (162)
AOCI Attributable to Parent [Member]        
Balance (2,720) (5,910) (2,329) (6,249)
Other comprehensive income (loss) before reclassifications 58 (91) 51 167
Amounts reclassified from accumulated other comprehensive loss (232) (418) (616) (499)
Amounts reclassified from accumulated other comprehensive loss 232 418 616 499
Net current period other comprehensive income (loss) (174) 327 (565) 666
Balance $ (2,894) $ (5,583) $ (2,894) $ (5,583)
v3.24.2.u1
Note 13 - Accumulated Other Comprehensive Loss - Reclassifications Out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Cost of Revenues $ (2,933) $ (3,524) $ (5,436) $ (7,032)
Research and development (18,758) (18,056) (36,749) (36,730)
Sales and marketing (3,095) (2,632) (5,911) (5,351)
General and administrative (3,537) (3,911) (7,109) (7,738)
Total, before income taxes 1,313 (4,344) (2,450) (5,626)
Income tax expense (benefit) 1,604 546 3,289 1,963
Net loss (291) (5,818) (5,739) (10,690)
Financial income, net 1,406 1,118 2,663 2,573
Reclassification out of Accumulated Other Comprehensive Income [Member]        
Net loss 232 (418) 616 (499)
Unrealized Gains (Losses) on Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]        
Cost of Revenues 5 (7) 13 (11)
Research and development 194 (348) 518 (495)
Sales and marketing 6 (9) 15 (13)
General and administrative 22 (39) 61 (55)
Total, before income taxes 227 (403) 607 (574)
Income tax expense (benefit) 1 0 1 2
Net loss 226 (403) 606 (576)
Unrealized Gains (Losses) on Available-for-sale Marketable Securities [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]        
Income tax expense (benefit) 0 (1) 0 (1)
Net loss 6 (15) 10 77
Financial income, net $ 6 $ (16) $ 10 $ 76
v3.24.2.u1
Note 14 - Share Repurchase Program (Details Textual) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Treasury Stock, Shares, Acquired 100,431 0 157,303 0
Shares Acquired, Average Cost Per Share (in dollars per share) $ 19.89   $ 20.83  
Treasury Stock Value Acquired Weighted Average Method $ 1,998   $ 3,276  
Share Repurchase Program, Remaining Authorized, Number of Shares 542,697   542,697  

CEVA (NASDAQ:CEVA)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more CEVA Charts.
CEVA (NASDAQ:CEVA)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more CEVA Charts.